Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific nTPM"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific nTPM"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific nTPM"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific nTPM"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific nTPM"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific nTPM"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific nTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific nTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Blood expression cluster"	"Tissue expression cluster"	"Cell line expression cluster"	"Single cell expression cluster"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [nTPM]"	"Tissue RNA - adrenal gland [nTPM]"	"Tissue RNA - amygdala [nTPM]"	"Tissue RNA - appendix [nTPM]"	"Tissue RNA - basal ganglia [nTPM]"	"Tissue RNA - bone marrow [nTPM]"	"Tissue RNA - breast [nTPM]"	"Tissue RNA - cerebellum [nTPM]"	"Tissue RNA - cerebral cortex [nTPM]"	"Tissue RNA - cervix [nTPM]"	"Tissue RNA - choroid plexus [nTPM]"	"Tissue RNA - colon [nTPM]"	"Tissue RNA - duodenum [nTPM]"	"Tissue RNA - endometrium 1 [nTPM]"	"Tissue RNA - epididymis [nTPM]"	"Tissue RNA - esophagus [nTPM]"	"Tissue RNA - fallopian tube [nTPM]"	"Tissue RNA - gallbladder [nTPM]"	"Tissue RNA - heart muscle [nTPM]"	"Tissue RNA - hippocampal formation [nTPM]"	"Tissue RNA - hypothalamus [nTPM]"	"Tissue RNA - kidney [nTPM]"	"Tissue RNA - liver [nTPM]"	"Tissue RNA - lung [nTPM]"	"Tissue RNA - lymph node [nTPM]"	"Tissue RNA - medulla oblongata [nTPM]"	"Tissue RNA - midbrain [nTPM]"	"Tissue RNA - ovary [nTPM]"	"Tissue RNA - pancreas [nTPM]"	"Tissue RNA - parathyroid gland [nTPM]"	"Tissue RNA - pituitary gland [nTPM]"	"Tissue RNA - placenta [nTPM]"	"Tissue RNA - pons [nTPM]"	"Tissue RNA - prostate [nTPM]"	"Tissue RNA - rectum [nTPM]"	"Tissue RNA - retina [nTPM]"	"Tissue RNA - salivary gland [nTPM]"	"Tissue RNA - seminal vesicle [nTPM]"	"Tissue RNA - skeletal muscle [nTPM]"	"Tissue RNA - skin 1 [nTPM]"	"Tissue RNA - small intestine [nTPM]"	"Tissue RNA - smooth muscle [nTPM]"	"Tissue RNA - spinal cord [nTPM]"	"Tissue RNA - spleen [nTPM]"	"Tissue RNA - stomach 1 [nTPM]"	"Tissue RNA - testis [nTPM]"	"Tissue RNA - thalamus [nTPM]"	"Tissue RNA - thymus [nTPM]"	"Tissue RNA - thyroid gland [nTPM]"	"Tissue RNA - tongue [nTPM]"	"Tissue RNA - tonsil [nTPM]"	"Tissue RNA - urinary bladder [nTPM]"	"Tissue RNA - vagina [nTPM]"	"Tissue RNA - white matter [nTPM]"	"Cell RNA - A-431 [nTPM]"	"Cell RNA - A549 [nTPM]"	"Cell RNA - AF22 [nTPM]"	"Cell RNA - AN3-CA [nTPM]"	"Cell RNA - ASC diff [nTPM]"	"Cell RNA - ASC TERT1 [nTPM]"	"Cell RNA - BEWO [nTPM]"	"Cell RNA - BJ [nTPM]"	"Cell RNA - BJ hTERT+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [nTPM]"	"Cell RNA - CACO-2 [nTPM]"	"Cell RNA - CAPAN-2 [nTPM]"	"Cell RNA - Daudi [nTPM]"	"Cell RNA - EFO-21 [nTPM]"	"Cell RNA - fHDF/TERT166 [nTPM]"	"Cell RNA - GAMG [nTPM]"	"Cell RNA - HaCaT [nTPM]"	"Cell RNA - HAP1 [nTPM]"	"Cell RNA - HBEC3-KT [nTPM]"	"Cell RNA - HBF TERT88 [nTPM]"	"Cell RNA - HDLM-2 [nTPM]"	"Cell RNA - HEK 293 [nTPM]"	"Cell RNA - HEL [nTPM]"	"Cell RNA - HeLa [nTPM]"	"Cell RNA - Hep G2 [nTPM]"	"Cell RNA - HHSteC [nTPM]"	"Cell RNA - HL-60 [nTPM]"	"Cell RNA - HMC-1 [nTPM]"	"Cell RNA - HSkMC [nTPM]"	"Cell RNA - hTCEpi [nTPM]"	"Cell RNA - hTEC/SVTERT24-B [nTPM]"	"Cell RNA - hTERT-HME1 [nTPM]"	"Cell RNA - hTERT-RPE1 [nTPM]"	"Cell RNA - HUVEC TERT2 [nTPM]"	"Cell RNA - JURKAT [nTPM]"	"Cell RNA - K-562 [nTPM]"	"Cell RNA - Karpas-707 [nTPM]"	"Cell RNA - LHCN-M2 [nTPM]"	"Cell RNA - MCF7 [nTPM]"	"Cell RNA - MOLT-4 [nTPM]"	"Cell RNA - NB-4 [nTPM]"	"Cell RNA - NTERA-2 [nTPM]"	"Cell RNA - OE19 [nTPM]"	"Cell RNA - PC-3 [nTPM]"	"Cell RNA - REH [nTPM]"	"Cell RNA - RH-30 [nTPM]"	"Cell RNA - RPMI-8226 [nTPM]"	"Cell RNA - RPTEC TERT1 [nTPM]"	"Cell RNA - RT4 [nTPM]"	"Cell RNA - SCLC-21H [nTPM]"	"Cell RNA - SH-SY5Y [nTPM]"	"Cell RNA - SiHa [nTPM]"	"Cell RNA - SK-BR-3 [nTPM]"	"Cell RNA - SK-MEL-30 [nTPM]"	"Cell RNA - SuSa [nTPM]"	"Cell RNA - T-47d [nTPM]"	"Cell RNA - THP-1 [nTPM]"	"Cell RNA - TIME [nTPM]"	"Cell RNA - U-138 MG [nTPM]"	"Cell RNA - U-2 OS [nTPM]"	"Cell RNA - U-2197 [nTPM]"	"Cell RNA - U-251 MG [nTPM]"	"Cell RNA - U-266/70 [nTPM]"	"Cell RNA - U-266/84 [nTPM]"	"Cell RNA - U-698 [nTPM]"	"Cell RNA - U-87 MG [nTPM]"	"Cell RNA - U-937 [nTPM]"	"Cell RNA - WM-115 [nTPM]"	"Blood RNA - basophil [nTPM]"	"Blood RNA - classical monocyte [nTPM]"	"Blood RNA - eosinophil [nTPM]"	"Blood RNA - gdT-cell [nTPM]"	"Blood RNA - intermediate monocyte [nTPM]"	"Blood RNA - MAIT T-cell [nTPM]"	"Blood RNA - memory B-cell [nTPM]"	"Blood RNA - memory CD4 T-cell [nTPM]"	"Blood RNA - memory CD8 T-cell [nTPM]"	"Blood RNA - myeloid DC [nTPM]"	"Blood RNA - naive B-cell [nTPM]"	"Blood RNA - naive CD4 T-cell [nTPM]"	"Blood RNA - naive CD8 T-cell [nTPM]"	"Blood RNA - neutrophil [nTPM]"	"Blood RNA - NK-cell [nTPM]"	"Blood RNA - non-classical monocyte [nTPM]"	"Blood RNA - plasmacytoid DC [nTPM]"	"Blood RNA - T-reg [nTPM]"	"Blood RNA - total PBMC [nTPM]"	"Brain RNA - amygdala [nTPM]"	"Brain RNA - basal ganglia [nTPM]"	"Brain RNA - cerebellum [nTPM]"	"Brain RNA - cerebral cortex [nTPM]"	"Brain RNA - hippocampal formation [nTPM]"	"Brain RNA - hypothalamus [nTPM]"	"Brain RNA - medulla oblongata [nTPM]"	"Brain RNA - midbrain [nTPM]"	"Brain RNA - pons [nTPM]"	"Brain RNA - spinal cord [nTPM]"	"Brain RNA - thalamus [nTPM]"	"Brain RNA - white matter [nTPM]"	"Single Cell Type RNA - Adipocytes [nTPM]"	"Single Cell Type RNA - Alveolar cells type 1 [nTPM]"	"Single Cell Type RNA - Alveolar cells type 2 [nTPM]"	"Single Cell Type RNA - Astrocytes [nTPM]"	"Single Cell Type RNA - B-cells [nTPM]"	"Single Cell Type RNA - Basal keratinocytes [nTPM]"	"Single Cell Type RNA - Basal prostatic cells [nTPM]"	"Single Cell Type RNA - Basal respiratory cells [nTPM]"	"Single Cell Type RNA - Basal squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Bipolar cells [nTPM]"	"Single Cell Type RNA - Breast glandular cells [nTPM]"	"Single Cell Type RNA - Breast myoepithelial cells [nTPM]"	"Single Cell Type RNA - Cardiomyocytes [nTPM]"	"Single Cell Type RNA - Cholangiocytes [nTPM]"	"Single Cell Type RNA - Club cells [nTPM]"	"Single Cell Type RNA - Collecting duct cells [nTPM]"	"Single Cell Type RNA - Cone photoreceptor cells [nTPM]"	"Single Cell Type RNA - Cytotrophoblasts [nTPM]"	"Single Cell Type RNA - dendritic cells [nTPM]"	"Single Cell Type RNA - Distal enterocytes [nTPM]"	"Single Cell Type RNA - Distal tubular cells [nTPM]"	"Single Cell Type RNA - Ductal cells [nTPM]"	"Single Cell Type RNA - Early spermatids [nTPM]"	"Single Cell Type RNA - Endometrial ciliated cells [nTPM]"	"Single Cell Type RNA - Endometrial stromal cells [nTPM]"	"Single Cell Type RNA - Endothelial cells [nTPM]"	"Single Cell Type RNA - Enteroendocrine cells [nTPM]"	"Single Cell Type RNA - Erythroid cells [nTPM]"	"Single Cell Type RNA - Excitatory neurons [nTPM]"	"Single Cell Type RNA - Exocrine glandular cells [nTPM]"	"Single Cell Type RNA - Extravillous trophoblasts [nTPM]"	"Single Cell Type RNA - Fibroblasts [nTPM]"	"Single Cell Type RNA - Gastric mucus-secreting cells [nTPM]"	"Single Cell Type RNA - Glandular and luminal cells [nTPM]"	"Single Cell Type RNA - granulocytes [nTPM]"	"Single Cell Type RNA - Granulosa cells [nTPM]"	"Single Cell Type RNA - Hepatic stellate cells [nTPM]"	"Single Cell Type RNA - Hepatocytes [nTPM]"	"Single Cell Type RNA - Hofbauer cells [nTPM]"	"Single Cell Type RNA - Horizontal cells [nTPM]"	"Single Cell Type RNA - Inhibitory neurons [nTPM]"	"Single Cell Type RNA - Intestinal goblet cells [nTPM]"	"Single Cell Type RNA - Ionocytes [nTPM]"	"Single Cell Type RNA - Kupffer cells [nTPM]"	"Single Cell Type RNA - Langerhans cells [nTPM]"	"Single Cell Type RNA - Late spermatids [nTPM]"	"Single Cell Type RNA - Leydig cells [nTPM]"	"Single Cell Type RNA - Macrophages [nTPM]"	"Single Cell Type RNA - Melanocytes [nTPM]"	"Single Cell Type RNA - Microglial cells [nTPM]"	"Single Cell Type RNA - monocytes [nTPM]"	"Single Cell Type RNA - Muller glia cells [nTPM]"	"Single Cell Type RNA - NK-cells [nTPM]"	"Single Cell Type RNA - Oligodendrocyte precursor cells [nTPM]"	"Single Cell Type RNA - Oligodendrocytes [nTPM]"	"Single Cell Type RNA - Pancreatic endocrine cells [nTPM]"	"Single Cell Type RNA - Paneth cells [nTPM]"	"Single Cell Type RNA - Peritubular cells [nTPM]"	"Single Cell Type RNA - Plasma cells [nTPM]"	"Single Cell Type RNA - Prostatic glandular cells [nTPM]"	"Single Cell Type RNA - Proximal enterocytes [nTPM]"	"Single Cell Type RNA - Proximal tubular cells [nTPM]"	"Single Cell Type RNA - Respiratory ciliated cells [nTPM]"	"Single Cell Type RNA - Rod photoreceptor cells [nTPM]"	"Single Cell Type RNA - Sertoli cells [nTPM]"	"Single Cell Type RNA - Skeletal myocytes [nTPM]"	"Single Cell Type RNA - Smooth muscle cells [nTPM]"	"Single Cell Type RNA - Spermatocytes [nTPM]"	"Single Cell Type RNA - Spermatogonia [nTPM]"	"Single Cell Type RNA - Squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Suprabasal keratinocytes [nTPM]"	"Single Cell Type RNA - Syncytiotrophoblasts [nTPM]"	"Single Cell Type RNA - T-cells [nTPM]"	"Single Cell Type RNA - Theca cells [nTPM]"	"Single Cell Type RNA - Undifferentiated cells [nTPM]"	"Single Cell Type RNA - Urothelial cells [nTPM]"
ABI3BP	"DKFZP586L2024, NESHBP, TARSH"	ENSG00000154175	"ABI family member 3 binding protein"	Q7Z7G0	3	100749156-100993515	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 57.7;Fibroblasts: 213.8;Leydig cells: 97.3;Muller glia cells: 93.7;Skeletal myocytes: 106.8"	"Cancer enhanced"	"Detected in many"		"renal cancer: 10.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 437.3;hTEC/SVTERT24-B: 840.8;hTERT-HME1: 818.4;TIME: 1405.8;U-2197: 311.0"	"Group enriched"	"Detected in many"	4	"amygdala: 4.2;basal ganglia: 15.9;cerebellum: 5.5;cerebral cortex: 13.9;olfactory bulb: 12.0"	"Low region specificity"	"Detected in all"			HPA044127	Uncertain				"Secreted in other tissues"	NA	NA		550000000		"Cluster 46: Fibroblasts - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 50: Fibroblasts - ECM organization"			"HPA044127: AB_2678823"	"unprognostic (4.32e-2)"	"unprognostic (3.32e-2)"	"unprognostic (6.36e-2)"	"unprognostic (3.41e-1)"	"unprognostic (1.70e-1)"	"unprognostic (7.20e-2)"	"unprognostic (7.58e-2)"	"unprognostic (6.25e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.08e-1)"	"unprognostic (9.46e-2)"	"prognostic favorable (6.14e-4)"	"unprognostic (2.27e-2)"	"unprognostic (2.69e-2)"	"unprognostic (6.59e-2)"	"unprognostic (1.07e-3)"	41.3	9.9	3.9	57.0	9.7	0.2	23.1	0.8	4.1	56.4	3.1	36.5	5.3	49.5	10.7	35.1	46.9	97.9	44.5	3.8	26.6	12.2	7.8	68.7	25.9	3.4	5.7	89.4	12.7	3.0	4.7	51.9	7.3	8.7	56.2	57.5	13.7	12.3	6.7	14.0	15.4	72.0	5.6	12.4	25.5	17.1	6.7	7.9	25.0	41.1	39.9	96.7	23.7	9.1	1.3	0.3	0.1	0.0	37.0	437.3	0.4	91.9	90.2	171.4	79.9	0.0	0.2	0.9	0.4	25.0	0.3	0.0	0.1	1.0	278.2	0.8	0.7	2.4	1.6	0.0	23.7	0.5	0.1	26.6	1.0	840.8	818.4	3.6	267.1	0.0	0.5	1.3	158.6	0.0	0.5	0.3	0.1	0.0	87.5	0.4	0.7	0.7	54.0	0.2	0.2	0.6	0.0	0.6	0.1	0.8	0.3	0.1	1405.8	37.7	0.4	311.0	19.7	1.0	0.0	0.0	43.7	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	9.7	0.8	4.1	3.8	26.6	3.4	5.7	7.3	5.6	6.7	9.1	9.1	57.7	5.5	26.1	0.3	15.9	1.5	5.8	4.6	1.2	0.6	1.8	9.7	10.0	39.8	18.4	2.1	0.5	0.1	0.4	0.0	0.3	10.3	1.2	30.6	23.6	1.2	0.0	2.6	0.4	0.4	213.8	9.7	2.4	3.8	0.2	16.1	0.1	0.9	0.0	47.0	0.8	0.0	0.6	23.2	8.8	97.3	1.8	19.6	7.5	0.0	93.7	0.0	1.5	3.3	1.9	5.4	27.8	0.7	1.5	0.2	9.0	5.0	3.7	0.0	106.8	17.5	0.1	0.3	3.9	19.9	0.7	2.1	3.6	1.0	2.9
ADAMTSL2	KIAA0605	ENSG00000197859	"ADAMTS like 2"	Q86TH1	9	133532164-133575519	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 73.2;liver: 35.8"	"Cell type enhanced"	"Detected in some"		"Distal tubular cells: 5.9;Endothelial cells: 5.7;Fibroblasts: 8.5;Microglial cells: 12.2;Sertoli cells: 6.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 7.4;RPMI-8226: 10.1;SH-SY5Y: 30.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA045634, HPA053812"	Approved		Approved	Vesicles	"Secreted in other tissues"	NA	NA		170000000		"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 50: Fibroblasts - ECM organization"	Vesicles		"HPA045634: AB_2679399, HPA053812: AB_2682271"	"unprognostic (5.10e-2)"	"unprognostic (1.50e-2)"	"prognostic unfavorable (5.01e-4)"	"unprognostic (8.35e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.50e-2)"	"unprognostic (6.78e-3)"	"unprognostic (1.31e-2)"	"unprognostic (5.49e-2)"	"unprognostic (1.35e-1)"	"prognostic favorable (6.70e-4)"	"unprognostic (5.17e-2)"	"unprognostic (7.37e-2)"	"unprognostic (1.56e-1)"	"unprognostic (3.40e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.42e-1)"	3.7	28.5	6.8	1.0	7.3	0.1	1.5	12.0	10.1	2.3	1.4	2.7	1.4	3.1	3.1	1.8	3.1	2.5	73.2	5.8	7.9	25.9	35.8	23.2	3.4	19.3	11.1	4.9	7.1	1.2	15.9	1.5	20.8	8.4	0.3	0.3	3.4	2.2	4.3	0.8	3.2	0.9	8.5	6.4	2.3	3.1	9.3	0.6	12.1	0.5	0.6	5.3	1.6	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	7.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.6	0.5	0.0	1.1	0.7	10.1	0.0	0.0	1.4	30.1	0.0	0.0	0.0	0.1	0.0	0.6	0.1	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.8	7.3	12.0	10.1	5.8	7.9	19.3	11.1	20.8	8.5	9.3	7.6	1.4	0.0	0.5	4.9	0.1	0.1	0.1	0.0	0.0	4.2	0.0	0.1	2.3	0.0	0.0	1.8	0.0	0.1	0.0	1.4	5.9	0.2	0.1	0.1	0.1	5.7	5.3	0.0	5.0	0.0	0.1	8.5	0.0	0.0	0.0	0.1	4.6	0.9	0.3	0.0	3.8	0.4	0.0	0.3	0.8	1.1	4.7	0.6	0.0	12.2	0.0	0.4	0.0	2.5	4.0	0.2	0.5	3.0	0.0	0.2	0.0	0.7	0.0	0.2	6.6	1.1	1.6	0.1	0.8	0.4	0.3	0.0	0.6	0.7	1.1	0.2
AEBP1	ACLP	ENSG00000106624	"AE binding protein 1"	Q8IUX7	7	44104345-44114562	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Transcription, Transcription regulation"	"Calmodulin-binding, DNA-binding, Repressor"	"Disease variant, Ehlers-Danlos syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 103.0;Fibroblasts: 263.2;Leydig cells: 151.6;Peritubular cells: 508.9;Smooth muscle cells: 173.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	5	"plasmacytoid DC: 7.6"	"Lineage enriched"	"Detected in many"	5	"dendritic cells: 7.6"	"Cell line enhanced"	"Detected in many"		"ASC diff: 141.1;BJ: 193.0;BJ hTERT+: 126.0;fHDF/TERT166: 208.9;JURKAT: 145.0;WM-115: 117.9"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"spinal cord: 57.6"	"CAB009966, HPA047724, HPA063595, HPA064970"	Supported		Supported	Nucleoplasm,Vesicles,Cytosol	"Secreted - unknown location"	NA	NA		2700000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Vesicles	"Nucleoplasm, Cytosol"	"CAB009966: AB_2225690, HPA047724: AB_2680132, HPA063595: AB_2685052, HPA064970: AB_2685394"	"unprognostic (1.70e-2)"	"unprognostic (5.42e-2)"	"unprognostic (1.66e-2)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (1.60e-4)"	"unprognostic (1.13e-1)"	"unprognostic (7.00e-2)"	"unprognostic (8.79e-2)"	"unprognostic (2.52e-1)"	"unprognostic (3.27e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.94e-1)"	"prognostic unfavorable (9.31e-9)"	"unprognostic (2.88e-3)"	"unprognostic (9.58e-2)"	"unprognostic (1.17e-2)"	"unprognostic (6.28e-3)"	190.5	59.9	45.0	59.8	56.0	10.6	153.0	38.6	44.8	312.1	28.0	95.3	19.2	268.8	59.6	65.7	199.8	155.9	156.7	47.3	92.9	68.7	20.3	166.0	45.5	114.7	81.5	253.7	28.9	10.1	43.3	89.0	79.6	112.1	25.0	1.3	50.7	213.5	21.3	84.8	79.1	119.3	74.3	54.4	71.2	40.4	52.1	73.3	83.7	14.1	16.7	138.7	198.0	66.6	0.6	0.0	44.5	0.1	141.1	49.6	1.0	193.0	126.0	21.6	4.5	0.0	0.1	5.3	20.9	208.9	0.2	0.1	2.4	3.5	9.1	0.6	0.0	13.3	0.1	0.0	39.6	0.1	0.3	75.8	0.0	72.9	0.1	1.1	9.7	145.0	8.3	0.3	0.0	0.2	86.9	16.1	19.1	0.0	0.4	71.3	1.7	1.7	5.0	0.0	4.9	25.3	0.1	0.3	85.9	41.9	0.4	14.4	34.1	0.0	86.2	0.5	0.3	1.0	0.9	102.8	0.4	0.2	117.9	0.0	0.0	0.0	0.3	0.0	0.2	1.5	0.2	0.0	0.0	1.4	0.9	0.5	0.0	0.1	0.0	7.6	0.0	0.3	45.0	56.0	38.6	44.8	47.3	92.9	114.7	81.5	79.6	74.3	52.1	66.6	23.6	0.0	2.5	32.3	11.8	34.5	5.7	1.3	1.8	0.8	2.0	14.6	26.4	1.5	1.4	7.3	0.0	2.0	22.7	0.0	0.0	0.9	3.1	3.3	103.0	18.0	0.0	1.3	0.1	0.0	3.3	263.2	8.6	2.9	2.5	33.3	30.4	0.6	3.6	0.0	0.3	0.0	0.0	1.8	42.0	18.0	151.6	3.2	85.4	17.8	1.0	0.2	1.0	6.0	0.3	0.4	0.0	508.9	9.7	16.9	0.0	2.2	2.2	0.8	39.5	23.6	173.4	4.0	4.6	1.5	27.4	3.4	4.8	28.7	0.0	2.4
ALDH1A2	RALDH2	ENSG00000128918	"Aldehyde dehydrogenase 1 family member A2"	O94788	15	57953424-58497866	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 82.2;fallopian tube: 74.5"	"Group enriched"	"Detected in many"	4	"Early spermatids: 115.7;Endometrial stromal cells: 142.2;Late spermatids: 48.7;Microglial cells: 42.2;Spermatocytes: 78.9"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"cerebral cortex: 13.1;hippocampal formation: 8.4"	"Immune cell enriched"	"Detected in some"	15	"neutrophil: 32.6"	"Lineage enriched"	"Detected in single"	62	"granulocytes: 32.6"	"Group enriched"	"Detected in some"	5	"AN3-CA: 402.4;HEK 293: 128.8;JURKAT: 387.2;K-562: 316.2;MOLT-4: 408.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA010022	Approved					NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 36: Stromal cells - Cell proliferation"			"HPA010022: AB_1844723"	"unprognostic (1.11e-2)"	"unprognostic (2.52e-2)"	"unprognostic (2.00e-1)"	"unprognostic (3.09e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.04e-4)"	"unprognostic (1.08e-1)"	"unprognostic (9.03e-3)"	"unprognostic (6.92e-3)"	"unprognostic (5.48e-2)"	"unprognostic (6.19e-2)"	"unprognostic (2.57e-3)"	"unprognostic (3.18e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.80e-3)"	21.3	3.9	1.9	2.9	1.4	4.0	5.9	2.1	13.1	52.3	3.4	1.7	0.7	82.2	7.8	2.4	74.5	24.0	28.4	8.4	0.9	19.5	2.6	7.8	0.6	1.7	1.6	24.0	3.2	29.8	14.6	5.2	1.9	21.0	0.7	6.0	2.0	53.3	10.7	1.7	1.3	31.9	1.8	4.3	0.7	57.6	2.5	2.8	1.4	3.0	0.4	4.0	12.9	1.1	1.2	0.0	0.0	402.4	0.0	0.0	0.1	0.0	5.7	0.6	1.3	0.0	0.3	0.4	3.9	0.0	0.1	1.0	11.8	0.0	0.7	0.0	128.8	0.0	2.7	0.7	0.3	0.0	3.0	2.3	0.0	0.0	0.0	0.0	21.4	387.2	316.2	0.0	0.0	0.0	408.5	0.1	0.7	11.2	19.6	0.0	0.8	0.0	70.7	2.0	0.8	0.1	0.4	0.4	1.9	0.4	0.2	0.1	0.9	0.3	1.0	3.8	0.0	0.3	0.0	0.0	0.2	0.2	0.1	2.1	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.6	0.0	0.3	0.0	0.0	0.0	1.9	1.4	2.1	13.1	8.4	0.9	1.7	1.6	1.9	1.8	2.5	1.1	13.1	6.4	13.9	0.0	0.0	0.6	1.9	0.2	0.0	1.1	1.1	0.9	2.4	20.0	3.4	7.3	0.0	0.3	0.1	5.2	13.7	11.6	115.7	6.8	142.2	7.6	0.0	0.0	5.8	0.4	0.3	17.6	0.0	3.6	1.3	0.3	10.8	17.4	2.2	0.0	9.6	0.1	0.0	1.6	0.8	48.7	5.3	3.0	1.8	42.2	0.7	10.1	0.0	0.0	1.2	0.7	0.3	5.3	0.0	1.3	0.3	0.3	1.4	0.3	0.0	8.3	3.3	78.9	14.7	0.2	0.4	0.5	1.0	0.1	0.7	1.3
ANTXR1	"ATR, FLJ10601, FLJ21776, TEM8"	ENSG00000169604	"ANTXR cell adhesion molecule 1"	Q9H6X2	2	69013176-69249327	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		Receptor	Hypotrichosis	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 130.6;Endometrial stromal cells: 78.1;Oligodendrocyte precursor cells: 141.8;Skeletal myocytes: 111.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"LHCN-M2: 367.9;TIME: 240.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054785			Uncertain	Vesicles	"Intracellular and membrane"	NA	NA		11000000		"Cluster 89: Fibroblasts - ECM organization"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 33: Fibroblasts - ECM organization"	Vesicles		"HPA054785: "	"unprognostic (1.44e-1)"	"prognostic unfavorable (5.76e-4)"	"unprognostic (8.49e-2)"	"unprognostic (4.77e-2)"	"unprognostic (3.61e-1)"	"unprognostic (4.34e-2)"	"unprognostic (1.05e-1)"	"unprognostic (6.93e-2)"	"unprognostic (1.37e-1)"	"unprognostic (4.15e-3)"	"unprognostic (9.05e-3)"	"unprognostic (1.15e-1)"	"unprognostic (3.48e-3)"	"unprognostic (2.26e-3)"	"unprognostic (9.84e-2)"	"prognostic unfavorable (1.22e-5)"	"unprognostic (2.09e-2)"	38.7	63.1	25.7	20.3	24.1	0.2	32.7	26.6	16.1	77.8	70.2	32.7	12.9	81.4	25.2	33.9	44.1	114.6	39.9	27.9	69.2	11.0	8.2	44.8	12.1	42.5	49.5	107.2	6.7	35.4	14.6	78.8	45.6	47.9	21.4	9.5	28.6	55.4	11.3	39.3	20.2	62.1	36.5	28.3	14.5	11.7	38.3	10.5	43.3	24.0	13.0	52.3	42.4	36.6	36.8	39.5	36.4	33.9	162.7	78.8	0.6	57.1	115.6	63.2	51.5	0.4	3.0	0.0	31.6	147.4	41.7	31.7	30.7	33.8	59.9	0.1	24.4	9.5	90.5	11.9	71.1	7.6	5.1	129.7	13.4	55.5	36.4	140.9	17.3	19.4	6.7	0.1	367.9	15.2	22.1	0.5	35.8	0.0	26.5	0.1	186.3	0.6	13.8	27.9	21.1	91.0	104.3	0.5	37.5	23.7	11.0	2.3	240.4	71.3	61.6	72.1	59.6	0.2	0.1	0.2	37.3	6.7	32.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	25.7	24.1	26.6	16.1	27.9	69.2	42.5	49.5	45.6	36.5	38.3	36.6	4.7	6.4	20.0	130.6	0.0	49.5	21.1	15.4	17.6	1.7	7.9	13.8	6.8	0.0	8.3	0.0	0.0	0.7	0.1	0.0	0.0	1.5	37.9	5.5	78.1	4.3	0.0	0.0	61.9	2.6	1.9	68.2	0.0	11.7	1.3	22.1	3.3	0.1	4.0	0.0	64.3	0.0	4.1	0.8	19.8	33.9	42.6	2.9	24.9	40.3	0.6	13.6	0.0	141.8	1.3	1.1	0.0	67.7	1.2	10.1	0.0	0.1	9.9	0.8	19.7	111.7	59.6	5.2	2.7	4.6	23.4	1.4	1.7	26.4	0.0	8.9
ARHGAP22	RhoGAP2	ENSG00000128805	"Rho GTPase activating protein 22"	Q7Z5H3	10	48446036-48656265	"Predicted intracellular proteins"	"Angiogenesis, Differentiation, Transcription, Transcription regulation"	"Developmental protein, GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 22.6"	"Cell type enhanced"	"Detected in many"		"Late spermatids: 122.7;Microglial cells: 227.7;Oligodendrocyte precursor cells: 141.8;Oligodendrocytes: 200.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"classical monocyte: 1.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 68.8;LHCN-M2: 64.8;TIME: 66.2;U-87 MG: 82.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020696, HPA040391, HPA064439"	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 70: Brain - Nervous system development"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB020696: , HPA040391: AB_2676957, HPA064439: AB_2685266"	"unprognostic (1.87e-1)"	"unprognostic (3.98e-2)"	"unprognostic (2.38e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.07e-1)"	"unprognostic (6.74e-3)"	"unprognostic (4.81e-3)"	"unprognostic (2.78e-1)"	"unprognostic (1.66e-1)"	"unprognostic (3.03e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.02e-1)"	"prognostic unfavorable (2.16e-8)"	"unprognostic (7.40e-2)"	"unprognostic (1.60e-1)"	"unprognostic (9.39e-2)"	"unprognostic (3.66e-2)"	2.6	1.9	12.0	3.0	15.7	1.4	1.6	17.6	14.5	1.6	7.7	2.0	0.6	1.1	0.7	1.4	1.8	1.8	4.4	11.9	12.7	1.3	0.8	2.0	2.7	22.6	17.0	4.8	1.7	0.9	2.0	0.8	20.1	3.3	1.0	0.4	2.0	1.1	1.9	2.2	1.6	1.4	16.9	2.8	1.2	4.8	17.0	2.8	6.6	1.6	2.2	2.1	2.2	22.2	6.2	1.4	0.4	0.0	5.1	20.8	4.3	31.9	15.1	3.0	4.1	7.0	0.9	0.0	1.2	13.1	2.1	12.4	0.4	11.2	5.4	0.6	11.5	18.2	0.2	0.1	2.7	2.0	2.0	5.0	11.2	37.1	3.0	68.8	20.6	0.0	17.4	3.0	64.8	0.2	0.2	0.1	7.2	0.0	0.5	0.1	0.0	7.9	6.5	0.7	1.1	6.4	1.5	0.1	0.6	0.6	0.4	0.3	66.2	30.1	0.4	3.8	23.8	0.0	0.0	0.0	82.5	0.3	4.9	0.0	1.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	12.0	15.7	17.6	14.5	11.9	12.7	22.6	17.0	20.1	16.9	17.0	22.2	0.9	0.0	1.7	4.2	2.9	3.4	4.1	6.8	4.6	1.1	0.8	3.0	2.9	1.5	2.9	0.0	2.1	11.6	3.2	0.2	0.0	2.8	53.6	0.7	1.6	2.4	0.0	10.9	51.7	4.4	0.7	6.5	0.5	1.0	0.0	4.4	1.8	0.0	10.3	0.0	29.8	0.3	2.0	7.6	14.2	122.7	2.8	15.6	1.8	227.7	14.8	1.8	0.0	141.8	200.8	2.5	0.0	6.0	0.5	1.9	0.0	0.2	3.8	1.4	0.0	1.6	4.2	1.6	4.3	0.4	0.6	1.0	0.7	10.6	0.1	0.6
ARSJ	FLJ23548	ENSG00000180801	"Arylsulfatase family member J"	Q5FYB0	4	113900284-113979727	"Predicted intracellular proteins, Predicted secreted proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 35.3;Astrocytes: 44.1;Basal prostatic cells: 60.3;Prostatic glandular cells: 49.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 46.4;HUVEC TERT2: 42.2;LHCN-M2: 42.8;TIME: 53.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA036481, HPA036482"	Uncertain		Enhanced	"Actin filaments"	"Secreted in other tissues"	NA	NA				"Cluster 46: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Actin filaments"		"HPA036481: AB_2675146, HPA036482: AB_10672356"	"unprognostic (1.98e-1)"	"unprognostic (1.55e-2)"	"unprognostic (4.23e-1)"	"unprognostic (5.31e-1)"	"unprognostic (6.23e-2)"	"prognostic unfavorable (6.08e-4)"	"unprognostic (2.54e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.04e-1)"	"unprognostic (5.31e-2)"	"unprognostic (2.20e-1)"	"prognostic favorable (2.97e-6)"	"unprognostic (2.26e-1)"	"unprognostic (8.37e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.07e-2)"	1.8	1.3	1.5	1.3	1.1	0.0	1.0	5.0	1.4	4.5	0.2	2.4	0.6	2.0	0.9	3.1	2.8	3.6	2.5	1.2	0.9	2.7	1.7	3.3	0.6	0.9	1.1	2.0	1.1	3.0	0.7	4.3	0.7	3.9	3.3	0.6	5.8	2.2	0.2	0.7	0.7	2.2	0.6	0.2	3.5	0.1	1.9	1.5	0.7	0.6	0.3	3.8	2.1	1.1	2.7	5.3	0.6	0.0	10.1	20.5	0.0	46.4	35.5	29.0	11.3	1.3	3.4	0.0	5.7	22.6	10.3	5.0	0.2	11.7	36.2	0.0	2.1	0.0	4.2	0.0	30.6	0.0	0.0	12.7	11.5	19.7	40.0	20.5	42.2	0.0	0.0	0.0	42.8	0.4	0.0	0.0	1.5	0.0	8.4	0.0	5.1	0.0	38.0	0.0	0.0	1.7	3.1	0.5	2.2	7.5	0.2	0.0	53.6	33.3	8.7	5.0	22.3	0.0	0.0	0.0	16.2	0.0	10.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	1.1	5.0	1.4	1.2	0.9	0.9	1.1	0.7	0.6	1.9	1.1	0.7	35.3	9.8	44.1	0.2	2.9	60.3	23.7	15.9	0.2	4.7	2.9	1.3	11.5	10.8	25.8	0.0	0.3	0.1	7.0	0.0	9.2	0.0	6.2	21.1	4.3	23.4	0.0	27.1	0.9	0.2	13.6	4.6	8.2	0.0	0.0	4.2	1.2	0.5	1.7	1.5	17.3	16.2	0.3	1.6	0.3	2.5	0.3	3.6	7.5	0.0	6.8	1.0	3.0	0.5	5.2	5.0	1.5	0.0	49.6	0.1	4.1	4.6	0.2	0.0	8.6	10.5	0.1	0.3	16.9	1.1	0.4	0.6	3.3	4.1	25.6
ASPN	"FLJ20129, PLAP-1, SLRR1C"	ENSG00000106819	Asporin	Q9BXN1	9	92456205-92482506	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	Biomineralization			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 95.3;smooth muscle: 110.5"	"Cell type enhanced"	"Detected in some"		"Basal keratinocytes: 67.2;Fibroblasts: 94.6;Microglial cells: 24.4;Sertoli cells: 39.5;Smooth muscle cells: 73.5;Suprabasal keratinocytes: 27.0"	"Cancer enhanced"	"Detected in all"		"breast cancer: 51.0"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"basophil: 2.4"	"Lineage enhanced"	"Detected in single"		"granulocytes: 2.4"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 16.0;BJ hTERT+: 5.7;HHSteC: 23.2;HSkMC: 4.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007894, HPA008435, HPA024230"	Approved		Uncertain	Nucleoplasm,Cytosol	"Secreted to extracellular matrix"	NA	NA		2100000	"Cluster 18: Basophils - Vesicular transport"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm	Cytosol	"HPA007894: , HPA008435: AB_1845112, HPA024230: AB_1845113"	"unprognostic (2.40e-1)"	"unprognostic (1.02e-2)"	"unprognostic (8.13e-3)"	"unprognostic (3.51e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.01e-2)"	"unprognostic (9.50e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.74e-3)"	"unprognostic (6.38e-2)"	"unprognostic (3.70e-2)"	"unprognostic (4.70e-2)"	"prognostic unfavorable (1.64e-7)"	"unprognostic (1.42e-3)"	"unprognostic (3.04e-2)"	"unprognostic (6.27e-3)"	"unprognostic (2.48e-2)"	29.6	7.6	1.2	5.7	1.7	0.1	11.8	2.3	2.0	40.9	0.9	25.5	9.6	69.6	9.7	10.1	16.9	65.9	95.3	1.2	1.2	11.2	41.1	14.3	3.0	1.3	1.2	7.1	13.4	3.8	2.5	4.3	1.6	4.7	11.3	0.2	3.2	11.7	7.8	12.1	17.6	110.5	1.0	2.3	12.0	1.2	1.8	2.5	11.1	19.8	5.5	13.4	5.0	1.7	0.1	0.0	0.0	0.0	1.4	16.0	0.2	2.6	5.7	0.0	0.1	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.2	0.0	0.0	23.2	0.2	0.0	4.5	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.4	0.0	0.3	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.1	0.0	0.0	1.2	1.7	2.3	2.0	1.2	1.2	1.3	1.2	1.6	1.0	1.8	1.7	12.9	0.0	1.1	0.3	0.1	67.2	0.1	0.0	0.0	0.4	0.4	0.1	8.5	0.0	0.6	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.4	0.1	4.2	6.8	0.0	0.0	2.0	0.0	0.1	94.6	0.5	0.2	1.3	0.1	13.9	0.4	0.2	0.0	1.7	0.0	0.0	0.0	13.5	0.6	5.9	0.8	14.2	24.4	0.0	0.1	0.0	1.5	1.1	0.0	0.0	1.9	0.3	0.0	0.0	0.0	0.7	0.6	39.5	4.3	73.5	0.0	0.1	0.3	27.0	0.0	1.7	0.3	0.0	0.0
BICC1		ENSG00000122870	"BicC family RNA binding protein 1"	Q9H694	10	58512872-58831435	"Disease related genes, Predicted intracellular proteins"		"Developmental protein, RNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 28.6"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 120.5;Cholangiocytes: 158.7;Collecting duct cells: 86.5;Ductal cells: 98.5;Fibroblasts: 79.6;Microglial cells: 165.8;Proximal tubular cells: 148.2"	"Group enriched"	"Detected in all"	4	"pancreatic cancer: 9.2;renal cancer: 25.6"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	10	"basophil: 6.2"	"Lineage enriched"	"Detected in single"	10	"granulocytes: 6.2"	"Cell line enhanced"	"Detected in many"		"A549: 59.1;BJ hTERT+: 61.4;CACO-2: 93.1;RPTEC TERT1: 140.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA070797			Approved	Centrosome,Cytosol		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 50: Fibroblasts - ECM organization"	Cytosol	Centrosome	"HPA070797: "	"unprognostic (1.27e-1)"	"unprognostic (1.57e-3)"	"unprognostic (3.61e-1)"	"unprognostic (1.96e-1)"	"unprognostic (6.09e-3)"	"unprognostic (1.72e-1)"	"unprognostic (9.98e-3)"	"unprognostic (1.79e-2)"	"unprognostic (6.69e-2)"	"unprognostic (4.56e-2)"	"unprognostic (4.40e-3)"	"unprognostic (7.16e-2)"	"unprognostic (6.44e-2)"	"unprognostic (1.37e-3)"	"unprognostic (4.19e-2)"	"unprognostic (6.23e-2)"	"unprognostic (2.94e-2)"	10.6	6.1	0.3	4.0	0.5	0.3	8.7	0.0	1.6	5.8	1.9	4.5	1.2	4.9	4.0	3.5	7.5	11.6	10.5	0.6	1.0	28.6	2.4	5.8	2.4	1.2	0.6	13.9	16.9	0.8	3.6	3.6	0.2	3.8	4.1	1.4	4.3	4.2	7.6	6.1	2.7	4.7	1.2	2.9	2.7	3.1	0.7	1.4	4.6	6.2	2.7	5.5	5.6	0.7	0.0	59.1	0.8	0.0	17.9	23.0	0.0	38.5	61.4	34.4	40.4	93.1	12.3	0.0	39.8	39.3	8.8	0.8	6.1	7.0	47.4	0.1	5.9	0.0	7.4	0.1	11.5	0.0	0.0	36.0	2.2	26.9	28.6	42.3	0.1	0.0	0.0	0.2	13.4	0.1	0.0	0.0	0.5	0.0	3.8	0.0	14.3	0.0	140.8	7.1	0.2	7.3	0.1	0.4	3.4	2.4	0.0	0.6	0.0	8.2	7.7	1.4	5.0	0.0	0.0	0.1	23.8	0.0	7.8	6.2	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.5	0.2	0.5	0.1	0.0	0.3	0.5	0.0	1.6	0.6	1.0	1.2	0.6	0.2	1.2	0.7	0.7	4.1	0.0	0.5	120.5	1.5	7.1	1.3	1.3	0.6	0.6	1.1	4.3	3.3	158.7	1.7	86.5	0.0	0.4	0.1	0.3	78.2	98.5	5.2	43.8	14.4	1.4	3.6	0.0	70.4	3.5	0.2	79.6	0.5	7.2	0.0	4.2	3.3	1.4	3.5	0.0	37.2	1.2	0.0	0.6	18.5	3.2	71.1	1.7	21.4	165.8	1.1	10.1	0.0	25.6	2.7	35.3	1.2	50.0	0.3	2.4	0.0	148.2	14.1	0.2	6.6	40.0	9.8	0.1	3.9	0.3	4.7	4.1	1.5	8.7	1.6	0.1
BNC2	"BSN2, FLJ20043"	ENSG00000173068	"Basonuclin 2"	Q6ZN30	9	16409503-16870843	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 26.9;ovary: 31.7;smooth muscle: 31.7"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 46.7;Leydig cells: 90.1;Microglial cells: 230.5;Peritubular cells: 67.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	5	"gdT-cell: 2.5"	"Lineage enriched"	"Detected in single"	5	"T-cells: 2.5"	"Cell line enhanced"	"Detected in many"		"HSkMC: 31.9;Karpas-707: 40.4;RPMI-8226: 28.0"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA018525, HPA059419"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm		"HPA018525: AB_1845402, HPA059419: AB_2732637"	"unprognostic (2.68e-1)"	"unprognostic (2.89e-1)"	"unprognostic (3.64e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.56e-2)"	"unprognostic (5.07e-2)"	"unprognostic (2.81e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.94e-2)"	"unprognostic (6.05e-2)"	"unprognostic (5.99e-2)"	"unprognostic (3.87e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.36e-2)"	"unprognostic (1.62e-1)"	"unprognostic (6.74e-2)"	"unprognostic (1.14e-3)"	5.6	1.0	1.4	3.7	2.5	0.7	3.3	2.3	4.4	12.1	8.2	10.1	1.3	26.9	2.1	4.6	18.4	7.2	2.9	2.6	2.7	6.4	0.3	3.1	0.8	4.7	6.0	31.7	0.5	2.9	1.7	3.4	3.9	3.7	3.0	0.8	1.3	4.8	3.5	3.4	3.3	31.7	3.5	0.7	3.0	6.9	4.7	2.5	2.1	1.9	1.1	6.3	5.8	4.9	0.3	1.7	1.2	0.1	17.5	21.1	2.7	11.4	19.5	7.8	6.4	0.1	0.0	0.0	3.7	7.8	5.8	0.1	5.1	0.0	7.9	0.2	2.0	0.1	5.3	0.0	13.4	0.1	0.5	31.9	0.0	16.6	0.1	13.7	18.0	0.0	0.0	40.4	11.1	0.0	0.0	2.8	6.6	0.1	10.2	0.0	12.5	28.0	6.0	0.3	0.2	1.0	0.1	0.1	18.6	8.3	0.1	0.0	17.7	18.6	13.5	15.1	20.9	0.2	0.0	0.1	7.6	2.5	2.5	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.5	0.0	0.0	0.0	1.5	1.4	2.5	2.3	4.4	2.6	2.7	4.7	6.0	3.9	3.5	4.7	4.9	5.5	0.0	2.2	46.7	0.0	10.1	0.6	0.0	33.6	8.2	0.2	0.4	4.8	0.0	0.6	0.0	0.0	3.2	10.7	0.1	0.0	1.0	7.2	2.2	9.1	10.5	0.0	0.0	1.6	0.4	1.2	38.6	3.1	2.0	22.2	25.1	10.4	0.3	7.3	0.0	1.9	1.1	6.1	1.6	2.3	4.5	90.1	4.2	10.6	230.5	0.1	2.6	30.9	1.0	1.6	0.1	0.0	67.7	3.9	0.7	5.7	35.5	0.7	0.3	6.6	31.5	5.1	0.9	13.5	5.7	5.5	1.2	3.1	36.5	1.8	0.1
BOC	CDON2	ENSG00000144857	"BOC cell adhesion associated, oncogene regulated"	Q9BWV1	3	113211003-113287459	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 71.8;Basal squamous epithelial cells: 112.1;Fibroblasts: 55.4;Leydig cells: 84.8;Peritubular cells: 47.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 79.2;ASC diff: 113.6;BJ hTERT+: 41.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB025806	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Plasma membrane"	"Intracellular and membrane"	NA	No		7900000		"Cluster 57: Non-specific - Angiogenesis"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 50: Fibroblasts - ECM organization"	"Nuclear bodies, Plasma membrane"	Nucleoplasm	"CAB025806: "	"unprognostic (6.89e-3)"	"unprognostic (1.34e-2)"	"unprognostic (2.62e-3)"	"unprognostic (1.03e-2)"	"unprognostic (5.03e-3)"	"prognostic favorable (4.89e-4)"	"unprognostic (8.66e-5)"	"unprognostic (1.10e-1)"	"unprognostic (1.19e-2)"	"unprognostic (4.78e-3)"	"unprognostic (3.42e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.65e-3)"	"unprognostic (4.94e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.66e-1)"	"prognostic unfavorable (1.18e-5)"	41.6	5.8	15.8	10.4	15.5	0.2	29.8	13.1	12.1	26.0	33.2	49.1	4.9	46.6	10.1	24.9	63.2	19.3	14.3	17.1	15.2	9.7	1.0	6.6	3.6	53.2	30.1	35.2	16.1	2.7	20.8	2.2	23.2	33.8	4.6	3.2	23.8	21.3	6.3	34.9	18.3	32.6	32.3	4.6	19.0	5.0	26.3	5.7	24.6	9.0	3.1	32.5	25.8	23.4	0.0	7.6	27.6	79.2	113.6	6.0	0.9	12.8	41.9	3.2	2.7	0.0	0.0	0.1	7.8	21.8	1.7	0.0	5.6	2.7	1.1	0.0	3.4	0.0	2.3	0.0	0.6	0.3	0.2	19.7	1.8	1.7	0.2	25.7	0.0	0.0	0.1	0.0	0.6	2.1	0.2	1.4	7.0	0.0	6.9	0.2	12.3	0.0	0.7	0.1	8.2	11.7	0.1	0.5	0.3	8.1	3.4	0.4	0.0	4.5	7.3	0.1	4.2	0.0	0.0	0.0	9.6	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.8	15.5	13.1	12.1	17.1	15.2	53.2	30.1	23.2	32.3	26.3	23.4	9.6	0.0	0.5	71.8	0.0	21.2	3.1	3.6	112.1	0.6	3.7	17.3	1.1	1.5	0.7	5.5	0.0	4.8	0.2	0.0	0.0	0.1	1.4	12.6	10.5	5.6	1.8	0.0	8.8	0.0	4.3	55.4	0.5	11.7	0.0	5.7	3.3	0.1	0.8	0.0	2.5	0.0	0.0	0.3	5.5	3.3	84.8	1.0	10.6	6.5	0.0	12.2	0.0	24.1	0.7	0.3	0.0	47.8	0.6	3.3	0.0	0.0	0.3	0.5	0.0	18.0	13.5	1.5	3.2	11.5	11.1	1.9	0.8	1.1	0.0	0.9
CAMK2N1	CaMKIINalpha	ENSG00000162545	"Calcium/calmodulin dependent protein kinase II inhibitor 1"	Q7Z7J9	1	20482391-20486210	"Predicted intracellular proteins"		"Protein kinase inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 461.3"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 640.5;Intestinal goblet cells: 431.4;Paneth cells: 367.7;Proximal tubular cells: 519.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"gdT-cell: 1.6;MAIT T-cell: 1.1"	"Lineage enhanced"	"Detected in single"		"T-cells: 1.6"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 212.1;CAPAN-2: 199.1;Hep G2: 165.6;SK-BR-3: 159.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA075200	Approved					NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 65: Brain - Ion transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA075200: "	"unprognostic (1.67e-1)"	"unprognostic (2.70e-3)"	"unprognostic (9.71e-3)"	"unprognostic (3.13e-1)"	"unprognostic (6.89e-3)"	"prognostic unfavorable (1.37e-7)"	"prognostic unfavorable (5.49e-4)"	"prognostic unfavorable (1.66e-4)"	"unprognostic (4.77e-2)"	"unprognostic (1.31e-1)"	"unprognostic (7.48e-3)"	"unprognostic (1.93e-2)"	"unprognostic (1.40e-3)"	"unprognostic (4.44e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.96e-2)"	"unprognostic (1.31e-2)"	20.1	61.6	340.5	9.3	322.3	0.5	19.8	172.0	461.3	32.5	115.4	85.0	80.4	27.8	38.1	27.8	22.3	27.4	22.3	354.6	206.5	86.2	53.8	67.9	1.9	224.8	222.4	30.2	8.8	42.4	37.7	11.6	215.9	35.8	77.0	32.6	30.4	40.8	7.1	12.0	86.9	22.7	226.7	12.2	19.5	4.7	265.4	2.0	10.8	9.9	7.0	27.3	24.3	348.6	63.1	17.5	15.0	212.1	28.4	52.6	2.2	52.6	119.0	9.5	4.8	20.1	199.1	6.3	14.7	21.7	7.7	103.2	4.6	90.0	5.9	11.7	3.8	1.3	0.9	165.6	31.4	0.1	6.2	8.4	41.2	5.6	21.2	19.6	16.4	4.3	6.3	0.5	105.8	17.4	0.2	0.5	2.8	109.7	3.9	5.6	9.4	0.4	59.3	93.5	57.6	16.2	28.5	159.6	16.3	10.2	30.6	0.6	5.0	34.9	46.1	48.5	21.1	0.1	0.1	2.5	119.5	13.5	22.0	0.0	0.0	0.0	1.6	0.0	1.1	0.5	0.5	0.4	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.1	340.5	322.3	172.0	461.3	354.6	206.5	224.8	222.4	215.9	226.7	265.4	348.6	28.3	3.2	1.1	35.6	7.6	9.3	11.7	2.3	0.6	248.6	96.5	104.5	20.8	178.7	2.5	248.3	6.2	0.5	10.1	640.5	229.0	20.1	0.8	6.2	45.6	20.0	299.2	8.0	132.5	40.8	2.9	65.1	9.2	12.0	1.3	4.6	9.3	201.6	0.3	85.8	108.7	431.4	14.2	1.9	12.1	3.9	62.7	5.6	39.2	26.2	0.6	81.1	0.0	27.6	249.1	141.5	367.7	94.0	3.5	37.7	183.2	519.2	1.2	35.6	131.5	86.2	96.4	0.8	2.8	1.0	7.5	2.1	14.7	0.8	223.5	50.3
CAPN5	"ADNIV, HTRA3, nCL-3, VRNI"	ENSG00000149260	"Calpain 5"	O15484	11	77066961-77126155	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 60.7"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 170.3;Gastric mucus-secreting cells: 80.0;Intestinal goblet cells: 89.8;Paneth cells: 72.6;Proximal enterocytes: 75.6;Undifferentiated cells: 69.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"gdT-cell: 1.3"	"Lineage enriched"	"Detected in single"	4	"T-cells: 1.3"	"Cell line enhanced"	"Detected in many"		"OE19: 106.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033237, HPA072319"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	Cytosol	"CAB033237: AB_2069673, HPA072319: AB_2686512"	"unprognostic (6.81e-3)"	"unprognostic (1.31e-1)"	"unprognostic (3.36e-2)"	"prognostic unfavorable (2.16e-6)"	"unprognostic (3.47e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.13e-1)"	"unprognostic (5.30e-2)"	"unprognostic (2.52e-1)"	"unprognostic (2.21e-2)"	"unprognostic (5.35e-3)"	"unprognostic (4.64e-1)"	"unprognostic (3.17e-3)"	"unprognostic (8.58e-3)"	"unprognostic (3.25e-1)"	"unprognostic (2.31e-2)"	"unprognostic (2.30e-3)"	6.7	12.2	8.5	10.9	7.9	2.7	4.9	6.4	8.6	13.5	3.5	60.5	60.7	10.0	5.7	31.6	10.8	36.3	7.2	8.5	8.7	15.1	52.1	4.8	1.9	11.7	8.2	13.2	5.6	1.0	5.1	2.8	12.5	16.0	49.9	3.8	7.7	8.9	1.6	3.1	52.4	11.3	9.9	3.5	47.9	21.5	7.9	2.8	4.7	1.7	2.7	15.4	10.5	8.1	0.8	12.5	8.6	7.8	32.0	30.4	0.7	11.8	22.9	13.4	10.0	6.9	3.6	0.4	7.7	24.5	14.4	0.5	3.8	1.0	6.4	0.5	0.8	2.1	0.5	0.9	7.9	0.2	0.4	16.1	1.4	22.6	5.2	18.8	14.4	5.1	0.2	0.0	26.9	19.9	1.8	0.3	6.6	106.6	9.3	2.0	27.0	0.4	4.6	16.4	0.5	13.5	1.0	2.7	5.9	5.7	1.7	0.1	23.9	25.4	12.3	34.8	1.3	0.8	1.7	0.1	13.1	0.3	5.7	0.0	0.2	0.0	1.3	0.3	0.1	0.0	0.1	0.5	0.2	0.0	0.6	0.8	0.0	0.0	0.0	0.1	0.0	0.7	8.5	7.9	6.4	8.6	8.5	8.7	11.7	8.2	12.5	9.9	7.9	8.1	1.6	0.0	0.5	4.2	1.0	1.7	0.3	2.2	0.0	3.1	0.5	1.8	1.7	24.3	10.3	23.9	0.0	0.1	3.4	170.3	1.9	10.3	1.1	1.9	5.9	2.4	22.3	5.7	4.6	32.7	0.4	7.6	80.0	3.5	0.0	10.2	2.9	40.4	0.9	1.7	6.7	89.8	10.2	1.6	1.8	1.3	12.5	1.2	7.2	1.0	0.3	5.8	5.2	11.6	0.7	22.4	72.6	4.5	0.9	2.0	75.6	9.9	11.1	2.1	0.0	8.3	4.1	0.5	2.3	2.5	0.9	0.0	1.5	5.3	69.2	2.4
CCDC80	"CL2, DRO1, LINC01279, SSG1, TCONS_00006930, URB"	ENSG00000091986	"Coiled-coil domain containing 80"	Q76M96	3	112596797-112649530	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 450.8;Fibroblasts: 921.6;Late spermatids: 353.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 521.4;fHDF/TERT166: 1281.3;hTERT-RPE1: 2404.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002266	Approved				"Secreted to extracellular matrix"	NA	NA		510000	"Cluster 41: Basophils - Cellular respiration"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"			"HPA002266: AB_1078423"	"unprognostic (1.26e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.26e-2)"	"unprognostic (3.19e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.82e-1)"	"unprognostic (2.53e-2)"	"unprognostic (2.30e-3)"	"unprognostic (1.99e-3)"	"unprognostic (8.40e-2)"	"unprognostic (6.30e-2)"	"prognostic unfavorable (2.86e-5)"	"unprognostic (5.97e-3)"	"unprognostic (1.65e-1)"	"unprognostic (1.55e-1)"	"prognostic unfavorable (1.26e-4)"	244.9	15.0	6.4	83.5	6.9	1.1	218.3	9.6	8.6	305.3	24.4	74.5	8.7	276.5	76.8	92.4	82.2	234.0	218.8	6.8	10.2	17.7	6.6	74.0	18.5	12.2	11.4	62.2	28.7	12.4	10.8	26.0	9.3	67.8	73.4	9.4	34.7	78.7	13.4	79.1	25.1	360.3	11.1	34.8	47.5	42.7	9.2	17.1	87.5	34.9	30.8	194.4	131.8	13.5	26.1	11.0	127.6	5.8	521.4	411.2	6.9	359.0	108.5	118.6	171.8	2.9	2.1	1.2	13.5	1281.3	11.4	33.5	5.3	4.8	123.7	24.3	1.2	0.7	27.7	0.7	109.5	1.0	0.5	409.7	14.4	174.9	11.0	2404.9	27.8	0.6	0.4	1.0	352.7	0.5	0.3	0.7	31.6	0.7	4.2	0.3	14.0	0.6	3.3	0.5	0.4	2.5	53.5	2.3	1.8	23.0	2.1	1.0	141.7	345.6	56.6	66.6	160.1	1.6	0.8	1.2	102.4	0.7	56.8	0.9	0.3	0.2	0.3	0.1	0.3	0.4	0.3	0.3	0.1	0.6	0.4	0.4	0.3	0.3	0.2	0.7	0.2	0.0	6.4	6.9	9.6	8.6	6.8	10.2	12.2	11.4	9.3	11.1	9.2	13.5	104.5	6.4	15.9	13.1	1.5	60.9	4.2	44.7	26.7	1.1	5.9	59.7	22.5	10.0	62.7	5.5	0.0	57.9	1.0	0.3	1.9	23.7	450.8	95.4	93.2	43.9	0.0	0.0	1.0	1.2	101.5	921.6	16.8	18.4	1.3	44.3	53.6	0.9	9.4	0.0	0.3	0.8	30.5	2.2	121.5	353.6	77.0	9.7	144.1	3.7	2.0	101.4	0.0	0.0	0.0	13.5	0.0	34.6	5.8	3.6	0.0	0.1	112.4	2.5	19.7	177.7	198.4	6.9	4.9	11.9	51.7	27.9	9.0	23.0	0.1	1.9
CERCAM	"CEECAM1, GLT25D3"	ENSG00000167123	"Cerebral endothelial cell adhesion molecule"	Q5T4B2	9	128411751-128437351	"Metabolic proteins, Predicted intracellular proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 551.5"	"Cell type enriched"	"Detected in many"	7	"Oligodendrocytes: 626.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 280.5;ASC TERT1: 284.1;fHDF/TERT166: 271.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021657, HPA051595"	Uncertain		Approved	"Nucleoplasm,Nucleoli,Cell Junctions"	"Intracellular and membrane"	NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 70: Brain - Nervous system development"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nucleoplasm, Nucleoli"	"Cell Junctions"	"HPA021657: AB_1846507, HPA051595: AB_2681545"	"unprognostic (2.87e-2)"	"unprognostic (1.37e-3)"	"unprognostic (1.89e-3)"	"unprognostic (2.19e-1)"	"unprognostic (4.68e-3)"	"unprognostic (7.79e-3)"	"unprognostic (3.29e-3)"	"unprognostic (5.68e-2)"	"unprognostic (1.00e-1)"	"prognostic unfavorable (5.22e-4)"	"unprognostic (1.59e-1)"	"unprognostic (5.93e-2)"	"prognostic unfavorable (3.33e-16)"	"unprognostic (1.34e-2)"	"unprognostic (1.04e-1)"	"unprognostic (6.05e-3)"	"prognostic unfavorable (3.30e-5)"	26.1	8.9	249.9	12.3	411.3	2.5	24.5	248.6	378.3	42.4	140.1	20.9	7.9	35.0	9.7	13.1	23.4	31.2	34.0	261.5	322.7	25.9	3.7	16.9	4.1	344.1	349.4	31.2	30.1	31.0	106.4	49.4	323.9	27.9	7.7	1.0	21.4	22.8	7.0	15.0	12.3	47.4	224.7	10.9	15.8	11.1	386.4	2.4	23.4	7.0	3.9	29.9	30.8	551.5	44.7	26.0	35.2	38.2	280.5	284.1	27.4	145.5	149.7	41.2	32.0	10.3	2.4	0.0	58.3	271.9	33.5	33.8	14.7	22.2	13.9	11.7	25.6	2.9	24.1	15.5	89.7	5.4	84.4	171.6	11.7	48.4	10.5	157.7	44.3	3.0	13.0	36.5	51.8	82.3	2.3	55.7	1.8	2.3	25.4	4.7	23.6	7.3	18.4	15.5	4.9	8.5	33.8	43.1	16.7	10.1	34.4	13.7	48.2	103.5	27.3	138.1	23.2	42.2	35.0	0.8	99.7	17.1	21.0	0.1	0.6	0.0	1.8	0.7	0.1	0.1	0.1	2.1	0.7	0.0	0.0	2.3	0.0	0.6	0.0	1.0	0.0	1.3	249.9	411.3	248.6	378.3	261.5	322.7	344.1	349.4	323.9	224.7	386.4	551.5	8.5	6.4	10.3	7.2	3.5	8.9	6.5	7.0	10.8	1.7	8.7	6.9	3.9	0.0	13.6	11.0	0.0	18.4	5.8	0.0	0.0	11.6	2.7	3.1	18.7	7.7	0.0	2.5	2.9	3.4	61.1	82.3	3.6	6.7	8.8	9.8	16.8	0.1	6.2	6.7	3.3	0.0	2.0	0.8	10.4	2.3	24.2	2.9	40.9	3.7	1.3	0.1	17.5	11.6	626.9	4.5	0.0	26.4	17.9	5.0	0.0	0.9	3.9	0.9	6.6	27.8	26.4	8.6	22.2	2.4	4.1	19.6	3.3	5.9	0.0	2.8
CHRD		ENSG00000090539	Chordin	Q9H2X0	3	184380073-184390736	"Plasma proteins, Predicted secreted proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 130.0"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 31.2;Excitatory neurons: 28.2;Fibroblasts: 16.4;Hepatocytes: 36.4;Inhibitory neurons: 37.5;Skeletal myocytes: 19.1;Smooth muscle cells: 16.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 2.8;Hep G2: 11.8;MCF7: 2.5;SuSa: 4.0;U-2 OS: 3.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA035827	Approved				"Secreted in other tissues"	NA	NA		350000		"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 36: Stromal cells - Cell proliferation"			"HPA035827: AB_10669657"	"unprognostic (2.26e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.63e-2)"	"unprognostic (2.21e-1)"	"unprognostic (6.52e-2)"	"unprognostic (3.16e-1)"	"unprognostic (2.88e-1)"	"unprognostic (9.58e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.12e-2)"	"unprognostic (6.55e-2)"	"prognostic unfavorable (6.09e-7)"	"unprognostic (5.53e-3)"	"unprognostic (1.85e-1)"	"unprognostic (9.84e-2)"	"unprognostic (7.99e-3)"	11.1	12.2	13.9	2.1	13.9	0.0	9.9	19.0	21.2	40.0	9.1	7.6	1.6	32.9	3.2	3.3	15.0	2.5	11.2	15.1	9.4	18.8	130.0	7.2	1.5	10.1	9.9	16.3	17.1	1.1	6.0	2.4	10.2	9.7	0.8	0.0	3.8	5.2	4.4	5.4	6.0	4.6	10.3	9.7	7.8	1.1	9.7	0.2	7.7	2.7	0.3	7.2	15.4	13.6	0.0	0.0	0.3	1.1	0.1	0.1	1.4	0.3	0.0	0.2	0.1	2.8	0.0	0.0	1.1	0.3	1.0	0.0	1.7	0.0	0.0	0.0	0.7	0.0	0.0	11.8	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	1.5	2.0	0.0	0.0	0.6	0.0	0.1	0.1	0.1	4.0	1.4	0.0	0.0	0.0	3.8	0.0	0.4	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.9	13.9	19.0	21.2	15.1	9.4	10.1	9.9	10.2	10.3	9.7	13.6	2.6	0.0	0.0	11.8	0.4	2.7	0.0	0.0	0.6	2.9	2.1	1.8	3.1	0.0	0.0	1.8	0.0	0.1	0.0	0.0	0.0	0.1	0.1	3.6	31.2	2.6	0.0	0.0	28.2	3.1	0.0	16.4	1.1	4.5	0.0	0.9	3.3	36.4	0.7	0.0	37.5	0.2	0.0	3.2	3.1	0.0	3.7	0.4	1.8	4.7	0.0	0.0	0.0	7.1	2.5	1.1	0.0	2.2	0.0	0.1	0.0	4.0	0.0	0.5	6.6	19.1	16.4	0.3	0.3	0.3	1.1	0.1	0.7	0.1	0.0	0.3
CLEC11A	"CLECSF3, LSLCL, P47, SCGF"	ENSG00000105472	"C-type lectin domain containing 11A"	Q9Y240	19	50723364-50725718	"Plasma proteins, Predicted secreted proteins"	Osteogenesis	"Growth factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 132.6"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 119.3;Fibroblasts: 107.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"classical monocyte: 24.3"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"HEL: 363.0;HMC-1: 637.3;NB-4: 901.1;THP-1: 694.7;U-937: 358.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA042690	Approved		Approved	Centrosome	"Secreted in other tissues"	NA	NA		1300000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 24: NB-4 - Immune response"	"Cluster 48: Smooth muscle cells - ECM organization"	Centrosome		"HPA042690: AB_10795511"	"unprognostic (9.33e-2)"	"unprognostic (6.66e-2)"	"unprognostic (2.40e-2)"	"prognostic favorable (6.91e-4)"	"unprognostic (2.33e-1)"	"unprognostic (8.22e-2)"	"unprognostic (5.52e-2)"	"unprognostic (1.29e-2)"	"unprognostic (5.26e-2)"	"unprognostic (4.99e-2)"	"unprognostic (2.79e-2)"	"unprognostic (8.30e-2)"	"prognostic unfavorable (1.02e-5)"	"unprognostic (6.09e-2)"	"unprognostic (8.66e-3)"	"unprognostic (4.00e-2)"	"unprognostic (1.57e-2)"	17.5	17.5	5.0	7.0	5.6	132.6	14.1	7.9	9.1	44.4	2.9	12.0	4.8	31.9	1.6	8.4	37.5	6.2	16.3	4.4	7.2	21.1	12.1	15.0	2.7	10.2	7.9	31.5	7.5	2.4	22.3	5.5	8.1	22.5	1.9	0.7	6.9	4.8	4.4	16.8	9.7	8.1	7.2	14.0	8.0	9.1	6.2	2.6	12.8	1.0	0.8	19.2	28.2	6.0	2.6	3.5	0.0	2.9	33.7	45.3	79.2	139.3	37.9	15.6	15.7	0.1	0.0	0.4	1.7	70.2	0.8	1.6	0.4	0.2	10.7	0.6	22.9	363.0	0.1	0.0	21.3	0.2	637.3	33.7	0.2	1.9	2.3	0.1	17.9	16.1	4.1	2.2	29.0	2.6	3.1	901.1	1.6	0.3	4.6	30.7	0.2	0.2	0.8	0.4	0.0	3.8	4.2	0.0	58.1	0.0	0.9	694.7	100.3	1.1	41.6	0.7	0.7	2.1	2.2	0.5	47.3	358.7	44.2	1.4	24.3	0.4	0.9	11.5	0.1	0.6	0.3	0.2	17.7	0.4	2.0	4.5	1.6	5.7	5.6	4.8	0.2	8.2	5.0	5.6	7.9	9.1	4.4	7.2	10.2	7.9	8.1	7.2	6.2	6.0	12.4	3.2	5.4	10.4	3.9	32.0	32.2	2.9	27.3	20.5	30.8	31.9	3.4	8.6	4.0	29.5	10.4	8.6	5.0	1.7	119.3	11.0	6.5	17.0	70.7	16.9	26.5	36.4	9.0	3.1	72.4	107.2	4.1	14.1	5.7	18.9	51.4	6.3	49.4	21.9	8.3	4.5	10.2	21.5	73.3	19.9	70.8	29.6	78.2	9.4	11.2	70.4	14.4	8.0	12.9	3.1	1.7	67.4	0.9	21.4	0.5	13.7	5.0	20.7	65.7	20.2	59.2	17.2	21.7	26.3	45.9	18.3	5.8	56.7	3.5	17.8
CMTM3	"BNAS2, CKLFSF3, FLJ31762"	ENSG00000140931	"CKLF like MARVEL transmembrane domain containing 3"	Q96MX0	16	66603874-66613892	"Predicted intracellular proteins, Predicted membrane proteins"	Chemotaxis	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 222.1;Granulosa cells: 140.8;Hofbauer cells: 119.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"REH: 164.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013870, HPA072695"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 28: Placenta - Pregnancy"	"Cluster 12: NES - Nervous system development"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm		"HPA013870: AB_1847003, HPA072695: AB_2732210"	"unprognostic (1.59e-1)"	"unprognostic (2.83e-2)"	"unprognostic (7.63e-2)"	"unprognostic (1.49e-1)"	"unprognostic (4.21e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.80e-3)"	"unprognostic (6.65e-3)"	"unprognostic (7.75e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.22e-2)"	"unprognostic (7.38e-2)"	"prognostic unfavorable (4.42e-6)"	"prognostic unfavorable (1.85e-4)"	"unprognostic (7.56e-2)"	"unprognostic (1.93e-2)"	"unprognostic (2.81e-2)"	49.3	16.6	15.5	25.0	14.3	20.0	32.8	15.6	28.1	40.2	9.5	16.8	7.1	30.4	16.6	10.4	25.5	32.7	26.2	15.6	18.0	19.7	10.7	35.4	32.3	24.9	15.8	38.9	7.9	29.4	10.1	44.4	19.3	23.4	12.1	3.0	17.4	16.7	6.4	22.2	18.8	27.7	17.0	36.1	11.9	59.7	19.1	35.5	16.1	13.0	20.9	34.3	26.7	20.4	6.7	33.8	93.4	66.2	68.4	42.6	59.2	17.5	78.6	34.4	34.0	18.6	21.0	0.2	47.7	49.0	59.7	7.8	63.7	57.4	27.3	34.6	23.2	21.5	4.4	53.5	92.2	65.8	77.4	85.5	4.5	36.6	7.7	141.3	78.9	59.5	34.6	0.7	42.8	7.8	53.1	108.9	45.0	0.5	31.8	164.7	65.6	3.3	16.4	0.8	9.9	33.9	8.5	0.3	58.5	59.9	0.7	59.3	54.0	48.7	58.8	12.0	21.1	4.4	0.7	21.8	30.5	50.0	53.7	7.9	14.2	9.9	9.2	13.9	12.9	2.6	10.3	10.5	12.3	0.9	8.0	9.8	8.0	8.6	8.9	24.9	15.7	5.8	15.5	14.3	15.6	28.1	15.6	18.0	24.9	15.8	19.3	17.0	19.1	20.4	38.0	0.0	7.1	0.3	12.9	14.7	33.5	10.0	6.8	0.5	12.3	25.7	2.0	4.3	6.4	5.5	0.0	10.7	101.2	0.4	0.0	28.1	2.8	4.9	56.0	50.4	12.5	12.8	0.6	6.4	222.1	62.6	2.6	6.2	91.3	140.8	44.3	1.3	119.8	0.0	0.3	0.7	8.2	74.7	77.9	9.4	39.4	78.0	28.4	10.3	61.5	10.0	82.4	8.0	0.2	41.0	0.1	24.5	5.7	40.8	0.1	4.4	3.1	0.8	6.6	26.3	36.1	4.9	8.1	1.1	8.7	9.4	68.9	10.5	0.2	21.6
COL14A1	UND	ENSG00000187955	"Collagen type XIV alpha 1 chain"	Q05707	8	120059780-120373573	"Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 205.8"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 75.1;Endometrial stromal cells: 97.0;Fibroblasts: 235.9;Smooth muscle cells: 118.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 54.4;hTERT-RPE1: 29.7;RH-30: 123.4"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA023781	Uncertain		Approved	Vesicles	"Secreted to extracellular matrix"	NA	NA		3200000		"Cluster 46: Fibroblasts - ECM organization"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 50: Fibroblasts - ECM organization"	Vesicles		"HPA023781: AB_1847098"	"unprognostic (1.10e-1)"	"unprognostic (3.15e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.22e-3)"	"unprognostic (5.96e-2)"	"unprognostic (4.29e-2)"	"unprognostic (7.61e-2)"	"unprognostic (3.77e-2)"	"unprognostic (4.36e-1)"	"unprognostic (5.07e-2)"	"prognostic unfavorable (5.79e-5)"	"unprognostic (1.07e-2)"	"unprognostic (8.21e-3)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (1.01e-4)"	69.0	16.2	1.6	42.2	1.9	0.3	58.8	1.5	2.4	205.8	2.9	39.8	7.7	78.2	35.2	50.2	46.2	142.2	45.4	1.5	2.0	32.1	19.5	27.7	12.8	3.4	2.2	83.2	15.7	6.0	4.0	152.7	2.7	43.8	53.9	0.6	13.5	24.9	7.0	13.3	35.3	147.6	3.1	28.4	25.6	5.5	2.4	5.3	43.2	36.1	16.5	108.5	93.0	3.0	0.0	0.0	0.9	0.0	5.4	54.4	0.1	0.1	6.7	0.2	0.1	0.0	0.0	0.6	1.8	8.2	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.1	1.8	0.0	13.2	0.2	0.2	14.4	0.3	2.6	0.0	29.7	0.0	0.0	0.0	0.1	1.1	0.0	0.0	0.4	4.2	0.0	0.0	0.0	123.4	0.2	4.8	0.0	0.5	0.2	0.1	0.1	0.1	3.2	0.0	0.1	0.0	1.3	0.3	0.2	2.9	0.4	0.0	0.2	0.3	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	1.9	1.5	2.4	1.5	2.0	3.4	2.2	2.7	3.1	2.4	3.0	8.0	0.0	1.1	0.0	0.1	11.3	0.4	2.1	75.1	0.1	1.8	25.3	13.2	0.0	4.3	1.8	0.0	34.4	0.3	0.0	0.0	0.0	1.0	6.9	97.0	7.8	0.0	0.0	5.6	0.0	4.0	235.9	6.1	11.3	3.8	0.2	18.5	0.0	6.2	0.0	5.2	0.0	0.0	0.0	18.5	1.4	14.6	1.7	5.4	5.6	0.0	0.1	0.0	1.0	3.3	0.0	0.0	15.4	0.5	0.6	0.0	0.0	0.1	0.5	0.0	4.2	118.2	4.4	2.8	3.9	9.7	25.3	2.7	4.5	0.0	0.3
COL15A1		ENSG00000204291	"Collagen type XV alpha 1 chain"	P39059	9	98943179-99070792	"Plasma proteins, Predicted secreted proteins"	"Angiogenesis, Cell adhesion, Differentiation"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 229.2"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 307.0;Endothelial cells: 190.5;Fibroblasts: 202.3;Leydig cells: 326.8;Peritubular cells: 483.3;Theca cells: 333.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 26.4;BJ hTERT+: 55.6;HDLM-2: 24.5;K-562: 18.8;U-2197: 45.6;U-87 MG: 20.6;WM-115: 31.0"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in many"	7	"spinal cord: 44.3"	"HPA017913, HPA017915"	Enhanced		Approved	"Endoplasmic reticulum"	"Secreted to extracellular matrix"	NA	NA		28000000		"Cluster 28: Placenta - Pregnancy"	"Cluster 18: U-2197 - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Endoplasmic reticulum"		"HPA017913: AB_1847099, HPA017915: AB_1847100"	"unprognostic (4.30e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.22e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.09e-2)"	"prognostic favorable (5.47e-4)"	"unprognostic (3.08e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.84e-1)"	"unprognostic (7.87e-2)"	"unprognostic (1.20e-3)"	"unprognostic (3.66e-3)"	"unprognostic (8.98e-2)"	"unprognostic (6.98e-2)"	"prognostic unfavorable (3.08e-4)"	84.7	36.9	0.6	50.6	0.9	0.1	46.7	0.8	1.0	31.2	4.0	44.5	12.9	53.8	19.2	26.9	17.3	42.8	58.0	0.4	0.8	12.9	1.0	11.1	10.4	0.6	0.9	23.2	26.8	11.8	6.0	229.2	0.7	21.6	16.3	0.0	35.9	14.3	56.5	15.1	17.7	108.9	0.6	3.7	27.3	27.0	2.4	13.0	21.1	34.4	8.6	42.1	15.1	0.7	0.0	0.0	0.1	0.0	4.6	2.6	0.1	26.4	55.6	1.4	0.5	0.0	0.0	0.2	0.7	5.8	0.2	0.1	0.0	0.0	0.2	24.5	0.0	0.3	12.9	0.0	1.1	0.4	2.5	7.6	0.0	6.0	0.2	0.0	0.0	0.0	18.8	0.0	2.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	14.7	0.2	0.0	0.0	0.1	0.1	0.8	3.9	7.4	0.3	0.2	0.6	0.0	0.1	0.6	45.6	0.5	0.2	0.0	0.0	20.6	0.2	31.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.6	0.9	0.8	1.0	0.4	0.8	0.6	0.9	0.7	0.6	2.4	0.7	307.0	0.0	0.0	0.7	0.5	19.5	0.1	0.0	5.2	0.0	2.6	4.1	8.1	0.0	0.0	0.0	0.0	3.8	1.8	0.0	0.0	2.4	5.7	3.9	103.4	190.5	0.0	0.0	0.4	0.8	3.7	202.3	0.5	2.2	0.0	0.3	0.0	0.0	7.6	0.0	2.9	0.0	0.0	0.3	27.2	22.5	326.8	3.1	17.8	46.9	0.6	0.0	1.0	1.0	0.3	0.6	0.0	483.3	0.3	1.2	0.0	0.5	0.0	0.0	13.1	107.8	52.8	1.9	1.2	1.3	16.3	7.7	2.1	333.4	0.0	0.7
COL5A1		ENSG00000130635	"Collagen type V alpha 1 chain"	P20908	9	134641803-134844843	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		Heparin-binding	"Cancer-related genes, Disease variant, Ehlers-Danlos syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"cervix: 146.6"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 141.1;Fibroblasts: 134.9;Leydig cells: 61.2;Sertoli cells: 52.6;Skeletal myocytes: 78.3;Smooth muscle cells: 57.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 446.6;fHDF/TERT166: 414.6;HeLa: 297.0;HHSteC: 265.8;SiHa: 290.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA030769	Approved		Approved	Vesicles	"Secreted to extracellular matrix"	No	No		15000000		"Cluster 46: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"	Vesicles		"HPA030769: AB_2673603"	"unprognostic (7.77e-2)"	"unprognostic (4.55e-3)"	"unprognostic (2.22e-2)"	"unprognostic (2.33e-1)"	"prognostic unfavorable (9.56e-4)"	"unprognostic (8.07e-2)"	"unprognostic (8.09e-2)"	"unprognostic (2.38e-3)"	"unprognostic (1.54e-2)"	"unprognostic (5.03e-3)"	"unprognostic (5.05e-2)"	"unprognostic (1.40e-1)"	"prognostic unfavorable (2.07e-12)"	"unprognostic (2.02e-2)"	"unprognostic (4.73e-2)"	"unprognostic (1.65e-2)"	"unprognostic (2.50e-3)"	39.3	12.0	1.3	39.1	1.5	1.0	20.0	1.9	2.7	146.6	3.4	72.0	13.5	118.2	11.1	23.2	59.6	77.6	32.8	1.2	1.9	11.5	7.6	35.7	5.5	4.0	2.5	51.9	7.0	6.8	6.6	95.8	1.3	43.8	16.3	3.1	9.3	28.9	10.2	24.6	22.0	89.6	1.8	17.6	31.4	6.2	4.6	2.3	10.1	7.3	2.9	51.6	63.4	1.4	0.6	16.7	13.0	20.7	192.2	202.4	7.9	446.6	89.0	73.6	78.6	0.2	0.3	0.0	95.3	414.6	39.8	5.6	0.0	0.1	21.3	0.1	1.0	0.3	297.0	0.1	265.8	0.2	2.7	200.0	0.2	71.1	5.6	0.0	89.2	0.1	0.1	1.2	39.5	4.1	0.3	0.9	7.6	0.0	8.5	15.7	50.3	1.8	0.1	0.1	5.3	2.5	290.0	1.8	0.2	173.7	0.6	0.2	152.6	154.4	61.9	190.4	93.7	0.3	0.2	0.4	121.6	0.1	26.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	1.5	1.9	2.7	1.2	1.9	4.0	2.5	1.3	1.8	4.6	1.4	7.9	0.0	1.8	0.7	0.3	14.5	3.5	0.8	3.4	8.5	0.8	2.7	9.0	0.0	0.0	1.8	2.1	6.4	0.3	0.0	1.9	2.2	5.5	4.2	141.1	8.8	0.0	0.0	6.6	0.0	12.3	134.9	1.5	4.8	0.0	1.2	21.8	0.0	8.9	0.0	1.2	0.0	0.0	0.3	15.3	15.6	61.2	1.5	7.2	12.2	0.0	6.4	0.0	5.5	0.3	1.3	0.0	38.7	0.3	1.0	0.0	0.3	0.0	1.2	52.6	78.3	57.5	0.5	0.8	0.6	7.7	10.4	2.6	11.7	0.0	0.4
COL6A1		ENSG00000142156	"Collagen type VI alpha 1 chain"	P12109	21	45981769-46005050	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Cell adhesion"		"Cancer-related genes, Congenital muscular dystrophy, Disease variant, Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 796.8"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 578.3;Fibroblasts: 816.1;Leydig cells: 353.0;Peritubular cells: 251.3;Smooth muscle cells: 324.4;Theca cells: 246.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 1157.2;ASC TERT1: 2331.5;BJ: 927.1;HHSteC: 1025.3;HSkMC: 1711.4;U-138 MG: 1297.6"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"spinal cord: 46.8"	"HPA019142, HPA029401"	Enhanced		Approved	Cytosol	"Secreted to extracellular matrix"	NA	NA		250000000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"	Cytosol		"HPA019142: AB_1847093, HPA029401: AB_10601361"	"unprognostic (3.45e-1)"	"unprognostic (4.09e-2)"	"unprognostic (8.71e-2)"	"unprognostic (1.72e-1)"	"unprognostic (5.79e-3)"	"unprognostic (2.12e-1)"	"unprognostic (6.27e-2)"	"unprognostic (1.09e-2)"	"unprognostic (4.47e-2)"	"unprognostic (3.69e-2)"	"unprognostic (6.06e-3)"	"unprognostic (3.86e-1)"	"prognostic unfavorable (1.07e-8)"	"unprognostic (5.16e-2)"	"unprognostic (7.39e-2)"	"unprognostic (3.53e-3)"	"prognostic unfavorable (4.54e-4)"	285.9	50.1	15.7	153.3	9.0	0.7	173.9	33.9	20.4	499.3	32.1	796.8	73.3	556.3	24.6	91.1	411.5	194.4	155.6	10.3	14.9	66.1	48.3	140.3	37.5	23.1	18.4	491.4	57.8	29.1	117.8	287.1	21.5	246.8	40.5	3.4	97.7	142.3	85.4	123.4	217.7	177.9	11.3	70.7	230.5	32.8	14.9	30.7	92.6	39.5	16.6	478.7	284.7	9.7	2.9	20.2	31.2	99.6	1157.2	2331.5	3.9	927.1	586.3	231.7	80.7	16.2	62.8	0.1	75.1	522.2	183.6	4.3	13.5	2.3	19.5	0.5	14.9	0.0	3.7	5.2	1025.3	0.3	2.2	1711.4	1.0	578.6	7.8	20.9	5.6	0.2	0.7	0.6	60.9	1.4	0.3	3.2	22.4	13.4	263.2	0.1	19.5	4.3	1.6	11.1	1.0	39.9	87.6	1.1	17.9	10.4	4.2	4.2	0.5	1297.6	86.7	362.7	358.1	0.6	0.4	0.4	464.1	6.9	116.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.7	9.0	33.9	20.4	10.3	14.9	23.1	18.4	21.5	11.3	14.9	9.7	74.6	0.0	5.8	26.1	2.5	122.2	11.0	1.5	18.2	18.9	9.2	35.9	42.7	5.7	4.4	9.2	0.0	11.6	2.3	0.6	3.9	23.2	4.6	20.9	578.3	50.6	1.8	0.0	27.1	3.3	18.6	816.1	6.1	16.1	1.3	48.7	101.0	13.4	22.4	15.2	8.2	0.3	0.0	3.3	134.7	18.6	353.0	7.8	147.7	40.3	2.0	18.7	0.0	30.7	2.4	6.1	2.6	251.3	3.5	6.3	2.1	10.3	1.0	4.3	184.1	152.3	324.4	2.6	6.2	5.5	89.9	20.8	13.7	246.5	1.4	3.8
COL8A1	"C3orf7, MGC9568"	ENSG00000144810	"Collagen type VIII alpha 1 chain"	P27658	3	99638475-99799226	"Plasma proteins, Predicted secreted proteins"	"Angiogenesis, Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 246.8;Fibroblasts: 53.3;Hepatic stellate cells: 102.8;Smooth muscle cells: 51.6"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 34.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 1098.3;hTERT-RPE1: 431.9;LHCN-M2: 313.0;TIME: 471.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA053107	Enhanced		Supported	Vesicles	"Secreted to extracellular matrix"	NA	NA				"Cluster 46: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Vesicles		"HPA053107: AB_2682046"	"unprognostic (3.13e-2)"	"unprognostic (2.92e-2)"	"unprognostic (2.27e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.07e-3)"	"unprognostic (2.49e-1)"	"unprognostic (2.31e-2)"	"unprognostic (4.83e-2)"	"unprognostic (2.62e-2)"	"unprognostic (4.79e-2)"	"unprognostic (3.58e-2)"	"unprognostic (3.71e-1)"	"prognostic unfavorable (9.39e-8)"	"unprognostic (2.98e-3)"	"unprognostic (1.72e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.32e-3)"	33.0	7.0	1.7	5.8	2.9	0.0	5.7	1.8	2.6	3.8	4.4	12.4	1.0	5.2	2.7	11.1	9.1	10.8	39.1	1.3	3.0	5.9	0.9	32.8	0.9	3.1	3.9	9.2	1.2	17.9	11.3	4.2	3.4	12.7	6.9	0.5	7.0	12.0	2.3	3.2	3.7	31.5	2.7	1.0	5.3	0.5	2.6	0.4	27.5	7.8	0.5	25.0	5.4	2.5	0.1	0.4	3.0	0.3	142.2	236.4	0.2	68.5	45.7	69.6	138.6	0.0	0.3	0.1	5.9	1098.3	1.9	0.1	0.4	88.2	157.8	0.1	0.2	0.1	7.9	0.0	26.8	0.0	0.1	142.8	3.2	52.6	82.9	431.9	129.4	0.0	0.1	0.2	313.0	0.0	0.0	0.0	2.6	0.0	0.9	0.0	0.0	0.0	144.3	0.0	0.0	0.0	0.0	0.0	0.0	20.8	0.1	0.2	471.5	31.0	24.1	1.6	34.2	0.1	0.0	0.1	58.4	0.0	241.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	2.9	1.8	2.6	1.3	3.0	3.1	3.9	3.4	2.7	2.6	2.5	4.4	246.8	22.1	0.0	0.4	0.8	0.5	2.8	14.8	0.4	1.8	5.2	4.9	4.3	3.9	9.2	0.0	0.1	0.9	0.0	0.0	0.1	1.3	0.2	2.6	14.1	0.0	0.0	1.9	0.0	0.3	53.3	2.0	0.3	5.1	0.2	102.8	0.8	0.1	0.0	0.7	0.0	0.0	1.9	2.3	1.0	2.1	0.8	1.8	4.7	0.2	0.7	2.1	9.0	0.6	0.1	0.0	9.4	0.5	0.2	0.0	1.6	1.0	0.6	0.0	1.9	51.6	0.3	0.3	1.0	0.6	0.4	0.9	0.1	0.0	0.5
COL8A2	"FECD, FECD1, PPCD, PPCD2"	ENSG00000171812	"Collagen type VIII alpha 2 chain"	P25067	1	36095239-36125222	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Angiogenesis, Cell adhesion"		"Corneal dystrophy, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Breast myoepithelial cells: 10.2;Cardiomyocytes: 13.5;Fibroblasts: 13.4;Macrophages: 6.8;Melanocytes: 7.2;Microglial cells: 8.4;Sertoli cells: 6.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 5.8;fHDF/TERT166: 4.3;HHSteC: 14.1;hTERT-RPE1: 18.2;THP-1: 4.7"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"spinal cord: 3.6"	HPA049788	Uncertain		Uncertain	"Golgi apparatus"	"Secreted to extracellular matrix"	NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"	"Golgi apparatus"		"HPA049788: AB_2680882"	"unprognostic (9.98e-2)"	"unprognostic (3.26e-2)"	"unprognostic (2.51e-2)"	"unprognostic (8.41e-3)"	"unprognostic (8.76e-2)"	"prognostic favorable (9.44e-4)"	"unprognostic (1.15e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (7.26e-4)"	"unprognostic (3.50e-2)"	"unprognostic (3.01e-1)"	"prognostic unfavorable (9.35e-5)"	"unprognostic (1.08e-2)"	"unprognostic (6.77e-2)"	"unprognostic (2.24e-2)"	"unprognostic (1.16e-3)"	5.2	1.2	2.5	4.4	2.2	0.5	5.6	6.1	2.4	9.0	18.3	5.9	1.4	5.7	1.6	5.8	4.2	4.8	5.4	2.3	2.9	1.1	0.6	4.6	3.1	9.0	4.2	3.3	0.8	0.7	4.0	12.8	7.1	6.1	2.0	0.4	7.4	11.4	0.6	5.5	2.4	3.7	6.1	8.5	9.1	0.9	4.2	4.9	7.5	2.1	3.5	13.3	5.9	5.7	0.0	0.0	0.0	0.0	0.5	1.0	0.1	5.8	1.7	1.6	0.9	0.2	0.1	0.0	0.8	4.3	0.0	0.3	0.0	0.1	1.2	0.0	0.0	0.0	0.1	0.1	14.1	0.0	0.0	1.7	0.1	0.7	0.0	18.2	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.4	0.1	0.1	0.0	0.5	0.5	0.5	0.0	0.2	0.4	0.0	4.7	0.1	2.3	0.3	0.4	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	2.5	2.2	6.1	2.4	2.3	2.9	9.0	4.2	7.1	6.1	4.2	5.7	0.6	0.0	1.8	0.3	0.0	2.2	2.2	1.8	0.0	0.1	1.3	10.2	13.5	0.0	0.7	0.0	0.0	0.4	1.4	0.0	0.0	0.4	0.1	0.2	0.2	0.7	0.0	0.0	0.2	0.2	0.3	13.4	0.5	0.3	2.5	0.5	1.1	0.0	6.2	0.0	0.4	0.0	0.0	2.0	2.7	0.2	3.1	6.8	7.2	8.4	1.2	0.3	0.0	0.5	0.1	0.6	0.0	6.0	0.1	5.3	0.0	0.0	0.2	0.2	6.6	0.7	1.4	0.0	0.3	0.1	1.3	0.8	1.2	0.3	0.0	0.4
COLEC12	"CL-P1, SCARA4, SRCL"	ENSG00000158270	"Collectin subfamily member 12"	Q5KU26	18	316737-500722	"Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 31.6"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 104.4;Cytotrophoblasts: 149.0;Fibroblasts: 79.6;Hofbauer cells: 155.9;Microglial cells: 245.4;Muller glia cells: 74.5;Syncytiotrophoblasts: 111.2"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 14.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 24.3;BJ: 12.1;HSkMC: 20.0;U-2197: 31.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA047917, HPA071056"	Enhanced		Approved	"Golgi apparatus,Vesicles,Cell Junctions"		NA	NA		580000	"Cluster 17: Basophils - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 18: U-2197 - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Golgi apparatus, Vesicles"	"Cell Junctions"	"HPA047917: AB_2680208, HPA071056: AB_2686338"	"unprognostic (8.67e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.51e-2)"	"unprognostic (3.60e-2)"	"unprognostic (6.94e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.14e-4)"	"unprognostic (2.21e-1)"	"unprognostic (1.21e-1)"	"unprognostic (4.86e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.61e-1)"	"unprognostic (2.24e-3)"	"unprognostic (1.52e-2)"	"prognostic unfavorable (8.10e-4)"	"unprognostic (3.01e-3)"	12.4	1.7	5.1	2.4	4.8	0.2	5.5	4.7	5.7	31.6	9.7	5.5	1.5	9.0	1.0	2.0	6.5	4.4	6.6	4.6	7.2	2.4	0.3	11.4	2.0	7.7	6.5	2.0	1.1	0.9	0.9	20.0	5.2	4.0	2.4	5.3	4.1	1.4	3.1	3.6	3.5	5.1	4.3	0.3	3.4	1.4	6.5	1.3	5.2	2.0	2.5	8.1	4.0	5.5	0.0	0.0	2.1	0.0	2.3	24.3	0.8	12.1	4.2	1.7	3.1	0.0	0.0	0.0	0.1	2.0	0.1	0.0	0.3	0.0	0.0	0.0	1.7	0.0	0.1	0.0	0.1	0.0	0.0	20.0	0.0	1.0	0.0	0.7	4.7	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.4	0.0	0.0	0.7	0.0	6.5	0.0	0.0	0.1	0.3	0.0	0.1	0.0	1.9	0.1	0.0	0.0	2.8	0.4	31.3	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.4	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.1	0.1	0.1	0.0	0.0	5.1	4.8	4.7	5.7	4.6	7.2	7.7	6.5	5.2	4.3	6.5	5.5	6.8	3.2	104.4	34.3	2.1	4.1	3.2	0.0	1.2	6.4	2.6	1.7	4.0	2.8	10.7	3.7	10.4	149.0	1.4	0.3	0.0	0.2	11.1	0.5	3.9	15.8	15.7	2.7	0.5	0.0	5.3	79.6	0.0	0.8	13.9	1.2	5.7	0.4	155.9	6.7	1.4	1.0	0.0	4.9	8.9	31.4	61.5	32.1	1.8	245.4	16.2	74.5	3.1	2.0	10.4	0.3	0.6	7.2	1.2	6.5	1.4	0.2	1.7	12.4	0.0	13.2	21.6	1.3	2.5	1.8	3.8	111.2	4.8	11.6	0.8	1.3
CRABP2	CRABP-II	ENSG00000143320	"Cellular retinoic acid binding protein 2"	P29373	1	156699606-156705816	"Predicted intracellular proteins"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 1189.7;vagina: 604.9"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 485.4;Breast glandular cells: 224.2;Club cells: 266.7;Squamous epithelial cells: 714.0;Urothelial cells: 506.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 1592.5;MCF7: 625.9;T-47d: 1201.3"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"spinal cord: 36.0"	HPA004135	Supported		Supported	Nucleoplasm,Cytosol		NA	NA		76000	"Cluster 32: T-cells - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 6: T47d - Mammary gland"	"Cluster 61: Squamous epithelial cells - Keratinization"	Cytosol	Nucleoplasm	"HPA004135: AB_1846516"	"unprognostic (1.17e-2)"	"unprognostic (9.30e-2)"	"unprognostic (3.07e-2)"	"prognostic unfavorable (2.11e-5)"	"unprognostic (1.75e-2)"	"unprognostic (1.08e-1)"	"unprognostic (9.96e-2)"	"unprognostic (1.88e-1)"	"unprognostic (6.45e-2)"	"unprognostic (7.79e-2)"	"unprognostic (7.23e-3)"	"unprognostic (7.16e-2)"	"prognostic unfavorable (3.19e-13)"	"unprognostic (3.05e-3)"	"unprognostic (1.34e-1)"	"unprognostic (3.86e-2)"	"unprognostic (2.25e-2)"	22.2	8.0	9.6	4.8	11.5	5.7	104.5	10.5	18.8	273.7	29.4	13.3	0.9	76.3	4.7	1189.7	83.1	18.2	5.5	10.7	12.8	12.0	2.3	6.4	3.9	8.0	8.2	6.2	3.4	55.1	43.5	40.5	7.8	34.8	4.8	4.5	93.5	57.1	5.0	179.0	3.9	57.0	7.4	7.9	5.6	5.3	12.0	15.5	14.5	1.8	76.2	81.2	604.9	10.1	103.4	5.4	115.3	1.6	147.1	218.0	0.4	215.4	1592.5	17.3	21.3	184.9	369.8	1.6	103.1	234.0	2.2	131.2	28.1	0.8	5.1	2.9	8.1	0.1	13.5	1.6	29.0	0.3	2.5	69.3	10.6	25.4	0.5	13.8	0.7	2.0	1.0	2.2	1.9	625.9	1.7	1.9	136.5	12.3	57.3	1.7	0.8	3.4	2.3	4.0	280.7	20.2	3.0	366.2	1.5	214.9	1201.3	0.7	0.2	4.2	63.1	35.5	13.4	9.8	23.8	1.3	28.6	1.6	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	9.6	11.5	10.5	18.8	10.7	12.8	8.0	8.2	7.8	7.4	12.0	10.1	7.0	0.0	2.6	1.3	1.8	65.0	131.2	485.4	104.2	1.8	224.2	96.8	0.7	1.5	266.7	16.5	2.1	53.9	4.9	0.9	0.0	12.6	2.2	18.0	51.9	10.3	0.0	0.0	3.1	5.2	6.2	168.4	1.1	29.3	0.0	0.5	6.4	0.2	10.0	0.0	1.8	0.9	40.7	0.0	55.4	1.0	19.9	3.9	62.2	0.0	0.0	1.0	0.0	1.5	0.3	18.1	0.2	37.6	0.2	194.9	0.1	0.3	28.2	0.6	0.0	4.3	40.0	2.0	6.1	714.0	190.7	18.1	7.6	4.8	1.7	506.4
CTSK	"CTSO, CTSO2, PKND, PYCD"	ENSG00000143387	"Cathepsin K"	P43235	1	150794880-150809577	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protease, Thiol protease"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"cervix: 420.6"	"Cell type enhanced"	"Detected in many"		"Fibroblasts: 372.4;Langerhans cells: 123.6;Leydig cells: 119.0;Melanocytes: 97.8;Peritubular cells: 149.7;Theca cells: 80.9"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	6	"cerebral cortex: 18.1"	"Immune cell enhanced"	"Detected in some"		"classical monocyte: 1.8"	"Lineage enriched"	"Detected in single"	4	"monocytes: 1.8"	"Group enriched"	"Detected in many"	9	"ASC diff: 2284.0;ASC TERT1: 813.2;BJ hTERT+: 1949.1"	"Low region specificity"	"Detected in all"							HPA050346			Supported	Vesicles	"Intracellular and membrane"	NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Vesicles		"HPA050346: AB_2681101"	"unprognostic (1.48e-1)"	"unprognostic (9.29e-2)"	"unprognostic (1.21e-1)"	"unprognostic (7.61e-3)"	"unprognostic (5.08e-2)"	"unprognostic (6.57e-2)"	"unprognostic (1.02e-1)"	"unprognostic (6.60e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.54e-2)"	"prognostic unfavorable (7.12e-5)"	"unprognostic (6.07e-3)"	"unprognostic (2.98e-2)"	"unprognostic (5.93e-3)"	"unprognostic (6.41e-2)"	224.1	12.5	2.7	33.1	2.8	3.1	227.7	2.9	18.1	420.6	16.4	68.6	13.8	334.0	44.9	46.0	74.0	299.2	35.8	2.7	2.6	12.7	9.0	36.4	42.1	2.7	2.7	78.4	10.6	6.1	14.6	18.9	2.6	34.1	61.8	6.9	53.3	38.0	15.7	219.8	63.8	141.6	2.8	20.2	41.7	15.1	2.7	12.3	34.7	46.3	48.7	210.5	176.2	2.9	0.7	0.3	1.4	0.8	2284.0	813.2	1.0	55.2	1949.1	3.3	8.3	0.3	0.3	0.4	0.6	129.8	0.0	0.6	0.3	0.4	1.2	0.4	0.4	1.4	0.5	0.0	11.0	0.2	1.3	156.5	1.7	50.5	0.7	137.6	4.2	0.6	0.4	1.4	1.5	1.4	0.0	3.0	10.2	1.0	0.0	0.2	0.1	0.1	3.2	0.1	0.6	2.9	0.4	0.0	29.3	3.9	1.0	1.5	1.0	0.7	0.5	0.6	0.6	2.3	1.7	3.6	184.1	0.0	9.9	0.0	1.8	0.2	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.3	0.2	0.4	0.6	2.7	2.8	2.9	18.1	2.7	2.6	2.7	2.7	2.6	2.8	2.7	2.9	17.9	3.2	4.6	2.6	1.1	68.8	0.5	1.6	2.2	12.1	3.7	9.5	2.0	1.5	3.9	3.7	4.2	1.3	2.8	1.5	0.0	1.0	0.9	2.5	59.0	10.2	1.2	0.8	5.0	0.2	2.5	372.4	11.2	3.8	0.0	77.5	14.6	0.5	21.4	3.3	7.7	1.6	8.2	4.6	123.6	4.4	119.0	8.7	97.8	7.5	4.9	2.7	3.1	7.1	2.5	1.4	1.4	149.7	0.8	1.0	1.4	0.1	2.2	7.7	13.1	4.5	33.9	1.4	1.0	2.6	59.1	1.0	5.4	80.9	1.0	0.7
CYGB	"HGB, STAP"	ENSG00000161544	Cytoglobin	Q8WWM9	17	76527356-76551175	"Predicted intracellular proteins, Transporters"	"Oxygen transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 104.4"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 94.3;Fibroblasts: 87.6;Leydig cells: 95.7;Melanocytes: 78.2;Sertoli cells: 92.1;Smooth muscle cells: 95.6"	"Cancer enhanced"	"Detected in all"		"melanoma: 34.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"naive B-cell: 2.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 79.6;Hep G2: 61.7;HHSteC: 120.7;HSkMC: 95.4;SH-SY5Y: 129.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017757, HPA061642"	Approved	Approved	Supported	"Nuclear speckles,Cytosol"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 50: Fibroblasts - ECM organization"	"Nuclear speckles"	Cytosol	"HPA017757: AB_1847410, HPA061642: AB_2684573"	"unprognostic (6.96e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.97e-2)"	"prognostic favorable (2.55e-5)"	"prognostic unfavorable (1.85e-4)"	"unprognostic (3.36e-2)"	"unprognostic (3.31e-3)"	"unprognostic (2.01e-1)"	"unprognostic (7.83e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.08e-2)"	"unprognostic (4.14e-2)"	"prognostic unfavorable (2.13e-4)"	"unprognostic (3.34e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.49e-2)"	"unprognostic (7.76e-2)"	79.6	20.8	10.1	12.0	10.7	1.7	55.1	20.6	13.6	27.7	14.1	27.1	21.1	19.6	4.6	12.8	20.4	13.2	104.4	9.5	15.8	12.4	19.0	27.8	7.2	17.5	26.0	13.8	12.8	11.7	10.9	8.9	26.8	29.9	9.3	77.6	14.2	11.0	19.3	19.5	26.6	5.9	10.1	12.2	22.9	5.3	14.3	5.3	50.1	9.6	2.6	50.7	25.6	9.8	0.2	1.1	1.8	0.4	79.6	23.1	26.1	0.7	2.0	0.3	0.9	0.0	0.3	0.2	24.1	2.4	0.3	0.7	0.1	33.7	0.1	0.1	0.2	0.4	0.4	61.7	120.7	0.0	0.0	95.4	7.2	2.5	2.5	0.4	0.3	0.8	0.3	0.1	1.2	0.8	0.2	0.4	0.3	0.0	1.4	0.5	0.3	0.2	0.4	0.1	0.6	129.8	0.1	0.0	2.7	5.9	0.2	0.6	0.2	3.1	1.6	0.3	0.0	1.2	0.3	0.3	0.2	0.3	9.9	0.0	0.1	0.1	0.2	0.1	0.1	1.6	0.1	0.0	0.1	2.2	0.2	0.5	0.9	1.0	0.0	0.0	0.2	0.2	10.1	10.7	20.6	13.6	9.5	15.8	17.5	26.0	26.8	10.1	14.3	9.8	94.3	3.2	2.0	2.0	3.5	10.8	1.3	17.3	3.4	38.5	1.4	5.7	6.1	0.0	6.7	0.0	0.0	1.4	1.9	0.1	0.0	0.8	0.7	2.9	4.2	23.1	0.0	0.0	2.4	0.2	0.6	87.6	1.5	0.7	0.0	0.2	2.2	1.2	0.4	8.4	12.3	0.0	0.0	0.0	13.3	2.5	95.7	2.6	78.2	3.7	0.0	22.1	0.0	1.0	1.0	0.1	0.0	23.3	0.6	0.8	0.0	0.2	21.1	12.9	92.1	21.8	95.6	1.6	1.4	0.7	6.7	2.9	2.6	9.2	0.0	1.0
DCN	"DSPG2, SLRR1B"	ENSG00000011465	Decorin	P07585	12	91140484-91183217	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes, Corneal dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 1218.7;Fibroblasts: 7960.2;Leydig cells: 6281.9;Peritubular cells: 1856.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	9	"basophil: 24.5"	"Lineage enriched"	"Detected in single"	35	"granulocytes: 24.5"	"Cell line enhanced"	"Detected in many"		"ASC diff: 3291.1;ASC TERT1: 2371.6;BJ hTERT+: 2546.6;HSkMC: 2289.4"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	8	"spinal cord: 544.7"	"HPA003315, CAB017118, HPA064736, CAB068930"	Enhanced				"Secreted to extracellular matrix"	NA	NA		1900000	"Cluster 46: Basophils - DNA binding"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"			"CAB017118: , CAB068930: AB_425394, HPA003315: AB_1078639, HPA064736: AB_2685340"	"unprognostic (1.73e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.43e-1)"	"unprognostic (3.22e-2)"	"unprognostic (8.63e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.01e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.98e-1)"	"unprognostic (6.12e-2)"	"unprognostic (1.65e-1)"	"unprognostic (5.15e-2)"	"prognostic unfavorable (1.46e-5)"	"unprognostic (3.06e-3)"	"unprognostic (5.37e-2)"	"unprognostic (1.59e-3)"	"unprognostic (7.56e-3)"	1522.3	1171.7	60.6	272.0	80.0	4.4	2342.2	63.5	119.2	1493.0	111.6	549.9	163.5	1308.5	1302.0	932.8	1213.4	1802.7	2108.9	66.8	60.3	394.8	459.6	955.8	130.4	68.9	60.9	2681.4	257.9	80.2	112.0	1534.8	75.7	451.6	493.0	3.1	362.5	462.3	469.0	713.4	336.6	1027.8	70.2	20.0	434.5	279.6	72.8	183.0	479.3	1328.3	293.6	1895.5	783.7	57.9	0.2	0.4	4.4	0.6	3291.1	2371.6	6.2	608.7	2546.6	28.8	28.5	0.3	0.9	1.1	0.5	523.5	0.6	2.1	0.8	1.9	4.9	0.7	0.5	0.6	20.4	0.1	717.4	1.3	1.4	2289.4	8.9	78.3	38.5	12.1	1.0	0.2	0.8	0.7	63.0	0.6	1.5	10.8	1.2	0.4	1.6	0.7	2.3	2.8	3.4	0.5	2.7	11.9	10.3	1.1	0.9	1.8	0.6	0.4	0.9	132.3	1.2	497.5	0.6	3.3	3.1	2.0	8.0	2.0	0.8	24.5	0.3	0.6	0.3	0.1	0.3	0.3	0.3	0.2	0.1	0.6	0.4	0.4	2.7	0.4	0.2	0.7	0.2	0.0	60.6	80.0	63.5	119.2	66.8	60.3	68.9	60.9	75.7	70.2	72.8	57.9	351.1	41.7	44.1	2.3	4.1	609.1	5.4	0.0	264.6	1.9	25.5	31.5	154.7	10.0	11.8	20.2	0.0	31.2	12.8	0.0	1.9	1.0	25.0	39.4	1218.7	158.7	0.0	2.7	0.8	0.0	30.0	7960.2	54.0	22.0	21.5	0.2	214.9	1.4	58.8	0.0	17.1	0.1	0.0	2.8	962.7	103.0	6281.9	52.5	606.5	122.7	0.0	3.3	0.0	0.0	1.4	2.7	0.5	1856.9	23.2	5.8	0.0	0.4	5.8	0.7	210.4	236.8	408.2	13.4	9.2	36.8	482.5	63.9	72.3	70.2	0.0	10.7
DIO2	"SelY, TXDI2"	ENSG00000211448	"Iodothyronine deiodinase 2"	Q92813	14	80197526-80387757	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Thyroid hormones biosynthesis"	Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 163.9;thyroid gland: 355.8"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 150.7;Endometrial stromal cells: 158.3;Extravillous trophoblasts: 523.3;Muller glia cells: 246.4"	"Cancer enriched"	"Detected in many"	5	"thyroid cancer: 34.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 80.8;fHDF/TERT166: 41.8;HeLa: 95.4;HHSteC: 44.2;SiHa: 168.1;SK-BR-3: 35.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048002			Approved	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA				"Cluster 1: Thyroid gland - Transcription"	"Cluster 20: HeLa - Mitochondria"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Nucleoplasm, Vesicles"	"Plasma membrane"	"HPA048002: AB_2680230"	"unprognostic (1.22e-1)"	"unprognostic (1.69e-1)"	"prognostic favorable (1.67e-4)"	"prognostic favorable (4.62e-6)"	"unprognostic (2.76e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.07e-1)"	"unprognostic (8.78e-2)"	"unprognostic (3.68e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.00e-3)"	"unprognostic (5.08e-2)"	"unprognostic (3.43e-1)"	"unprognostic (8.40e-2)"	"unprognostic (7.15e-2)"	1.5	3.0	18.0	0.6	15.3	0.1	15.3	15.0	24.6	163.9	5.9	1.3	1.3	40.2	0.5	58.9	0.7	5.1	11.9	17.1	13.0	5.0	0.1	1.6	0.8	13.6	19.2	0.2	1.8	6.6	31.6	14.5	17.4	9.0	1.7	7.4	33.3	30.4	6.5	7.1	1.5	4.5	5.5	0.6	5.3	4.7	13.3	1.2	355.8	70.7	33.1	6.0	25.0	16.6	0.2	9.5	0.0	0.0	0.5	1.4	0.3	80.8	16.6	6.2	0.9	0.0	0.3	0.2	0.2	41.8	0.3	1.7	2.9	0.0	6.1	0.0	0.2	0.0	95.4	0.0	44.2	0.0	0.2	5.1	0.0	1.2	0.0	3.9	1.4	0.0	0.0	0.8	0.5	1.9	0.1	0.1	1.7	0.0	0.5	0.8	3.9	0.1	0.0	0.8	0.0	0.2	168.1	35.3	0.3	7.1	0.1	0.0	0.8	0.3	7.0	17.4	20.1	2.8	0.0	0.0	7.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.0	15.3	15.0	24.6	17.1	13.0	13.6	19.2	17.4	5.5	13.3	16.6	0.1	0.0	0.5	52.9	0.3	2.9	0.1	0.0	2.2	3.3	150.7	34.4	1.9	0.0	0.0	0.0	0.0	4.8	0.5	0.2	0.0	0.0	29.5	14.2	158.3	2.3	0.0	0.0	1.0	0.0	523.3	24.6	0.0	15.6	0.0	0.1	0.7	0.2	9.2	1.7	1.0	0.5	0.0	1.3	5.7	12.5	3.4	1.3	5.4	4.7	0.0	246.4	0.0	8.5	1.4	1.0	0.0	4.1	0.3	0.3	0.0	0.0	0.0	7.8	0.0	69.1	6.5	9.7	0.7	8.9	3.0	28.2	1.7	0.9	0.1	0.1
DNM1	DNM	ENSG00000106976	"Dynamin 1"	Q05193	9	128191655-128255248	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Endocytosis	"Hydrolase, Motor protein"	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 319.5"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 112.4;Cone photoreceptor cells: 89.6;Excitatory neurons: 176.1;Inhibitory neurons: 182.2;Rod photoreceptor cells: 78.4"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebral cortex: 319.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 126.9;U-87 MG: 46.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005920, HPA049910"	Enhanced					NA	NA		8800		"Cluster 10: Brain - Neuronal signaling"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"CAB005920: , HPA049910: AB_2680948"	"unprognostic (3.25e-2)"	"unprognostic (5.49e-2)"	"unprognostic (1.34e-3)"	"unprognostic (3.95e-2)"	"unprognostic (4.57e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.60e-3)"	"unprognostic (1.20e-1)"	"unprognostic (5.53e-2)"	"unprognostic (6.53e-2)"	"unprognostic (6.62e-3)"	"unprognostic (6.30e-1)"	"unprognostic (9.58e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.02e-1)"	"unprognostic (3.07e-3)"	"unprognostic (1.10e-3)"	22.2	7.9	99.8	3.7	129.1	2.0	13.2	13.6	319.5	30.8	0.0	8.0	1.9	8.8	2.4	5.5	9.4	13.4	7.8	140.1	15.9	14.1	5.3	4.6	2.4	50.7	4.1	2.5	8.4	4.1	33.6	2.5	36.6	9.0	2.7	68.3	9.0	3.0	3.2	15.0	9.0	5.3	0.0	1.0	5.0	4.9	10.0	0.9	5.2	4.0	1.8	10.6	21.6	123.1	8.7	126.9	11.3	2.8	3.6	36.8	0.6	8.0	18.9	15.7	6.5	1.7	2.6	0.2	10.7	16.7	0.6	15.3	1.8	0.8	8.6	0.1	12.1	8.3	19.5	0.5	2.6	1.1	5.6	9.8	0.2	12.4	0.2	15.2	0.0	7.3	3.1	0.5	0.0	3.6	0.7	2.7	12.2	2.2	23.1	15.6	0.4	3.9	2.4	0.0	16.1	27.1	27.1	0.8	1.2	1.4	0.3	11.2	0.6	0.5	34.8	36.2	16.6	1.0	0.4	0.8	46.8	0.4	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	99.8	129.1	13.6	319.5	140.1	15.9	50.7	4.1	36.6	0.0	10.0	123.1	2.2	0.0	0.0	18.9	0.9	7.9	1.7	0.3	8.0	112.4	2.9	3.9	2.0	5.7	0.8	0.0	89.6	0.3	0.2	0.4	1.9	0.8	0.9	1.3	19.0	1.8	0.0	0.0	176.1	0.9	0.4	24.3	2.6	1.4	1.3	2.8	0.7	0.6	10.6	50.5	182.2	0.9	0.0	0.6	10.5	1.0	2.8	9.2	3.6	22.5	1.3	10.7	0.0	33.7	14.3	0.6	5.0	1.5	0.7	0.8	2.5	5.3	1.1	78.4	0.0	2.1	3.8	1.0	1.8	2.5	7.5	0.8	1.6	2.1	1.6	0.8
DPYSL3	"CRMP4, DRP-3, ULIP"	ENSG00000113657	"Dihydropyrimidinase like 3"	Q14195	5	147390808-147510068	"Metabolic proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 101.5;Cone photoreceptor cells: 331.5;Granulosa cells: 261.9;Peritubular cells: 205.7;Rod photoreceptor cells: 125.0"	"Cancer enhanced"	"Detected in all"		"glioma: 109.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 685.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010948	Approved		Approved	Cytosol		NA	NA		740000		"Cluster 57: Non-specific - Angiogenesis"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 40: Granulosa cells - Unknown function"	Cytosol		"HPA010948: AB_1847245"	"unprognostic (3.92e-2)"	"unprognostic (1.90e-1)"	"unprognostic (5.00e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.30e-2)"	"unprognostic (5.99e-2)"	"unprognostic (6.92e-2)"	"unprognostic (4.72e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.20e-1)"	"prognostic unfavorable (3.87e-9)"	"unprognostic (1.14e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (8.23e-4)"	58.4	18.6	63.4	54.4	68.6	0.8	37.5	60.3	55.8	66.1	30.4	142.1	18.4	119.9	73.9	69.0	63.4	65.1	59.2	57.0	116.0	7.7	4.4	45.2	18.1	123.7	94.2	88.0	5.5	2.7	12.7	19.8	81.8	104.6	37.6	163.8	24.5	162.0	68.7	23.8	43.3	217.6	115.2	26.4	40.9	19.9	95.2	7.1	22.4	36.0	27.0	118.0	50.6	105.1	0.5	36.1	63.9	0.1	2.3	63.3	1.6	34.1	163.0	71.4	94.4	114.5	3.1	0.0	9.6	100.1	37.4	3.7	13.1	1.4	79.1	16.3	29.2	0.1	30.0	0.2	63.1	0.3	0.2	12.2	0.6	153.8	60.3	178.7	206.9	0.0	0.0	1.3	41.1	0.3	0.2	0.6	135.9	0.2	53.7	0.2	135.1	0.5	63.0	14.2	47.1	685.4	0.3	0.3	10.8	87.9	0.5	1.0	91.1	51.6	38.5	127.0	127.3	113.9	21.7	0.2	47.5	1.4	27.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	63.4	68.6	60.3	55.8	57.0	116.0	123.7	94.2	81.8	115.2	95.2	105.1	59.9	0.0	2.8	101.5	0.0	9.4	3.4	1.5	2.2	14.2	8.1	6.6	7.8	1.5	4.0	0.0	331.5	0.1	0.0	0.2	0.0	9.1	16.8	0.3	4.6	62.6	6.6	0.0	11.3	8.4	0.3	79.8	3.1	1.2	1.3	261.9	57.8	0.4	1.6	5.0	12.9	0.2	24.4	1.2	11.9	19.2	42.9	3.1	19.6	5.6	0.0	28.3	0.0	83.9	0.7	13.7	0.0	205.7	0.3	10.1	0.0	0.1	2.8	125.0	0.0	23.6	40.9	1.8	3.2	3.7	8.2	0.4	1.5	49.6	0.3	4.5
ECM1		ENSG00000143369	"Extracellular matrix protein 1"	Q16610	1	150508062-150513789	"Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Angiogenesis, Biomineralization, Mineral balance, Osteogenesis"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 484.1;esophagus: 1370.5"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 113.3;Fibroblasts: 118.6;Melanocytes: 74.7;Pancreatic endocrine cells: 70.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 402.1;BJ hTERT+: 293.1;fHDF/TERT166: 279.6;hTEC/SVTERT24-B: 195.6;LHCN-M2: 215.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027241, HPA076029"	Enhanced		Approved	Nucleoplasm,Cytosol	"Secreted to extracellular matrix"	NA	NA		8700000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Cytosol	Nucleoplasm	"HPA027241: AB_1847976, HPA076029: "	"unprognostic (2.89e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.09e-1)"	"unprognostic (6.79e-3)"	"unprognostic (8.42e-2)"	"unprognostic (2.15e-2)"	"unprognostic (4.90e-2)"	"unprognostic (7.50e-2)"	"prognostic unfavorable (3.55e-4)"	"unprognostic (5.33e-2)"	"prognostic unfavorable (1.51e-9)"	"unprognostic (1.23e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.36e-1)"	"prognostic unfavorable (1.20e-5)"	49.3	15.4	7.6	11.8	8.5	0.8	27.1	7.3	14.7	293.8	6.1	17.7	9.4	51.2	484.1	1370.5	20.1	76.5	81.3	8.1	8.3	15.9	61.2	26.3	1.2	17.4	8.9	8.9	4.1	3.5	12.7	44.6	15.4	15.5	18.1	0.9	223.9	14.0	7.0	70.0	12.4	32.6	8.9	11.5	12.4	2.7	9.4	1.3	11.1	7.8	135.0	24.4	360.1	10.7	35.4	3.5	12.6	0.2	73.9	402.1	11.4	126.9	293.1	76.2	99.5	1.9	19.1	0.6	1.3	279.6	8.8	71.5	0.2	15.0	79.3	0.6	0.7	5.7	4.1	0.7	20.4	0.3	125.5	35.7	0.9	195.6	7.2	112.8	21.3	0.7	27.7	0.8	215.2	0.1	0.4	4.2	1.4	147.8	4.1	2.0	92.7	0.5	2.8	0.1	0.8	0.4	28.8	0.9	106.4	5.8	0.3	34.0	5.8	159.3	23.9	18.3	27.9	0.5	1.1	1.5	84.6	11.7	22.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	7.6	8.5	7.3	14.7	8.1	8.3	17.4	8.9	15.4	8.9	9.4	10.7	9.1	0.0	1.1	2.9	0.6	14.7	1.9	6.9	0.0	0.7	0.5	0.6	1.8	7.2	7.9	3.7	0.0	2.2	0.6	1.0	0.0	6.2	0.3	3.1	113.3	15.7	0.0	0.0	12.1	4.3	40.9	118.6	7.7	2.5	10.2	1.0	42.5	1.0	17.0	1.7	10.9	1.4	18.3	2.2	22.8	0.3	9.9	10.8	74.7	2.8	0.1	0.5	0.0	1.0	4.4	70.2	1.1	22.2	0.4	1.5	0.1	0.1	0.4	1.2	13.1	4.1	32.3	0.7	0.6	28.1	19.0	10.9	2.1	5.0	0.5	6.9
EFEMP1	"DHRD, FBLN3, FBNL, MTLV, S1-5"	ENSG00000115380	"EGF containing fibulin extracellular matrix protein 1"	Q12805	2	55865967-55924139	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Growth factor"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 367.7;Cytotrophoblasts: 1365.8;Fibroblasts: 309.7;Syncytiotrophoblasts: 889.6"	"Cancer enhanced"	"Detected in all"		"glioma: 94.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HSkMC: 953.6;hTERT-RPE1: 2226.5;HUVEC TERT2: 4270.9;TIME: 3554.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016368, HPA049806, HPA070841, HPA071588"	Supported		Supported	Mitochondria	"Secreted to extracellular matrix"	NA	NA		1900000000		"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 47: Cytotrophoblasts - Unknown function"	Mitochondria		"CAB016368: AB_2277777, HPA049806: , HPA070841: AB_2686319, HPA071588: "	"unprognostic (8.21e-2)"	"unprognostic (7.68e-2)"	"unprognostic (9.01e-3)"	"prognostic unfavorable (4.72e-4)"	"unprognostic (3.43e-2)"	"unprognostic (1.73e-2)"	"unprognostic (4.86e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.46e-1)"	"unprognostic (9.07e-2)"	"unprognostic (1.55e-2)"	"unprognostic (1.50e-1)"	"prognostic unfavorable (3.89e-8)"	"unprognostic (3.15e-3)"	"unprognostic (4.94e-2)"	"unprognostic (3.09e-1)"	"prognostic unfavorable (6.68e-5)"	240.5	55.7	57.0	57.2	82.8	0.2	115.3	57.1	88.8	54.9	180.7	74.6	22.5	73.2	128.4	51.5	134.8	140.4	187.8	47.5	75.6	57.4	12.9	150.1	27.2	80.8	121.1	175.1	29.2	17.6	22.6	329.7	65.5	58.4	91.0	42.8	87.7	161.2	14.7	55.2	45.3	93.5	72.2	42.4	46.9	8.0	71.0	16.8	139.1	93.8	21.2	203.9	77.3	71.9	358.4	3.1	8.5	0.3	320.9	217.1	0.8	208.1	233.7	25.2	20.5	0.0	18.0	0.5	140.4	234.3	22.1	323.4	1.6	234.6	8.9	1.0	1.0	0.3	87.4	0.2	843.2	0.3	0.6	953.6	117.5	21.9	260.9	2226.5	4270.9	0.5	1.2	0.2	99.2	36.7	2.6	0.5	4.2	0.1	0.8	0.2	0.3	0.9	9.8	7.3	2.0	0.4	284.6	105.0	0.7	8.1	289.8	1.5	3554.3	1.5	107.5	397.9	138.5	13.7	0.5	1.4	73.1	0.3	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	57.0	82.8	57.1	88.8	47.5	75.6	80.8	121.1	65.5	72.2	71.0	71.9	26.6	250.0	109.1	234.1	0.1	79.4	79.1	367.7	42.1	2.8	6.2	78.2	12.5	12.8	98.2	27.6	0.0	1365.8	0.4	0.0	9.8	36.2	0.5	2.2	38.9	73.5	0.0	0.0	1.0	25.6	173.0	309.7	6.1	2.1	2.5	3.9	48.5	0.7	94.9	0.0	4.7	0.0	40.7	0.8	33.9	0.9	42.6	3.2	17.8	6.5	0.6	137.3	0.0	2.5	0.8	2.8	0.0	0.0	1.5	24.2	0.0	14.7	88.8	4.7	0.0	7.0	28.7	0.4	1.8	6.0	31.7	889.6	5.0	61.3	0.0	6.2
EVC2	LBN	ENSG00000173040	"EvC ciliary complex subunit 2"	Q86UK5	4	5542772-5709548	"Disease related genes, Human disease related genes, Predicted membrane proteins"			"Ciliopathy, Disease variant, Dwarfism, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 17.6;Basal squamous epithelial cells: 12.0;Fibroblasts: 8.9;Leydig cells: 11.5;Skeletal myocytes: 14.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 9.7;HHSteC: 13.0;hTERT-HME1: 10.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040910, HPA048122"	Uncertain		Approved	"Nucleoplasm,Microtubules,Cytokinetic bridge,Cytosol"		Yes	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 50: Fibroblasts - ECM organization"	"Microtubules, Cytokinetic bridge"	"Nucleoplasm, Cytosol"	"HPA040910: AB_2677195, HPA048122: AB_2680272"	"unprognostic (6.56e-2)"	"unprognostic (6.74e-2)"	"unprognostic (5.10e-2)"	"unprognostic (2.25e-1)"	"unprognostic (8.23e-3)"	"unprognostic (2.80e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.28e-1)"	"unprognostic (8.57e-2)"	"unprognostic (9.37e-2)"	"prognostic favorable (1.58e-4)"	"unprognostic (2.51e-2)"	"unprognostic (3.14e-1)"	"unprognostic (5.61e-2)"	"unprognostic (6.29e-5)"	4.8	0.7	1.3	1.5	1.4	0.1	3.6	1.2	1.1	6.0	2.3	3.7	0.6	4.7	1.7	2.2	4.7	2.7	3.1	1.3	1.4	2.6	0.7	2.1	1.9	1.6	1.5	7.8	1.7	3.1	1.1	1.3	1.2	3.2	0.6	0.3	2.8	2.0	1.1	3.8	2.0	2.3	1.4	1.0	2.1	1.6	1.5	1.0	3.8	1.9	1.7	4.1	4.4	1.3	0.0	2.7	0.0	6.6	8.4	9.3	0.0	4.1	9.7	3.6	6.0	0.0	0.0	5.2	0.0	3.3	2.0	2.8	0.0	1.7	3.4	0.0	0.0	0.0	0.0	0.0	13.0	0.0	0.0	5.9	4.6	4.6	10.6	0.0	3.9	0.0	0.0	0.2	5.3	0.0	0.0	0.0	3.9	0.0	0.0	8.6	8.2	0.0	0.4	0.0	0.4	0.6	0.0	0.0	0.0	1.6	0.0	0.5	6.7	0.0	0.0	2.4	0.0	4.1	4.7	1.2	2.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.3	1.4	1.2	1.1	1.3	1.4	1.6	1.5	1.2	1.4	1.5	1.3	0.6	0.0	0.5	17.6	0.8	2.2	4.9	2.3	12.0	0.0	0.9	2.2	1.0	1.5	1.3	0.0	0.0	8.3	1.7	0.0	0.0	1.9	2.2	0.7	5.6	1.2	0.0	0.4	0.3	0.5	0.3	8.9	0.5	1.7	2.5	4.7	1.4	0.1	0.5	0.0	0.3	0.0	0.0	0.3	1.2	0.9	11.5	0.8	0.0	6.5	0.0	1.9	1.0	1.0	0.3	0.6	0.0	7.9	1.7	2.8	0.0	0.9	1.0	0.1	0.0	14.7	3.2	1.8	2.1	4.4	0.9	1.4	2.8	3.4	0.0	1.4
FAM107B	"C10orf45, FLJ45505, HITS, MGC11034"	ENSG00000065809	"Family with sequence similarity 107 member B"	Q9H098	10	14518557-14774897	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 526.5;Proximal tubular cells: 359.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"granulocytes: 63.8;NK-cells: 53.8;T-cells: 106.2"	"Cell line enhanced"	"Detected in all"		"Daudi: 373.0;HDLM-2: 449.6;Karpas-707: 309.6;THP-1: 294.4"	"Low region specificity"	"Detected in all"							"HPA039661, HPA058814, HPA073195"	Approved		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA		15000	"Cluster 20: T-cells - T-cell receptor"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	"Golgi apparatus"	"HPA039661: AB_10794751, HPA058814: AB_2683825, HPA073195: AB_2732221"	"unprognostic (1.24e-1)"	"unprognostic (1.91e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.80e-2)"	"unprognostic (8.90e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.36e-1)"	"unprognostic (6.82e-2)"	"unprognostic (5.60e-2)"	"unprognostic (4.63e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.80e-1)"	"unprognostic (6.93e-2)"	"unprognostic (7.01e-2)"	"unprognostic (3.53e-2)"	48.4	44.7	82.3	90.2	150.8	171.5	44.3	112.4	112.5	42.2	90.8	64.2	32.7	48.2	11.4	22.8	20.6	66.1	11.1	84.2	102.1	119.6	147.3	64.8	152.3	136.8	125.9	7.3	70.6	70.0	21.3	22.2	130.7	27.6	42.5	15.2	68.6	113.7	3.5	22.2	55.9	31.4	95.5	50.6	122.8	37.3	118.7	48.0	12.6	9.3	134.0	66.7	17.1	223.6	60.8	129.1	50.3	3.4	7.6	1.7	21.3	59.7	85.8	35.9	25.6	79.9	49.9	373.0	52.8	27.5	13.4	18.6	16.1	36.4	63.5	449.6	13.9	10.3	55.6	95.0	26.7	136.6	23.3	4.2	28.0	14.9	7.2	42.4	154.6	72.5	1.1	309.6	28.2	15.6	33.6	39.5	12.5	72.7	28.2	240.8	39.1	140.2	81.9	39.0	18.7	53.5	23.6	12.4	39.0	44.7	46.0	294.4	50.8	37.0	31.2	118.3	20.3	136.2	131.7	241.3	6.5	117.5	10.1	52.3	6.0	63.8	100.2	7.1	97.7	12.4	79.4	85.0	5.2	12.6	105.7	106.2	25.2	53.8	14.9	3.5	78.0	74.8	82.3	150.8	112.4	112.5	84.2	102.1	136.8	125.9	130.7	95.5	118.7	223.6	12.8	105.8	44.4	7.2	203.6	89.7	147.1	25.4	16.5	4.8	94.6	30.4	4.1	134.4	52.5	286.9	2.1	18.1	194.7	65.9	223.0	44.3	27.0	234.9	98.7	37.8	14.3	22.7	1.6	106.8	38.2	49.7	175.3	268.2	119.2	32.7	72.8	177.4	37.1	201.9	7.3	110.5	36.7	53.9	120.9	53.2	2.5	110.7	51.6	15.0	68.8	13.6	198.8	11.1	526.5	90.3	44.3	4.9	176.6	139.6	25.9	359.9	85.3	15.0	0.0	5.4	64.6	56.2	35.7	8.3	82.3	62.5	237.7	3.8	39.9	240.2
FBLN5	"ARMD3, DANCE, EVEC, UP50"	ENSG00000140092	"Fibulin 5"	Q9UBX5	14	91869411-91947987	"Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Cell adhesion"		"Age-related macular degeneration, Charcot-Marie-Tooth disease, Disease variant, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"Fibroblasts: 209.4;Leydig cells: 626.6;Peritubular cells: 794.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 6.6"	"Group enriched"	"Detected in many"	19	"granulocytes: 6.6;T-cells: 1.8"	"Cell line enhanced"	"Detected in many"		"ASC diff: 457.1;ASC TERT1: 234.6;BJ: 202.0;BJ hTERT+: 202.5;fHDF/TERT166: 394.6;HSkMC: 216.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000848, HPA000868, CAB025843"	Supported		Uncertain	"Plasma membrane"	"Secreted to extracellular matrix"	NA	NA		12000000	"Cluster 46: Basophils - DNA binding"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane"		"CAB025843: , HPA000848: AB_1078620, HPA000868: AB_1078619"	"unprognostic (5.53e-3)"	"unprognostic (1.14e-1)"	"unprognostic (7.78e-2)"	"unprognostic (9.29e-2)"	"unprognostic (5.55e-3)"	"unprognostic (4.73e-2)"	"prognostic favorable (6.75e-4)"	"unprognostic (5.21e-3)"	"unprognostic (4.76e-2)"	"unprognostic (1.25e-2)"	"unprognostic (3.74e-2)"	"unprognostic (1.90e-1)"	"unprognostic (7.26e-2)"	"unprognostic (1.56e-3)"	"unprognostic (1.73e-1)"	"unprognostic (5.18e-2)"	"unprognostic (3.17e-3)"	182.2	73.4	10.7	17.7	12.8	7.5	110.4	7.4	12.5	124.9	15.7	80.3	19.1	178.4	40.0	26.8	143.0	130.2	211.1	9.4	8.6	108.4	29.3	164.8	25.5	15.5	10.9	107.3	46.4	16.8	14.5	67.0	14.2	49.0	20.6	0.6	55.8	70.9	30.4	66.9	52.7	88.7	13.1	130.9	68.9	35.6	12.7	21.8	79.5	36.0	15.7	117.5	93.3	7.5	0.0	1.6	0.2	0.0	457.1	234.6	22.5	202.0	202.5	5.8	4.5	4.7	0.0	0.0	4.2	394.6	0.6	0.1	9.8	1.0	1.0	0.0	2.3	0.4	4.7	0.0	74.2	0.0	0.1	216.6	0.4	3.9	14.1	2.8	10.4	0.1	0.0	0.1	25.3	0.4	0.5	0.5	0.5	0.0	0.5	0.4	30.2	0.2	1.2	0.1	0.2	0.1	12.3	0.7	2.6	7.0	2.9	0.3	1.9	3.2	6.6	3.8	0.1	0.1	0.0	0.2	0.4	0.0	0.0	6.6	0.1	2.2	0.8	0.2	0.5	0.0	0.3	0.1	0.0	0.1	1.1	1.8	2.5	0.0	0.2	0.0	0.1	0.4	10.7	12.8	7.4	12.5	9.4	8.6	15.5	10.9	14.2	13.1	12.7	7.5	31.4	83.3	13.1	0.0	2.1	9.2	2.4	7.1	1.8	0.0	11.2	9.3	5.2	0.0	11.5	5.5	0.0	2.5	2.5	0.1	5.9	4.7	5.9	13.3	67.4	15.2	0.0	0.4	2.6	4.7	2.5	209.4	2.0	12.0	2.5	1.8	34.2	0.4	7.8	0.0	3.6	0.1	18.3	2.5	18.4	27.5	626.6	5.8	21.4	15.9	1.6	0.0	8.2	5.0	2.3	2.2	0.0	794.8	0.7	1.3	0.0	32.5	21.4	0.0	6.6	28.0	14.5	3.0	2.8	1.3	8.7	3.7	15.5	3.5	0.4	1.2
FBXO17	"FBG4, Fbx17, FBXO26, FLJ11798, FLJ25205, MGC9379"	ENSG00000269190	"F-box protein 17"	Q96EF6	19	38941401-38975742	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 67.9"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 56.7;Hepatocytes: 58.5;Leydig cells: 83.0;Peritubular cells: 74.1;Proximal tubular cells: 70.3"	"Cancer enhanced"	"Detected in many"		"renal cancer: 18.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 37.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"									NA	NA				"Cluster 85: Liver - Metabolism"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 48: Smooth muscle cells - ECM organization"				"unprognostic (1.68e-1)"	"unprognostic (2.62e-2)"	"unprognostic (6.97e-3)"	"prognostic unfavorable (5.67e-4)"	"prognostic unfavorable (2.40e-4)"	"unprognostic (1.10e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.56e-3)"	"unprognostic (4.13e-2)"	"unprognostic (1.06e-2)"	"unprognostic (3.71e-3)"	"unprognostic (1.91e-2)"	"unprognostic (1.83e-3)"	"prognostic unfavorable (5.91e-4)"	"unprognostic (5.34e-2)"	"unprognostic (4.06e-4)"	"unprognostic (2.77e-3)"	22.9	5.2	5.7	1.7	5.1	0.4	17.5	7.7	5.5	28.1	4.6	18.7	2.1	25.1	5.9	7.3	20.8	4.7	12.8	4.9	4.7	42.8	67.9	10.3	1.5	4.3	4.3	33.6	11.7	4.8	9.1	2.9	4.4	18.5	1.5	3.8	7.1	7.6	3.1	13.9	6.9	9.2	3.9	4.4	10.2	4.4	5.6	0.8	5.5	1.9	1.2	18.1	18.8	4.0	19.7	37.3	0.1	23.4	16.7	11.7	0.5	7.7	7.8	9.8	11.8	17.0	0.3	0.4	6.3	12.6	19.2	5.3	4.2	5.5	8.9	0.1	14.9	0.1	2.8	19.5	10.9	0.2	0.6	10.2	4.6	16.5	7.7	18.9	13.1	0.1	21.5	0.1	10.1	9.8	0.1	0.3	7.9	0.0	0.1	0.0	0.1	0.1	11.8	0.1	0.2	15.3	10.9	0.0	9.1	5.4	9.5	0.3	3.9	24.4	17.8	10.1	10.5	0.3	1.1	0.1	21.7	0.1	11.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	5.7	5.1	7.7	5.5	4.9	4.7	4.3	4.3	4.4	3.9	5.6	4.0	5.3	0.0	1.1	15.0	0.2	18.7	11.3	9.9	33.0	4.1	3.0	14.4	3.1	17.2	5.4	14.7	35.5	6.9	0.2	0.1	56.7	6.7	4.1	0.6	29.6	8.1	0.0	0.0	14.5	2.0	5.4	34.1	0.0	0.5	0.0	20.1	14.6	58.5	38.8	5.0	19.2	0.0	8.2	0.8	8.5	3.4	83.0	1.9	19.6	13.1	0.0	10.2	0.0	16.1	2.0	2.0	0.0	74.1	1.2	15.8	0.0	70.3	2.0	13.0	52.6	20.6	19.8	0.7	4.4	10.0	17.5	5.1	0.9	16.1	0.0	4.1
FMOD	SLRR2E	ENSG00000122176	Fibromodulin	Q06828	1	203340628-203351758	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Breast myoepithelial cells: 26.7;Fibroblasts: 52.5;Intestinal goblet cells: 80.2;Leydig cells: 28.0;Peritubular cells: 28.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 10.6;CACO-2: 38.6;HHSteC: 11.8;HSkMC: 22.1;OE19: 45.8"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"spinal cord: 71.7"						"Secreted to extracellular matrix"	NA	NA		2600000		"Cluster 46: Fibroblasts - ECM organization"	"Cluster 21: OE19 - Mitochondria"	"Cluster 33: Fibroblasts - ECM organization"				"unprognostic (1.48e-1)"	"unprognostic (8.88e-2)"	"unprognostic (9.35e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.60e-2)"	"unprognostic (4.17e-3)"	"unprognostic (1.86e-1)"	"unprognostic (3.30e-1)"	"unprognostic (5.25e-3)"	"unprognostic (1.06e-2)"	"unprognostic (1.65e-2)"	"unprognostic (1.80e-1)"	"prognostic unfavorable (1.40e-5)"	"unprognostic (9.40e-3)"	"unprognostic (3.58e-2)"	"unprognostic (1.27e-3)"	"prognostic unfavorable (2.67e-4)"	122.7	13.6	1.3	31.1	2.3	0.1	64.4	1.5	3.9	100.1	9.0	39.4	49.6	105.8	17.2	19.1	85.8	123.6	149.0	1.0	1.5	24.3	11.0	60.2	28.6	2.4	0.9	125.1	33.1	28.0	21.7	81.2	1.5	58.4	62.1	9.9	49.6	49.2	12.6	25.9	21.2	106.5	2.1	18.2	135.6	6.3	1.5	9.6	71.3	25.6	33.8	45.4	60.0	1.4	0.0	0.1	0.0	0.0	10.6	0.7	0.2	7.1	8.1	0.0	1.1	38.6	0.0	0.0	0.8	7.7	0.0	0.3	0.0	0.6	0.5	0.0	0.0	0.0	0.9	0.0	11.8	0.0	0.0	22.1	0.1	0.0	0.4	5.2	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.3	0.0	45.8	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	1.5	0.4	0.0	0.1	1.0	0.3	2.0	0.0	0.3	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	2.3	1.5	3.9	1.0	1.5	2.4	0.9	1.5	2.1	1.5	1.4	9.3	0.0	6.3	0.0	0.0	6.9	5.0	1.5	6.2	0.2	10.3	26.7	1.6	2.8	2.1	7.3	0.0	1.1	0.4	2.9	0.0	1.9	0.1	1.1	12.1	8.3	6.1	0.0	0.1	0.7	0.7	52.5	12.8	1.6	0.0	0.5	19.2	0.1	1.2	0.0	0.0	80.2	0.0	0.3	9.3	0.4	28.0	0.6	12.4	7.5	0.6	11.9	0.0	0.0	0.0	1.5	2.2	28.6	0.0	11.7	0.7	0.2	0.7	1.0	6.6	1.3	15.5	0.0	0.3	0.6	4.3	3.1	1.2	2.0	8.6	1.6
FNDC1	"bA243O10.1, dJ322A24.1, FNDC2, KIAA1866"	ENSG00000164694	"Fibronectin type III domain containing 1"	Q4ZHG4	6	159169400-159272108	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 14.2;thyroid gland: 20.3"	"Group enriched"	"Detected in some"	4	"Fibroblasts: 28.7;Smooth muscle cells: 11.5"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 32.5"	"Group enriched"	"Detected in many"	6	"cerebral cortex: 5.4;hippocampal formation: 8.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 1.0;fHDF/TERT166: 2.9;SuSa: 3.1"	"Region enhanced"	"Detected in many"		"olfactory bulb: 7.0"	"Region enhanced"	"Detected in many"		"spinal cord: 10.3"	"HPA030962, HPA030963"	Approved		Approved	"Nuclear speckles"	"Secreted to extracellular matrix"	NA	NA		14000		"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 12: NES - Nervous system development"	"Cluster 50: Fibroblasts - ECM organization"	"Nuclear speckles"		"HPA030962: AB_10696212, HPA030963: AB_2673676"	"unprognostic (4.59e-2)"	"unprognostic (9.17e-3)"	"unprognostic (7.62e-2)"	"prognostic favorable (6.10e-5)"	"unprognostic (4.57e-1)"	"unprognostic (2.11e-1)"	"unprognostic (5.52e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.18e-2)"	"unprognostic (1.74e-1)"	"prognostic unfavorable (1.93e-6)"	"unprognostic (6.49e-3)"	"unprognostic (1.12e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.76e-3)"	5.4	0.5	0.5	1.9	0.3	0.0	2.1	0.1	5.4	6.5	0.2	12.9	2.5	2.2	0.0	1.1	0.6	14.2	3.9	8.7	0.3	0.6	0.7	1.6	2.8	0.1	1.0	1.2	1.1	0.3	0.2	0.9	0.0	0.4	1.8	0.1	0.9	0.8	2.1	0.9	4.2	11.7	0.3	0.5	0.4	0.4	0.4	0.1	20.3	9.6	2.4	1.0	1.6	1.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	1.0	2.9	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	3.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.1	5.4	8.7	0.3	0.1	1.0	0.0	0.3	0.4	1.2	2.6	0.0	0.6	0.0	0.0	3.2	0.0	0.0	0.0	0.3	0.1	0.5	2.1	0.0	0.6	0.0	0.0	0.1	0.0	0.0	1.9	0.0	0.3	0.4	4.7	0.7	0.0	0.0	0.2	0.0	0.2	28.7	0.0	0.3	0.0	0.1	1.4	0.0	0.2	0.0	1.7	0.0	0.0	0.0	3.1	0.0	0.3	0.2	1.8	2.8	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	3.0	11.5	1.1	1.4	0.0	1.4	0.1	0.5	0.1	0.0	0.0
FOXC2	"FKHL14, MFH-1"	ENSG00000176692	"Forkhead box C2"	Q99958	16	86566829-86569728	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 5.6"	"Group enriched"	"Detected in some"	4	"Peritubular cells: 30.9;Sertoli cells: 19.7;Smooth muscle cells: 33.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTEC/SVTERT24-B: 25.2;HUVEC TERT2: 19.5;LHCN-M2: 31.2;TIME: 36.0;U-138 MG: 18.4;U-2197: 31.5;U-87 MG: 24.0"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in many"	6	"spinal cord: 42.7"	HPA056302			Supported	"Nucleoplasm,Nuclear bodies"		NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nucleoplasm, Nuclear bodies"		"HPA056302: AB_2683093"	"unprognostic (3.17e-2)"	"unprognostic (1.76e-3)"	"unprognostic (4.87e-2)"	"unprognostic (4.32e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.60e-2)"	"unprognostic (4.49e-2)"	"unprognostic (1.15e-2)"	"unprognostic (4.71e-2)"	"unprognostic (8.88e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (3.57e-7)"	"unprognostic (1.12e-2)"	"unprognostic (3.47e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.84e-4)"	2.4	1.5	0.5	0.3	1.1	0.0	1.8	0.9	1.6	2.2	3.2	0.5	0.1	0.8	0.6	0.5	2.0	1.3	5.6	0.4	0.4	5.4	0.1	2.1	0.4	0.5	0.5	1.1	0.2	0.1	2.4	0.1	0.5	1.0	0.1	0.1	2.4	0.6	0.7	0.8	0.4	0.4	0.7	0.0	0.4	1.9	0.7	0.1	2.0	0.5	0.1	0.8	1.5	0.3	0.0	0.0	0.0	0.0	5.8	7.8	0.0	11.3	14.3	8.0	1.5	0.0	0.0	0.0	1.5	1.4	11.2	0.0	0.2	3.3	7.0	0.0	0.6	0.0	7.9	0.0	2.7	0.0	0.0	1.3	3.4	25.2	7.9	14.5	19.5	0.0	0.0	0.0	31.2	0.0	0.0	0.0	0.0	0.5	0.1	0.0	1.7	0.0	0.1	0.1	0.0	0.0	1.8	0.0	0.0	5.9	0.0	0.0	36.0	18.4	0.0	31.5	0.0	0.0	0.0	0.0	24.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.1	0.9	1.6	0.4	0.4	0.5	0.5	0.5	0.7	0.7	0.3	1.5	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	1.0	0.8	2.1	0.0	0.0	1.8	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.2	0.0	5.7	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.5	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	1.6	1.5	0.1	1.8	1.0	0.0	0.2	0.0	0.0	0.0	0.5	0.0	30.9	1.2	0.8	0.0	0.0	0.0	0.1	19.7	0.6	33.2	0.2	5.0	0.5	0.0	0.0	0.0	0.0	0.1	1.4
GAS1		ENSG00000180447	"Growth arrest specific 1"	P54826	9	86944362-86947506	"Cancer-related genes, Predicted intracellular proteins"	"Cell cycle, Growth arrest"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 105.4"	"Cell type enhanced"	"Detected in many"		"Fibroblasts: 127.1;Muller glia cells: 90.3;Skeletal myocytes: 213.7"	"Cancer enhanced"	"Detected in all"		"ovarian cancer: 30.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 44.2;ASC diff: 29.3;BJ hTERT+: 59.8;HSkMC: 41.1;RH-30: 91.1"	"Low region specificity"	"Detected in all"							"CAB024164, HPA036085, HPA066902"	Approved		Approved	"Nuclear speckles"		NA	NA		27000		"Cluster 89: Fibroblasts - ECM organization"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 50: Fibroblasts - ECM organization"	"Nuclear speckles"		"CAB024164: AB_2107950, HPA036085: AB_2674932, HPA066902: AB_2685746"	"unprognostic (2.78e-1)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (1.55e-4)"	"unprognostic (1.97e-2)"	"unprognostic (6.15e-2)"	"unprognostic (2.84e-2)"	"unprognostic (6.46e-2)"	"unprognostic (6.91e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.28e-3)"	"unprognostic (2.25e-3)"	"unprognostic (4.30e-2)"	"prognostic unfavorable (1.96e-5)"	"prognostic unfavorable (8.26e-4)"	"unprognostic (6.73e-2)"	"prognostic unfavorable (1.13e-5)"	"unprognostic (3.59e-2)"	81.5	6.4	3.6	16.6	4.4	0.2	38.3	3.5	4.4	27.1	16.1	27.6	2.2	105.4	15.2	5.8	60.7	10.5	27.1	3.2	2.7	12.5	2.2	7.8	6.8	3.8	3.8	45.1	11.2	1.9	8.4	22.1	3.6	22.6	2.3	3.3	13.1	9.6	12.2	22.2	9.3	43.4	3.4	3.6	16.3	1.8	3.8	7.1	15.9	9.3	3.1	22.5	27.1	6.8	0.0	0.0	7.5	44.2	29.3	10.9	0.8	8.8	59.8	2.9	2.6	0.0	0.1	0.0	0.5	15.8	0.3	0.6	0.0	0.3	1.2	5.2	17.8	0.0	25.0	0.0	14.9	0.1	0.7	41.1	6.3	1.0	5.3	0.0	0.0	0.9	0.0	0.0	12.6	0.0	0.0	0.4	9.5	0.3	0.1	9.6	91.1	0.0	0.4	0.0	1.0	4.0	12.9	0.0	14.1	4.8	0.1	0.2	0.1	13.0	3.6	0.9	3.0	0.0	0.0	0.0	0.4	0.6	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	4.4	3.5	4.4	3.2	2.7	3.8	3.8	3.6	3.4	3.8	6.8	15.8	0.0	0.6	2.0	0.4	25.9	7.5	10.9	10.2	8.3	3.9	28.3	5.5	0.0	3.1	14.7	10.4	21.5	7.8	0.1	9.8	0.5	0.1	2.4	36.6	5.6	0.0	0.4	1.2	0.4	3.7	127.1	1.1	2.0	0.0	2.1	22.9	0.3	5.8	5.0	2.6	0.3	0.0	1.0	15.4	0.9	32.3	2.2	17.8	1.9	0.2	90.3	7.2	8.5	4.4	0.2	0.0	12.4	2.1	4.5	0.0	2.6	0.7	3.2	39.5	213.7	15.4	0.3	1.3	1.0	12.5	4.5	2.1	0.8	0.2	0.4
GDNF	"ATF1, ATF2, HFB1-GDNF"	ENSG00000168621	"Glial cell derived neurotrophic factor"	P39905	5	37812677-37840041	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"		"Growth factor"	"Cancer-related genes, Disease variant, Hirschsprung disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 8.2;skeletal muscle: 10.1"	"Cell type enhanced"	"Detected in some"		"Fibroblasts: 3.3;Skeletal myocytes: 11.5;Spermatogonia: 3.4;Theca cells: 2.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTEC/SVTERT24-B: 41.4;SuSa: 12.6;U-87 MG: 12.6;WM-115: 46.5"	"Region enhanced"	"Detected in single"		"basal ganglia: 2.8"	"Low region specificity"	"Detected in some"			"CAB005210, HPA070283"	Supported		Approved	Nucleoplasm,Vesicles	"Secreted in other tissues"	NA	NA				"Cluster 80: Striated muscle - Unknown function"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 37: Myocytes - Muscle contraction"	Vesicles	Nucleoplasm	"CAB005210: AB_2247684, HPA070283: AB_2686246"	"unprognostic (1.08e-1)"	"unprognostic (6.30e-2)"	"unprognostic (3.54e-2)"	"unprognostic (8.87e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.08e-1)"	"unprognostic (5.33e-2)"	"unprognostic (1.92e-1)"	"unprognostic (3.71e-2)"	"unprognostic (2.01e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.16e-4)"	"unprognostic (2.04e-1)"	"unprognostic (8.86e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.42e-2)"	0.1	0.4	2.3	1.6	1.5	0.1	0.3	5.8	1.4	0.8	0.0	8.2	1.4	1.3	2.5	0.9	0.9	0.9	0.8	0.6	1.6	0.9	0.7	0.0	0.1	0.7	3.1	3.6	0.0	0.0	0.1	5.0	1.0	1.3	2.4	0.3	0.2	4.5	10.1	1.3	2.0	2.1	0.2	0.4	1.6	0.4	6.1	0.1	0.1	4.3	0.0	0.7	0.8	2.9	0.0	0.0	0.1	0.1	1.8	1.0	0.0	5.5	3.4	1.1	1.6	0.0	0.1	0.1	0.0	7.4	0.1	0.2	0.0	0.1	2.2	0.0	0.2	0.0	0.4	0.5	0.2	0.1	0.1	1.8	0.1	41.4	0.0	1.4	0.0	0.0	0.0	0.0	2.4	0.2	0.0	0.1	0.4	0.1	0.0	0.1	9.0	0.0	0.0	0.2	0.5	0.0	0.3	0.2	2.7	12.6	0.1	0.0	0.0	5.5	0.0	1.4	6.2	4.0	0.0	0.0	12.6	0.0	46.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.3	1.5	5.8	1.4	0.6	1.6	0.7	3.1	1.0	0.2	6.1	2.9	0.0	0.0	0.0	0.0	0.0	0.9	0.0	1.0	0.6	0.6	0.0	0.3	0.7	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.2	0.0	0.0	0.2	0.0	0.1	3.3	0.0	0.0	0.0	0.1	0.4	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.1	0.0	1.5	0.6	0.0	0.0	0.4	0.0	0.2	0.0	0.7	0.1	0.0	0.0	11.5	1.8	0.9	3.4	0.0	0.3	0.1	0.0	2.6	0.0	0.5
GLI2	"HPE9, THP1, THP2"	ENSG00000074047	"GLI family zinc finger 2"	P10070	2	120735623-120992653	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"	"Disease variant, Holoprosencephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 10.9"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 39.5;Fibroblasts: 10.4;Leydig cells: 25.1;Peritubular cells: 30.9;Skeletal myocytes: 16.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 20.1;hTEC/SVTERT24-B: 13.1;U-2 OS: 17.9;WM-115: 18.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"CAB008558, HPA074275"	Approved		Supported	Nucleoplasm,Nucleoli		No	No				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 50: Fibroblasts - ECM organization"	"Nucleoplasm, Nucleoli"		"CAB008558: AB_2111910, HPA074275: AB_2686677"	"unprognostic (6.76e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.05e-1)"	"unprognostic (9.83e-3)"	"unprognostic (4.63e-2)"	"unprognostic (2.04e-1)"	"unprognostic (9.43e-2)"	"unprognostic (1.65e-2)"	"unprognostic (2.19e-3)"	"unprognostic (2.58e-1)"	"unprognostic (9.23e-3)"	"unprognostic (1.81e-2)"	"unprognostic (4.49e-10)"	"unprognostic (1.13e-1)"	"unprognostic (8.88e-2)"	"unprognostic (2.32e-2)"	"unprognostic (1.42e-3)"	1.6	1.0	1.9	0.9	2.2	0.0	1.4	1.4	1.3	4.3	0.6	3.4	0.4	4.7	1.2	0.8	2.8	2.1	2.3	1.1	1.9	1.4	0.4	2.0	0.3	2.1	2.1	10.9	0.3	0.1	1.8	0.8	1.8	2.9	0.6	0.0	1.4	1.1	0.9	2.7	1.6	1.9	1.6	0.8	1.6	2.4	1.8	1.3	1.0	0.4	0.3	3.1	2.4	0.9	0.0	10.3	20.1	5.5	3.2	4.0	0.0	5.8	1.8	2.4	2.4	0.0	0.5	0.0	0.9	5.2	0.9	0.3	4.3	0.2	1.9	0.0	2.1	0.4	6.1	0.2	3.8	0.0	1.2	2.3	0.0	13.1	0.0	2.1	0.2	0.0	0.0	0.0	0.8	0.0	0.0	0.0	10.6	1.6	4.3	0.1	2.2	3.5	0.0	0.0	2.0	2.1	3.8	0.0	0.2	4.3	0.1	0.0	5.1	0.0	17.9	2.5	0.0	0.0	0.1	0.0	7.4	0.0	18.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	2.2	1.4	1.3	1.1	1.9	2.1	2.1	1.8	1.6	1.8	0.9	0.3	0.0	0.0	39.5	0.0	2.0	0.1	0.5	0.6	0.0	0.1	0.9	1.4	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.2	1.1	0.3	6.1	0.5	0.0	0.0	0.7	0.2	0.1	10.4	0.0	1.0	0.0	0.1	0.0	0.0	0.1	0.0	1.7	0.0	0.0	0.0	1.5	2.1	25.1	0.1	0.0	2.8	0.0	0.0	1.0	3.0	0.3	1.0	0.0	30.9	0.1	0.1	0.0	0.0	0.0	0.0	0.0	16.0	3.4	0.1	3.6	0.1	1.7	0.0	0.0	7.9	0.0	0.1
GLIPR2	"C9orf19, GAPR-1"	ENSG00000122694	"GLI pathogenesis related 2"	Q9H4G4	9	36136536-36163913	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 188.5;Langerhans cells: 203.6;Macrophages: 117.6;monocytes: 203.0;NK-cells: 180.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 71.6;HDLM-2: 72.9;TIME: 127.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029478	Approved		Uncertain	Vesicles,Microtubules		NA	NA		19000000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 4: Macrophages - Innate immune response"	Vesicles	Microtubules	"HPA029478: AB_10670038"	"unprognostic (1.57e-2)"	"unprognostic (5.70e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.46e-2)"	"unprognostic (1.33e-2)"	"unprognostic (9.90e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.84e-2)"	"unprognostic (4.26e-2)"	"unprognostic (3.21e-1)"	"unprognostic (5.87e-2)"	"prognostic unfavorable (6.54e-7)"	"unprognostic (6.57e-3)"	"unprognostic (4.94e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.43e-2)"	38.5	20.9	17.6	52.7	22.8	73.8	32.4	21.0	22.6	45.9	14.1	73.7	14.7	77.8	15.1	18.6	36.9	24.1	24.2	17.2	19.3	8.8	6.9	62.6	29.9	24.8	22.1	13.3	5.6	2.5	4.9	8.8	22.3	38.3	33.1	2.7	15.3	39.3	7.7	12.2	32.2	63.8	22.8	41.3	25.3	3.4	26.7	18.7	15.8	11.1	19.2	38.8	27.4	27.6	3.7	2.9	20.9	22.3	71.6	33.3	2.4	32.9	20.0	7.8	14.1	1.3	0.3	0.2	10.2	30.9	19.7	0.2	7.9	1.1	4.7	72.9	6.4	8.8	6.2	0.4	27.9	5.7	28.3	23.4	1.0	44.5	7.8	14.0	62.5	22.6	0.4	5.0	17.4	7.9	27.9	15.2	20.1	0.3	10.7	18.9	44.1	1.0	1.6	1.8	5.6	11.3	4.4	2.2	3.6	42.2	2.3	24.0	127.3	10.7	24.8	9.6	28.0	7.8	2.2	12.7	11.0	35.0	2.5	268.6	360.9	540.3	168.4	162.5	89.1	24.4	114.3	108.2	208.3	24.5	47.0	74.7	657.0	125.5	124.9	18.5	132.2	414.0	17.6	22.8	21.0	22.6	17.2	19.3	24.8	22.1	22.3	22.8	26.7	27.6	11.9	3.2	25.4	4.6	22.3	13.4	2.5	14.7	1.8	0.3	46.9	19.0	2.6	2.8	30.9	5.5	0.0	3.8	66.9	14.7	0.0	21.2	0.7	1.8	33.9	13.3	8.4	58.7	1.1	1.3	3.3	54.3	11.7	2.1	52.6	1.9	16.1	0.9	188.5	0.0	0.8	42.4	14.2	83.2	203.6	2.3	18.0	117.6	62.2	2.8	203.0	21.4	180.2	3.0	28.6	5.2	16.1	25.9	22.8	16.0	4.0	1.1	64.3	0.5	46.0	44.7	43.2	0.9	6.4	0.9	10.2	3.4	75.5	10.9	45.3	3.3
GLIS3	"MGC33662, ZNF515"	ENSG00000107249	"GLIS family zinc finger 3"	Q8NEA6	9	3824127-4348392	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Congenital hypothyroidism, Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 24.2;choroid plexus: 20.5"	"Cell type enriched"	"Detected in many"	7	"Astrocytes: 649.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 21.5;HSkMC: 29.5;RPTEC TERT1: 20.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA056426	Approved		Supported	Nucleoplasm	"Intracellular and membrane"	NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 64: Astrocytes - Nervous system maintenance"	Nucleoplasm		"HPA056426: AB_2683128"	"unprognostic (6.24e-2)"	"unprognostic (2.30e-2)"	"unprognostic (1.54e-1)"	"unprognostic (3.63e-3)"	"unprognostic (4.10e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.81e-2)"	"unprognostic (7.14e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.91e-3)"	"unprognostic (6.88e-3)"	"unprognostic (8.54e-2)"	"unprognostic (1.04e-1)"	"unprognostic (6.35e-2)"	4.3	1.6	5.1	2.1	5.5	0.2	1.9	4.9	4.6	7.8	20.5	2.0	0.7	3.3	2.8	0.5	8.7	6.5	2.9	5.4	10.8	7.8	3.3	3.8	1.1	24.2	18.0	6.6	9.7	2.4	2.4	1.4	11.4	3.3	2.1	1.3	3.1	8.2	1.3	0.8	1.5	2.1	13.7	2.0	1.8	2.8	6.5	0.2	18.6	0.8	0.7	4.0	2.4	13.2	1.0	8.5	2.5	0.0	3.7	9.5	0.4	5.9	21.5	3.1	4.4	1.3	3.4	0.0	4.3	5.5	9.6	0.0	2.0	0.0	6.7	2.5	1.2	0.0	0.4	0.0	11.0	0.9	0.0	29.5	0.0	9.8	1.1	5.8	0.4	0.1	0.0	0.2	2.9	0.4	0.0	1.5	0.2	0.0	0.8	0.0	5.2	0.0	20.8	0.0	0.0	0.0	0.8	0.0	0.0	1.1	0.0	0.0	5.5	3.4	0.9	3.2	13.3	0.0	0.0	0.0	8.1	0.0	3.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	5.1	5.5	4.9	4.6	5.4	10.8	24.2	18.0	11.4	13.7	6.5	13.2	8.1	9.6	24.0	649.7	1.0	1.9	9.3	17.1	0.6	1.0	4.6	1.3	1.6	75.8	34.5	69.9	0.0	3.2	0.3	3.7	0.0	51.0	5.2	79.6	17.5	11.2	43.7	0.0	18.3	22.6	3.2	21.9	4.1	82.3	1.3	1.6	6.8	8.3	2.4	0.0	54.2	1.6	12.2	0.8	4.0	2.4	13.7	3.4	3.6	86.2	2.2	15.6	0.0	26.7	4.1	49.1	3.9	11.3	0.0	16.5	2.4	16.4	35.7	0.4	0.0	34.4	19.0	1.3	7.4	0.6	1.3	4.2	1.2	8.8	6.6	6.1
HTRA3	"Prsp, Tasp"	ENSG00000170801	"HtrA serine peptidase 3"	P83110	4	8269754-8307098	"Enzymes, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 194.9"	"Cell type enhanced"	"Detected in some"		"Fibroblasts: 158.8;Leydig cells: 43.5;Peritubular cells: 42.9;Skeletal myocytes: 99.0;Theca cells: 25.2"	"Cancer enhanced"	"Detected in all"		"pancreatic cancer: 67.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	5	"U-2197: 182.1"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"spinal cord: 10.3"	"HPA021187, HPA063810"	Approved		Approved	Vesicles	"Secreted in other tissues"	NA	NA				"Cluster 46: Fibroblasts - ECM organization"	"Cluster 18: U-2197 - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Vesicles		"HPA021187: AB_1851311, HPA063810: AB_2685129"	"unprognostic (5.87e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.89e-2)"	"unprognostic (9.32e-2)"	"unprognostic (1.84e-1)"	"unprognostic (3.09e-2)"	"unprognostic (1.12e-3)"	"unprognostic (5.29e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.95e-2)"	"unprognostic (2.79e-1)"	"prognostic unfavorable (1.61e-9)"	"unprognostic (1.65e-3)"	"unprognostic (2.56e-2)"	"prognostic unfavorable (1.29e-4)"	"unprognostic (1.34e-2)"	68.0	6.0	0.9	8.7	1.3	13.4	50.4	0.9	1.3	35.4	5.0	33.9	8.7	42.4	10.6	15.1	26.2	35.5	194.9	0.9	1.0	6.2	3.2	38.0	1.2	1.0	1.0	93.0	6.8	0.4	15.7	20.4	1.0	26.3	4.8	0.1	22.8	6.7	32.1	28.1	16.9	11.8	1.0	2.9	21.9	4.3	1.7	2.2	26.0	12.9	0.7	62.4	32.6	0.7	0.0	1.0	1.4	0.0	5.8	10.8	0.3	2.4	0.2	2.8	0.6	0.1	0.1	0.0	13.6	6.4	1.4	0.1	1.2	0.0	0.9	0.0	2.3	1.3	13.9	0.0	6.1	0.0	0.6	1.2	0.0	4.2	0.0	1.7	9.8	0.0	0.3	0.0	10.2	0.0	0.2	36.5	6.1	0.0	0.3	0.3	0.0	0.1	0.0	0.0	15.8	0.3	26.4	0.5	0.2	28.8	0.1	1.1	8.1	1.4	4.7	182.1	0.0	1.3	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	1.3	0.9	1.3	0.9	1.0	1.0	1.0	1.0	1.0	1.7	0.7	12.6	0.0	0.0	0.0	0.0	5.2	0.5	0.0	0.6	0.0	0.5	0.9	16.5	0.0	0.6	0.0	0.0	0.8	0.1	0.0	0.0	0.1	1.2	0.3	8.1	5.3	0.0	0.0	0.0	0.0	4.2	158.8	0.5	0.3	0.0	6.0	3.3	0.0	1.4	0.0	0.0	0.0	0.0	0.0	8.6	1.4	43.5	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	42.9	0.4	0.4	0.0	0.1	0.0	0.0	0.0	99.0	10.6	0.4	0.7	0.6	5.3	1.4	0.9	25.2	0.0	0.2
IL33	"C9orf26, DKFZp586H0523, DVS27, IL1F11, NF-HEV"	ENSG00000137033	"Interleukin 33"	O95760	9	6215786-6257983	"Predicted intracellular proteins, Predicted secreted proteins"	Transcription	Cytokine		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"urinary bladder: 120.7"	"Cell type enhanced"	"Detected in many"		"Endothelial cells: 141.8;Fibroblasts: 87.5;Hepatic stellate cells: 499.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"hTERT-RPE1: 53.6;U-2197: 162.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB007057, HPA022899, HPA024426"	Supported		Supported	Nucleoplasm,Vesicles	"Secreted to blood"	NA	NA				"Cluster 46: Fibroblasts - ECM organization"	"Cluster 18: U-2197 - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm	Vesicles	"CAB007057: , HPA022899: , HPA024426: AB_1845820"	"prognostic favorable (4.42e-4)"	"unprognostic (8.36e-2)"	"unprognostic (5.67e-3)"	"unprognostic (7.67e-3)"	"unprognostic (4.27e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.59e-3)"	"unprognostic (2.66e-3)"	"unprognostic (3.18e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.43e-1)"	"unprognostic (8.08e-2)"	"unprognostic (1.58e-3)"	"unprognostic (4.70e-3)"	"unprognostic (4.10e-2)"	"unprognostic (2.64e-1)"	"unprognostic (6.85e-3)"	38.7	16.7	9.2	44.6	9.3	0.2	27.2	7.0	12.1	56.2	6.4	24.8	8.8	50.0	15.9	24.5	25.9	33.4	40.9	8.5	10.8	5.0	36.7	53.0	47.1	7.8	8.3	5.0	3.4	3.7	5.7	61.1	7.1	30.0	19.4	2.0	18.9	31.5	6.1	44.0	15.6	50.8	8.3	20.5	33.6	5.8	10.8	13.1	12.6	13.8	43.0	120.7	21.2	8.6	0.0	0.0	0.0	0.0	0.3	1.4	0.0	2.9	0.3	0.0	0.0	0.0	0.0	0.1	16.9	0.3	0.0	0.1	0.0	1.2	0.0	0.0	0.1	0.0	0.0	0.0	1.8	0.0	0.0	0.9	0.7	0.3	0.4	53.6	8.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.0	0.4	0.0	0.0	0.0	0.0	1.8	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.1	162.9	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.2	9.3	7.0	12.1	8.5	10.8	7.8	8.3	7.1	8.3	10.8	8.6	63.5	6.4	7.2	39.5	1.0	24.2	17.0	73.9	27.3	0.0	9.4	4.1	5.8	4.3	77.8	0.0	0.0	0.0	0.1	2.2	0.0	3.0	0.5	12.4	7.1	141.8	10.7	8.0	0.2	7.9	0.0	87.5	48.4	20.6	1.3	0.0	499.4	5.0	0.1	0.0	0.1	0.2	2.0	20.8	10.2	1.6	20.5	1.7	1.8	1.0	0.0	9.5	0.0	0.5	0.1	12.1	0.2	12.4	0.2	5.2	0.0	0.0	62.1	0.1	0.0	65.5	11.5	0.0	0.4	3.3	48.4	0.1	1.2	0.1	1.1	4.9
INHBA		ENSG00000122641	"Inhibin subunit beta A"	P08476	7	41667168-41705834	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"		"Growth factor, Hormone"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 21.6"	"Cell type enhanced"	"Detected in many"		"Granulosa cells: 94.4;Langerhans cells: 68.0;Leydig cells: 137.6;Smooth muscle cells: 218.3;Syncytiotrophoblasts: 178.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 75.9;hTEC/SVTERT24-B: 227.0;hTERT-HME1: 92.9;hTERT-RPE1: 139.2;TIME: 120.1;U-138 MG: 174.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"								"Secreted to blood"	NA	NA		210000		"Cluster 85: Liver - Metabolism"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"				"unprognostic (4.11e-3)"	"prognostic unfavorable (1.46e-5)"	"unprognostic (4.22e-2)"	"unprognostic (1.08e-1)"	"unprognostic (5.18e-2)"	"prognostic unfavorable (4.34e-4)"	"unprognostic (2.05e-2)"	"prognostic unfavorable (7.72e-4)"	"unprognostic (1.44e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.23e-2)"	"unprognostic (2.04e-1)"	"prognostic unfavorable (7.91e-8)"	"unprognostic (6.22e-3)"	"unprognostic (1.11e-2)"	"unprognostic (3.25e-2)"	"unprognostic (3.18e-3)"	2.3	1.5	2.1	5.1	2.0	10.4	0.9	2.3	7.8	1.5	0.7	1.0	0.8	17.3	3.7	2.1	1.2	21.6	5.4	8.7	3.3	2.8	9.5	11.0	1.2	4.3	8.1	6.8	0.6	0.5	0.5	10.9	3.4	3.2	0.6	2.3	5.4	5.0	0.5	2.0	0.5	4.3	4.5	0.5	0.8	1.7	3.0	0.2	1.2	4.6	0.4	10.3	1.1	3.4	4.2	0.0	0.4	0.1	3.3	7.1	0.0	18.2	1.9	9.9	3.3	0.0	0.4	0.0	1.1	6.9	11.6	15.3	0.0	75.9	9.6	5.1	0.0	0.0	0.0	0.0	13.9	0.0	0.2	7.0	4.2	227.0	92.9	139.2	8.2	0.0	0.5	0.0	23.0	0.2	0.0	0.3	1.5	0.0	10.5	0.0	0.0	0.0	0.0	0.1	0.1	5.7	11.1	0.6	0.0	6.2	0.1	0.2	120.1	174.7	49.7	18.9	19.0	0.0	0.0	0.0	6.7	0.1	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	2.1	2.0	2.3	7.8	8.7	3.3	4.3	8.1	3.4	4.5	3.0	3.4	0.7	3.2	15.7	0.0	0.9	17.3	10.8	13.5	2.2	0.1	3.5	6.5	6.0	0.0	4.4	0.0	0.0	1.4	0.3	0.1	0.0	23.6	0.6	1.4	4.1	5.9	0.0	0.0	2.4	2.0	4.6	42.0	0.0	2.6	7.6	94.4	0.7	18.5	1.5	0.0	0.2	0.2	4.1	1.4	68.0	5.9	137.6	55.8	14.2	0.0	27.0	16.1	0.0	4.0	0.3	11.1	0.1	23.3	0.0	12.5	0.0	0.1	2.8	1.3	0.0	4.9	218.3	0.7	0.3	1.4	8.9	178.4	1.7	18.8	0.2	2.3
ITGBL1	"OSCP, TIED"	ENSG00000198542	"Integrin subunit beta like 1"	O95965	13	101452593-101720856	"Predicted intracellular proteins, Predicted secreted proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Fibroblasts: 76.1;Skeletal myocytes: 93.0"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 7.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 208.3;ASC TERT1: 138.7;fHDF/TERT166: 345.3;LHCN-M2: 311.8"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in many"	12	"spinal cord: 56.9"						"Secreted - unknown location"	NA	NA		37000		"Cluster 82: Adipose tissue - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"				"unprognostic (1.70e-1)"	"unprognostic (2.12e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.55e-2)"	"unprognostic (2.12e-4)"	"unprognostic (1.45e-1)"	"unprognostic (3.18e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.86e-1)"	"unprognostic (8.84e-2)"	"unprognostic (2.16e-2)"	"unprognostic (9.50e-2)"	"unprognostic (1.13e-5)"	"unprognostic (1.44e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.68e-1)"	"prognostic unfavorable (2.70e-4)"	16.9	9.2	1.8	0.7	1.8	0.1	18.0	2.6	2.3	23.8	2.5	1.5	0.5	2.0	0.5	9.7	4.9	38.3	18.3	1.9	3.6	2.7	7.7	25.4	1.3	3.9	2.3	5.3	7.9	5.6	10.3	33.4	4.3	4.0	2.5	0.1	11.7	4.4	4.5	13.2	0.5	4.1	3.5	4.0	7.2	2.5	2.2	0.9	8.4	14.9	4.3	17.8	10.0	6.5	4.2	0.3	0.0	0.0	208.3	138.7	0.0	65.8	67.7	29.3	18.7	0.0	2.4	0.0	0.3	345.3	13.9	70.9	0.0	24.1	46.0	0.0	0.0	21.3	0.6	0.0	21.7	0.0	0.0	59.3	1.5	16.8	46.6	55.3	76.8	0.0	1.5	0.7	311.8	0.0	0.0	0.0	0.0	0.0	24.0	0.1	0.0	0.0	0.0	2.7	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	8.8	24.0	33.2	27.3	0.1	8.3	0.0	0.0	50.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	1.8	2.6	2.3	1.9	3.6	3.9	2.3	4.3	3.5	2.2	6.5	1.9	3.2	0.5	5.5	0.1	4.0	0.1	1.3	0.6	1.8	4.2	19.0	0.5	0.0	0.1	0.0	0.0	0.7	0.1	0.0	0.0	0.5	4.5	0.5	7.7	1.2	0.0	0.0	3.6	0.2	0.8	76.1	5.6	1.1	0.0	0.0	8.6	0.5	0.7	5.0	6.7	0.0	0.0	0.0	4.7	2.1	0.0	0.8	5.4	13.1	0.0	0.5	0.0	2.0	5.0	1.1	0.0	8.2	0.6	0.2	0.0	0.1	0.0	0.7	0.0	93.0	4.8	11.6	8.4	0.7	2.4	0.8	0.4	1.2	0.0	0.2
KCNE4	MiRP3	ENSG00000152049	"Potassium voltage-gated channel subfamily E regulatory subunit 4"	Q8WWG9	2	223051814-223198399	"Predicted membrane proteins"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 37.5"	"Cell type enhanced"	"Detected in many"		"Fibroblasts: 32.3;Melanocytes: 32.0;Sertoli cells: 118.3;Smooth muscle cells: 128.3"	"Cancer enhanced"	"Detected in all"		"breast cancer: 20.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"AN3-CA: 164.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA011420	Approved		Approved	"Nuclear bodies,Microtubules"		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 48: Smooth muscle cells - ECM organization"	Microtubules	"Nuclear bodies"	"HPA011420: AB_1079170"	"unprognostic (1.23e-1)"	"unprognostic (2.02e-3)"	"prognostic unfavorable (9.42e-5)"	"unprognostic (2.17e-2)"	"unprognostic (7.56e-2)"	"unprognostic (2.79e-1)"	"unprognostic (4.54e-2)"	"unprognostic (9.06e-2)"	"unprognostic (3.32e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.80e-1)"	"unprognostic (7.89e-2)"	"prognostic unfavorable (2.02e-7)"	"unprognostic (4.70e-3)"	"unprognostic (1.20e-1)"	"unprognostic (6.24e-3)"	"unprognostic (9.08e-3)"	13.3	3.4	7.7	11.0	6.9	0.5	6.9	6.0	11.2	5.0	5.8	8.0	1.3	30.7	2.3	5.1	7.9	20.3	13.5	8.0	6.9	7.5	5.1	3.1	5.7	9.5	8.1	12.3	10.3	1.8	10.3	6.7	9.3	4.4	2.0	3.3	2.7	5.5	5.4	3.2	3.6	37.5	6.9	4.5	12.5	1.1	7.5	0.7	9.4	3.2	1.1	10.7	3.8	8.0	0.0	0.8	0.0	164.3	36.6	3.7	0.2	4.0	3.8	0.8	1.8	0.0	0.2	0.0	0.0	2.5	5.8	0.1	0.0	0.0	0.5	0.0	0.1	0.0	0.3	0.0	4.5	0.0	0.1	6.3	0.0	5.5	0.0	0.0	0.0	0.1	0.0	0.2	6.7	0.0	0.0	0.2	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.4	0.1	0.1	0.4	6.4	0.1	12.1	0.7	0.1	0.0	0.0	3.8	0.1	3.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	7.7	6.9	6.0	11.2	8.0	6.9	9.5	8.1	9.3	6.9	7.5	8.0	8.2	0.0	2.2	4.2	0.0	3.8	0.4	0.2	0.0	0.1	1.8	0.4	4.9	0.0	1.4	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.1	0.8	16.3	19.8	4.8	0.0	0.0	0.0	0.2	32.3	9.2	0.6	3.8	0.4	3.9	0.2	0.1	3.3	0.3	0.0	2.0	0.0	5.8	0.3	21.1	1.0	32.0	5.6	0.0	6.1	0.0	1.0	0.0	0.4	0.1	17.0	0.4	1.4	0.0	0.0	3.7	0.7	118.3	1.7	128.3	0.1	0.2	0.4	3.1	0.3	0.6	0.1	0.2	1.8
LMX1B	NPS1	ENSG00000136944	"LIM homeobox transcription factor 1 beta"	O60663	9	126613928-126701032	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 9.2;salivary gland: 18.5"	"Cell type enhanced"	"Detected in some"		"Breast glandular cells: 8.3;Breast myoepithelial cells: 7.2;Cardiomyocytes: 1.9;Early spermatids: 1.6;Spermatogonia: 2.1"	"Cancer enriched"	"Detected in some"	14	"breast cancer: 12.9"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 3.5;HEK 293: 3.6;MCF7: 11.9;OE19: 10.4;T-47d: 8.1"	"Region enhanced"	"Detected in some"		"pons and medulla: 2.3"	"Region enhanced"	"Detected in many"		"midbrain: 5.0"	"HPA073716, HPA075656"			Approved	Nucleoplasm		NA	NA				"Cluster 27: Brain & Skin - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 35: Glandular cells - Unknown function"	Nucleoplasm		"HPA073716: AB_2686630, HPA075656: "	"unprognostic (4.17e-1)"	"unprognostic (4.72e-2)"	"unprognostic (2.81e-2)"	"unprognostic (2.53e-4)"	"unprognostic (1.73e-1)"	"unprognostic (1.50e-4)"	"unprognostic (1.86e-1)"	"unprognostic (2.20e-2)"	"unprognostic (3.41e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.34e-2)"	"unprognostic (3.51e-3)"	"unprognostic (1.63e-5)"	"unprognostic (1.69e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.56e-6)"	"unprognostic (1.13e-2)"	0.6	0.0	0.1	0.0	0.1	0.1	4.1	0.1	5.6	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	2.0	1.0	1.0	3.6	0.0	0.1	0.0	3.8	9.2	0.0	0.2	1.1	0.2	0.0	3.3	0.0	0.0	0.0	18.5	0.0	0.1	2.1	0.1	0.0	6.8	0.0	0.1	1.4	2.6	0.0	0.4	0.0	0.0	0.0	0.0	0.5	1.2	0.6	0.3	2.7	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.9	0.6	0.0	0.3	0.0	2.5	0.6	3.5	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.5	0.0	1.8	0.0	0.0	0.1	0.0	0.0	0.0	11.9	0.0	0.0	0.0	10.4	0.0	0.0	2.4	0.0	0.0	0.1	0.0	1.1	0.3	0.0	0.2	0.1	8.1	0.1	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	5.6	1.0	1.0	3.8	9.2	3.3	6.8	2.6	0.5	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	8.3	7.2	1.9	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.8	1.6	0.2	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.1	2.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0
LUM	"LDC, SLRR2D"	ENSG00000139329	Lumican	P51884	12	91102629-91111494	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 739.0;placenta: 535.9"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 966.4;Fibroblasts: 2136.1;Leydig cells: 401.7"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in some"	4	"cerebral cortex: 5.6"	"Immune cell enriched"	"Detected in single"	122	"basophil: 12.1"	"Lineage enriched"	"Detected in single"	122	"granulocytes: 12.1"	"Cell line enriched"	"Detected in some"	5	"BJ hTERT+: 1991.0"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	9	"spinal cord: 149.2"	"HPA001522, CAB025783"	Supported				"Secreted to extracellular matrix"	NA	NA		29000000000	"Cluster 38: Basophils - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"			"CAB025783: , HPA001522: AB_1079285"	"unprognostic (5.54e-2)"	"unprognostic (2.27e-1)"	"unprognostic (3.32e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.65e-1)"	"unprognostic (8.38e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.87e-1)"	"unprognostic (4.08e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.65e-2)"	"unprognostic (2.20e-2)"	"prognostic unfavorable (1.75e-6)"	"unprognostic (5.25e-3)"	"unprognostic (2.27e-2)"	"unprognostic (2.38e-2)"	"unprognostic (2.06e-2)"	161.5	133.5	0.6	68.1	0.7	0.3	153.2	0.6	5.6	199.8	4.2	85.0	56.1	301.0	88.3	75.7	59.2	739.0	183.8	0.7	0.9	85.0	34.6	211.4	41.3	0.9	0.8	92.9	72.9	26.3	5.3	535.9	0.8	115.2	133.0	5.7	14.3	67.4	9.6	20.0	90.6	354.5	0.7	4.8	47.1	17.5	1.3	13.4	30.8	73.0	80.3	486.0	39.2	0.8	0.0	0.3	6.9	0.0	237.4	115.9	0.7	400.8	1991.0	16.0	24.3	0.0	0.1	0.0	0.0	339.9	0.0	0.6	0.0	0.0	5.4	0.0	0.0	0.0	21.5	0.0	183.7	0.6	0.1	160.5	0.0	33.7	1.0	0.9	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.6	1.2	0.0	0.9	0.0	0.2	0.1	0.0	0.0	0.3	14.9	0.1	0.0	10.8	16.3	0.0	0.0	0.0	17.0	4.5	14.3	0.0	0.2	0.0	0.0	8.8	0.1	0.0	12.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.7	0.6	5.6	0.7	0.9	0.9	0.8	0.8	0.7	1.3	0.8	77.5	12.8	30.9	0.0	0.6	97.6	1.2	0.8	3.4	0.2	9.4	8.6	15.2	0.0	5.0	0.0	2.1	44.9	4.0	0.1	0.0	0.7	3.5	27.0	966.4	27.2	0.0	0.0	0.0	0.0	38.9	2136.1	8.6	15.2	18.3	0.0	55.0	0.3	63.6	0.0	0.2	0.3	0.0	0.3	143.5	8.7	401.7	9.5	117.4	16.9	1.0	86.9	0.0	0.0	0.0	2.1	0.0	44.8	6.3	4.9	0.4	0.3	0.8	3.0	0.0	39.1	165.5	0.2	0.9	5.9	100.2	84.0	14.5	27.4	0.0	4.1
MARVELD1	"bA548K23.8, FLJ22343, FLJ23440, GB14, MGC4415, MRVLDC1"	ENSG00000155254	"MARVEL domain containing 1"	Q9BSK0	10	97713173-97718150	"Predicted membrane proteins"	"Cell cycle"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Granulosa cells: 86.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"classical monocyte: 3.2;intermediate monocyte: 2.7;myeloid DC: 3.1"	"Group enriched"	"Detected in many"	18	"dendritic cells: 3.1;monocytes: 3.2"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 141.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 40: Granulosa cells - Unknown function"				"unprognostic (3.28e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.26e-3)"	"unprognostic (3.05e-2)"	"unprognostic (1.36e-3)"	"unprognostic (8.82e-2)"	"unprognostic (7.40e-3)"	"prognostic unfavorable (5.85e-5)"	"unprognostic (1.54e-2)"	"unprognostic (7.44e-3)"	"unprognostic (3.40e-2)"	"unprognostic (3.44e-2)"	"prognostic unfavorable (8.89e-7)"	"unprognostic (3.92e-3)"	"unprognostic (7.02e-2)"	"unprognostic (1.50e-1)"	"unprognostic (3.86e-3)"	35.9	8.9	4.7	12.6	5.4	5.2	26.7	4.5	5.5	56.8	24.5	57.1	7.7	60.0	16.7	19.7	48.1	20.4	24.8	4.6	7.5	12.4	5.6	29.7	6.9	6.4	5.7	40.5	7.0	11.3	20.0	25.0	5.5	44.3	24.5	2.0	19.1	48.5	6.1	30.8	22.3	47.7	5.8	16.0	23.7	6.8	6.6	5.3	15.9	7.0	6.0	46.5	41.3	5.9	42.0	30.7	26.1	99.9	97.8	94.0	27.0	56.4	141.3	51.6	34.5	13.5	70.4	0.0	44.5	105.1	7.3	50.3	22.4	53.5	25.9	3.2	28.0	20.3	24.6	0.0	40.9	28.6	0.0	82.7	137.5	33.2	38.3	95.3	65.0	17.6	5.7	0.1	57.7	24.1	3.8	9.9	19.5	4.5	30.6	26.1	22.4	7.0	27.4	8.9	16.9	17.8	34.0	0.3	59.7	16.0	13.4	33.7	65.8	51.9	21.2	50.7	21.4	0.0	3.1	0.1	26.5	0.1	40.2	0.0	3.2	0.0	0.0	2.7	0.1	0.0	0.0	0.1	3.1	0.0	0.0	0.1	0.0	0.0	0.7	0.8	0.0	1.0	4.7	5.4	4.5	5.5	4.6	7.5	6.4	5.7	5.5	5.8	6.6	5.9	7.0	9.6	6.3	10.7	0.9	7.6	31.4	13.4	9.6	2.5	7.1	21.0	4.4	11.5	5.7	12.9	6.2	10.5	0.1	31.9	0.0	8.3	0.7	3.1	32.3	10.5	3.0	4.6	2.3	0.9	21.0	29.9	2.0	6.3	2.5	86.6	12.8	0.6	12.9	0.0	2.8	28.9	4.1	32.6	13.4	2.9	23.0	15.6	12.4	7.5	11.7	13.7	0.0	2.5	0.6	1.9	7.0	38.7	0.3	4.0	2.0	0.2	0.7	3.2	0.0	10.0	31.9	0.3	1.6	1.0	5.4	3.4	1.2	13.1	9.4	6.9
MFAP2	"MAGP, MAGP-1"	ENSG00000117122	"Microfibril associated protein 2"	P55001	1	16974502-16980632	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 81.8"	"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 197.8;Fibroblasts: 75.8;Granulosa cells: 93.3;Leydig cells: 53.7;Peritubular cells: 63.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 249.4;ASC TERT1: 249.6;HUVEC TERT2: 263.1;SH-SY5Y: 212.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA007354	Enhanced				"Secreted to extracellular matrix"	NA	NA		210000		"Cluster 46: Fibroblasts - ECM organization"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 33: Fibroblasts - ECM organization"			"HPA007354: AB_1079365"	"unprognostic (5.10e-2)"	"unprognostic (3.81e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.92e-2)"	"unprognostic (4.86e-1)"	"unprognostic (1.53e-3)"	"unprognostic (3.72e-3)"	"unprognostic (2.21e-1)"	"unprognostic (1.85e-2)"	"unprognostic (1.98e-1)"	"unprognostic (9.45e-3)"	"unprognostic (9.12e-2)"	"prognostic unfavorable (2.52e-8)"	"unprognostic (2.18e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.93e-1)"	"unprognostic (5.66e-3)"	36.6	4.2	0.4	13.3	0.6	0.1	22.7	0.5	1.1	81.8	1.6	15.0	5.0	61.4	22.1	6.1	19.0	73.2	13.8	0.5	0.6	9.4	1.6	20.1	4.2	0.7	0.9	35.8	18.8	4.5	13.2	42.4	0.7	22.1	4.8	4.9	16.5	12.1	2.6	27.6	12.1	30.6	0.5	2.7	8.3	11.2	0.7	1.6	9.5	3.0	2.3	22.5	36.7	0.6	0.0	0.2	93.2	0.3	249.4	249.6	6.2	26.3	102.5	39.7	73.7	24.1	1.1	0.0	82.6	89.7	0.1	0.1	7.2	7.7	15.9	0.1	78.0	0.0	37.1	2.1	23.4	0.1	0.1	104.4	18.8	109.4	42.7	113.1	263.1	0.0	0.2	16.2	19.2	12.5	0.1	0.1	108.8	0.5	0.8	1.5	0.0	4.0	0.9	0.3	5.0	212.1	9.0	36.6	9.6	71.1	11.9	13.0	75.6	65.6	128.4	51.7	2.8	0.1	0.3	0.2	53.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.6	0.5	1.1	0.5	0.6	0.7	0.9	0.7	0.5	0.7	0.6	5.5	0.0	1.7	0.0	0.1	6.6	7.8	28.7	8.0	0.2	2.1	3.9	0.9	2.8	10.7	3.7	0.0	4.5	0.0	0.1	0.0	1.3	12.9	5.6	28.7	7.1	10.1	0.0	0.0	0.8	197.8	75.8	2.0	8.3	0.0	93.3	1.4	0.0	7.4	0.0	0.0	0.4	12.2	0.0	7.7	7.6	53.7	0.6	17.8	2.8	0.0	27.7	0.0	0.0	0.0	1.9	0.0	63.9	0.5	1.5	0.0	0.0	1.9	0.8	0.0	3.3	14.7	3.2	8.7	0.6	6.3	29.0	0.9	0.5	0.2	1.2
MFAP4		ENSG00000166482	"Microfibril associated protein 4"	P55083	17	19383442-19387190	"Plasma proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Fibroblasts: 903.5;Peritubular cells: 240.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	11	"eosinophil: 1.0;intermediate monocyte: 1.8;non-classical monocyte: 1.9"	"Group enriched"	"Detected in many"	15	"granulocytes: 1.0;monocytes: 1.9"	"Cell line enhanced"	"Detected in many"		"ASC diff: 394.8;ASC TERT1: 597.9;fHDF/TERT166: 284.0;HHSteC: 275.4;HSkMC: 417.8;MOLT-4: 375.8;SH-SY5Y: 350.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA054097	Supported		Approved	"Endoplasmic reticulum"	"Secreted to extracellular matrix"	NA	NA		110000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Endoplasmic reticulum"		"HPA054097: AB_2682378"	"unprognostic (3.02e-2)"	"unprognostic (9.07e-2)"	"unprognostic (3.39e-1)"	"unprognostic (8.56e-3)"	"unprognostic (9.80e-2)"	"prognostic favorable (3.51e-4)"	"unprognostic (2.20e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.87e-2)"	"prognostic unfavorable (4.64e-4)"	"unprognostic (1.37e-1)"	"unprognostic (1.77e-1)"	"prognostic unfavorable (6.83e-7)"	"unprognostic (1.07e-2)"	"unprognostic (2.92e-2)"	"unprognostic (3.50e-2)"	"prognostic unfavorable (7.12e-4)"	271.8	81.9	6.5	74.0	10.0	2.7	197.7	7.0	9.5	326.1	13.1	287.5	102.0	237.3	289.0	293.2	227.5	646.2	273.2	6.1	8.3	61.4	45.6	634.7	65.7	7.7	9.0	325.8	71.3	7.0	87.5	156.7	6.6	226.7	139.1	17.3	108.1	129.8	41.6	144.7	187.6	262.7	6.9	59.8	176.1	31.8	8.1	42.4	114.5	249.7	78.6	488.8	244.6	6.9	0.3	0.7	0.6	0.1	394.8	597.9	0.8	44.8	160.0	4.6	3.2	0.2	0.0	0.2	0.1	284.0	0.1	0.2	0.1	0.0	0.8	0.3	1.2	0.0	0.3	0.0	275.4	14.4	0.2	417.8	0.0	2.6	0.1	4.7	0.0	3.9	0.1	0.0	0.4	0.0	375.8	33.8	7.1	0.1	0.4	26.4	24.9	0.7	0.0	0.2	35.8	350.2	0.4	0.2	0.3	2.4	0.4	82.4	0.2	50.9	3.3	2.3	0.1	0.4	0.5	0.1	48.9	15.4	0.1	0.0	0.1	1.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	6.5	10.0	7.0	9.5	6.1	8.3	7.7	9.0	6.6	6.9	8.1	6.9	35.1	3.2	12.1	0.0	0.3	47.5	0.7	0.2	5.7	0.7	2.3	4.2	10.7	0.0	3.1	1.8	0.0	7.2	1.3	0.0	0.0	0.2	0.7	0.3	21.4	15.9	0.0	0.0	0.0	0.0	3.6	903.5	6.1	0.4	1.3	0.1	15.4	0.2	9.4	0.0	0.0	0.0	0.0	0.0	62.9	6.3	78.3	3.9	67.6	14.0	0.0	80.2	0.0	0.5	0.1	0.1	0.0	240.0	2.6	2.2	0.0	0.0	2.9	3.3	19.7	38.6	103.1	0.4	0.5	8.8	41.1	19.4	6.9	0.2	0.0	2.2
MN1	"MGCR, MGCR1, MGCR1-PEN"	ENSG00000169184	"MN1 proto-oncogene, transcriptional regulator"	Q10571	22	27748277-27801756	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Developmental protein"	"Cancer-related genes, Disease variant, Mental retardation, Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 20.7;skeletal muscle: 61.6;tongue: 42.6"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 12.1;Early spermatids: 22.3;Fibroblasts: 13.9;Langerhans cells: 11.2;Late spermatids: 15.2;Oligodendrocyte precursor cells: 13.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 30.7;HeLa: 12.7;hTERT-RPE1: 13.7;RH-30: 12.4;TIME: 20.1;U-2 OS: 16.3;U-2197: 17.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA003072	Approved		Approved	Nucleoplasm		NA	NA				"Cluster 80: Striated muscle - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm		"HPA003072: AB_1079399"	"unprognostic (5.64e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.88e-2)"	"unprognostic (2.52e-2)"	"unprognostic (7.01e-2)"	"unprognostic (3.03e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.64e-1)"	"unprognostic (4.00e-2)"	"unprognostic (7.33e-2)"	"unprognostic (5.13e-7)"	"unprognostic (3.84e-2)"	"unprognostic (2.00e-1)"	"unprognostic (5.28e-3)"	"unprognostic (2.21e-4)"	4.1	0.8	6.0	1.6	20.7	1.3	2.3	6.4	9.5	2.2	0.5	6.1	0.8	2.7	1.0	3.6	4.3	3.0	6.7	1.9	5.3	0.9	0.4	3.3	0.1	4.3	13.0	9.6	0.7	0.1	2.7	1.3	6.8	2.3	0.9	1.8	2.7	1.2	61.6	1.8	2.1	2.5	2.1	0.4	4.0	0.8	8.5	0.3	2.1	42.6	0.7	3.3	3.5	3.1	0.0	1.5	30.7	0.9	0.6	1.3	0.0	0.7	1.1	0.0	0.0	0.0	0.1	0.0	3.1	5.7	1.3	2.7	1.5	1.8	0.0	0.0	0.8	0.0	12.7	0.0	0.7	0.0	0.3	0.1	3.5	0.7	3.0	13.7	0.3	0.0	0.0	0.2	1.0	0.0	0.0	0.4	4.0	0.0	2.8	5.3	12.4	0.0	0.4	0.0	0.1	0.4	2.7	0.0	0.0	7.5	0.3	0.1	20.1	1.0	16.3	17.9	0.3	0.2	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	6.0	20.7	6.4	9.5	1.9	5.3	4.3	13.0	6.8	2.1	8.5	3.1	2.1	3.2	2.3	12.1	0.3	4.2	0.1	2.6	3.4	8.4	1.8	0.6	7.4	1.5	0.7	0.0	0.0	0.1	0.2	0.0	0.0	1.4	22.3	1.4	1.0	6.6	0.0	0.0	6.4	1.0	0.1	13.9	0.5	3.1	0.0	0.6	2.5	0.6	0.3	0.0	9.6	0.0	2.0	1.4	11.2	15.2	5.0	2.7	0.0	2.8	0.3	3.9	0.0	13.0	4.3	2.8	0.0	10.1	1.3	0.2	0.0	0.1	0.1	0.7	0.0	2.4	2.3	0.4	1.1	1.9	2.7	0.0	0.3	0.4	0.0	0.2
MOXD1	"dJ248E1.1, DKFZP564G202, MOX"	ENSG00000079931	"Monooxygenase DBH like 1"	Q6UVY6	6	132296055-132401475	"Predicted intracellular proteins, Predicted membrane proteins"		"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 64.2;smooth muscle: 78.6"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 92.7;Basal squamous epithelial cells: 153.1;Early spermatids: 70.2;Endometrial stromal cells: 57.8;Excitatory neurons: 36.0;Oligodendrocyte precursor cells: 33.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	33	"memory B-cell: 3.1;naive B-cell: 1.7;plasmacytoid DC: 5.1"	"Group enriched"	"Detected in many"	41	"B-cells: 3.1;dendritic cells: 5.1"	"Cell line enhanced"	"Detected in many"		"ASC diff: 164.8;ASC TERT1: 131.7;BJ: 106.1;fHDF/TERT166: 196.5;HBF TERT88: 120.6;U-2197: 310.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035740	Approved		Approved	Cytosol		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 36: Stromal cells - Cell proliferation"	Cytosol		"HPA035740: AB_10610141"	"unprognostic (1.74e-1)"	"unprognostic (1.28e-1)"	"unprognostic (8.05e-2)"	"unprognostic (9.87e-3)"	"unprognostic (5.62e-2)"	"prognostic favorable (7.09e-5)"	"unprognostic (5.77e-2)"	"unprognostic (2.48e-1)"	"unprognostic (6.55e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.60e-1)"	"unprognostic (9.54e-2)"	"unprognostic (2.56e-3)"	"prognostic unfavorable (3.72e-4)"	"unprognostic (2.92e-2)"	"unprognostic (6.24e-2)"	"unprognostic (1.73e-2)"	2.8	36.5	18.0	5.7	10.6	0.1	2.5	3.1	11.7	25.7	3.5	13.4	5.2	64.2	11.0	23.5	3.4	28.7	5.4	10.9	4.0	37.0	1.8	25.3	6.2	3.5	3.8	0.8	2.2	0.5	4.5	1.4	3.9	32.0	8.8	5.0	12.2	39.6	0.3	14.4	7.5	78.6	3.6	4.7	5.2	1.8	6.7	2.1	1.8	0.5	15.6	19.1	12.8	10.8	0.1	0.9	4.1	0.0	164.8	131.7	0.2	106.1	71.0	37.7	65.8	0.2	1.2	0.4	0.1	196.5	30.9	0.1	1.4	0.5	120.6	0.0	19.3	0.0	0.1	0.0	1.5	0.1	0.1	31.8	0.0	76.6	2.5	46.6	0.0	0.0	0.0	7.8	22.4	0.0	0.1	0.2	3.5	0.0	0.7	1.1	0.4	0.2	46.3	0.4	2.8	0.2	0.0	0.4	2.4	9.6	0.1	5.9	0.5	17.4	15.9	310.0	56.1	4.1	0.0	0.0	43.9	0.0	51.9	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.1	18.0	10.6	3.1	11.7	10.9	4.0	3.5	3.8	3.9	3.6	6.7	10.8	0.4	0.0	1.3	92.7	5.4	28.0	0.4	0.1	153.1	0.3	0.4	0.6	0.7	0.0	2.5	1.8	0.0	0.9	2.7	0.0	0.0	0.6	70.2	1.0	57.8	0.6	0.0	0.0	36.0	0.0	1.5	23.9	0.5	1.2	3.8	0.0	0.0	0.0	0.4	0.0	8.6	0.0	0.0	0.3	4.7	11.8	0.3	0.3	7.2	4.7	0.0	16.4	0.0	33.7	1.1	0.4	0.0	0.4	9.5	1.5	0.0	0.3	0.0	0.8	0.0	6.2	3.3	0.5	0.8	14.6	6.8	0.0	0.5	0.1	0.1	0.0
MSC	"ABF-1, bHLHa22"	ENSG00000178860	Musculin	O60682	8	71841560-71844412	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Exocrine glandular cells: 40.9;Fibroblasts: 31.4;Leydig cells: 42.6;Melanocytes: 26.6;monocytes: 50.7;Pancreatic endocrine cells: 27.5;Peritubular cells: 41.3;Sertoli cells: 26.3;Skeletal myocytes: 70.0;Smooth muscle cells: 27.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"memory CD8 T-cell: 25.8"	"Group enriched"	"Detected in many"	37	"B-cells: 6.9;dendritic cells: 6.4;T-cells: 25.8"	"Cell line enriched"	"Detected in many"	15	"HDLM-2: 819.3"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	8	"cerebral cortex: 16.3;hippocampal formation: 13.2"	HPA062878			Supported	Nucleoplasm		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm		"HPA062878: AB_2684891"	"unprognostic (2.58e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.35e-3)"	"prognostic unfavorable (5.21e-4)"	"unprognostic (3.70e-2)"	"prognostic unfavorable (4.83e-5)"	"unprognostic (3.95e-2)"	"unprognostic (7.92e-2)"	"unprognostic (3.75e-2)"	"unprognostic (3.73e-1)"	"unprognostic (2.31e-1)"	"prognostic unfavorable (1.07e-13)"	"unprognostic (1.65e-2)"	"unprognostic (1.45e-1)"	"unprognostic (7.48e-2)"	"unprognostic (1.40e-2)"	13.3	8.9	2.5	11.4	1.2	3.9	7.0	0.4	4.5	6.7	0.9	3.0	2.2	4.8	0.9	3.1	4.2	11.1	19.9	5.9	0.6	6.3	3.6	9.5	12.1	3.1	0.7	5.1	5.2	0.3	3.3	16.3	1.0	5.5	1.1	0.0	4.3	3.1	3.0	3.5	5.3	2.3	0.6	6.4	5.4	3.0	0.7	1.6	4.4	2.4	3.5	20.5	6.5	2.8	0.1	6.2	0.0	0.0	28.1	4.9	0.0	1.2	23.8	0.5	1.3	0.0	0.0	0.0	0.3	4.8	28.5	1.3	0.0	1.5	0.0	819.3	0.3	0.0	0.0	0.0	49.8	0.0	2.8	11.1	0.0	49.2	30.1	11.9	0.0	0.0	0.0	0.0	1.0	0.0	0.0	1.2	6.7	0.0	0.0	0.0	55.3	0.0	0.0	0.0	2.4	0.0	0.1	0.0	44.9	0.5	0.0	5.5	0.0	0.2	0.1	7.8	0.3	5.0	0.2	0.1	20.4	0.1	34.5	0.0	0.1	0.0	5.2	0.1	7.2	6.9	9.2	25.8	0.1	6.2	0.2	8.7	0.2	0.0	0.3	6.4	13.0	3.2	2.5	1.2	0.4	4.5	5.9	0.6	3.1	0.7	1.0	0.6	0.7	2.8	1.2	0.0	0.0	0.0	2.7	5.1	0.2	0.4	0.0	0.0	0.2	0.3	1.9	0.0	0.0	1.8	0.0	0.1	4.3	0.0	0.0	16.1	0.6	0.3	1.0	4.5	0.0	0.0	1.1	40.9	0.1	31.4	1.5	0.1	0.0	0.0	3.9	0.0	1.8	0.0	0.1	0.0	0.0	0.3	8.9	1.5	42.6	5.8	26.6	0.0	50.7	0.0	0.0	0.0	0.2	27.5	0.0	41.3	7.0	0.7	0.0	1.2	0.0	0.0	26.3	70.0	27.8	0.4	0.3	0.3	3.3	0.0	10.0	8.1	0.0	0.3
MXRA8	DKFZp586E2023	ENSG00000162576	"Matrix remodeling associated 8"	Q9BRK3	1	1352689-1361777	"Predicted membrane proteins"	"Cell adhesion, Host-virus interaction"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 149.5;Extravillous trophoblasts: 259.9;Fibroblasts: 183.3;Leydig cells: 176.1;Peritubular cells: 183.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	7	"naive CD8 T-cell: 6.4"	"Lineage enriched"	"Detected in single"	64	"T-cells: 6.4"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 46.0;BJ: 143.6;BJ hTERT+: 66.9;fHDF/TERT166: 71.9;HSkMC: 54.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053958, HPA055780"	Uncertain		Approved	Nucleoli		NA	NA		760000	"Cluster 32: T-cells - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoli		"HPA053958: AB_2682322, HPA055780: AB_2682918"	"unprognostic (1.39e-1)"	"unprognostic (2.85e-1)"	"unprognostic (7.31e-3)"	"unprognostic (1.26e-2)"	"unprognostic (1.94e-3)"	"unprognostic (2.61e-1)"	"unprognostic (6.75e-2)"	"unprognostic (2.03e-1)"	"unprognostic (4.22e-2)"	"unprognostic (5.38e-2)"	"unprognostic (2.97e-2)"	"unprognostic (7.13e-2)"	"prognostic unfavorable (3.43e-6)"	"prognostic unfavorable (9.93e-4)"	"unprognostic (1.55e-1)"	"unprognostic (2.89e-2)"	"prognostic unfavorable (9.87e-4)"	103.6	11.7	2.9	8.2	2.5	0.6	70.0	1.1	2.9	100.4	1.7	58.2	6.3	117.2	2.6	17.6	57.4	19.4	42.8	4.0	2.4	26.4	7.4	53.9	2.5	5.9	4.5	81.9	8.7	1.1	21.7	11.6	2.6	39.0	1.7	0.8	32.4	11.4	16.6	41.6	29.5	6.4	2.3	26.4	28.9	14.7	3.2	0.6	46.6	5.0	0.8	52.8	59.3	3.0	4.1	0.8	1.2	1.0	16.5	46.0	42.3	143.6	66.9	16.6	19.9	8.0	3.3	1.7	0.6	71.9	0.1	3.0	1.0	0.0	3.2	3.2	1.3	1.2	3.1	12.8	43.4	0.2	1.6	54.8	0.0	6.2	0.0	32.4	0.0	0.9	17.3	1.4	21.5	0.4	0.4	0.5	14.0	0.3	4.7	0.6	0.3	0.4	0.0	0.7	3.2	8.9	0.5	1.4	0.1	10.4	11.1	0.7	1.3	0.7	23.1	21.8	0.6	3.3	0.3	0.2	5.5	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.8	6.4	0.0	0.0	0.0	0.0	0.0	0.2	2.9	2.5	1.1	2.9	4.0	2.4	5.9	4.5	2.6	2.3	3.2	3.0	22.2	3.2	0.0	7.5	0.5	10.7	1.1	0.7	2.2	0.7	7.0	47.9	3.5	0.0	0.0	9.2	0.0	9.5	1.1	0.0	0.0	5.7	1.7	4.3	149.5	5.1	0.0	0.0	0.3	0.0	259.9	183.3	2.6	3.7	0.0	0.5	6.4	0.1	9.3	0.0	0.4	0.0	0.0	0.0	19.7	11.4	176.1	1.7	10.6	6.5	0.7	50.7	0.0	0.0	0.1	1.1	0.0	183.6	1.4	0.6	0.0	1.4	0.0	1.5	13.1	65.8	74.7	0.7	5.4	1.3	10.5	29.4	2.2	0.8	0.0	0.3
NBL1	"D1S1733E, DAN, DAND1, NB, NO3"	ENSG00000158747	"NBL1, DAN family BMP antagonist"	P41271	1	19596979-19658456	"Predicted intracellular proteins, Predicted secreted proteins"			"Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"cervix: 676.6"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 395.1;Leydig cells: 386.8;Paneth cells: 313.2;Peritubular cells: 356.9;Prostatic glandular cells: 293.3;Proximal enterocytes: 413.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 431.7;HSkMC: 305.6;SK-MEL-30: 473.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007394, CAB026132"	Uncertain				"Secreted in other tissues"	NA	NA		8100000	"Cluster 32: T-cells - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"CAB026132: , HPA007394: AB_10601272"	"unprognostic (1.65e-1)"	"unprognostic (1.65e-2)"	"unprognostic (9.03e-2)"	"unprognostic (2.85e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.18e-2)"	"unprognostic (3.15e-2)"	"unprognostic (3.92e-1)"	"unprognostic (7.88e-2)"	"unprognostic (3.10e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.39e-1)"	"unprognostic (6.21e-2)"	"unprognostic (2.26e-2)"	166.3	27.7	116.1	61.4	115.2	5.7	183.3	90.6	156.0	676.6	125.7	259.3	195.0	253.9	48.3	206.8	281.5	202.6	119.1	147.1	117.1	67.2	5.8	312.0	57.3	101.7	140.7	635.9	27.1	48.3	125.3	21.6	117.0	376.0	109.3	14.5	65.4	113.5	26.6	199.1	314.1	113.0	95.0	25.8	139.9	44.5	109.5	25.3	85.9	28.4	22.4	246.5	373.8	97.3	138.8	42.9	7.2	38.5	431.7	222.7	19.7	195.5	238.6	64.1	64.7	11.8	242.6	0.2	122.2	245.7	44.8	153.4	40.8	180.1	19.6	132.9	23.0	6.8	40.5	72.4	69.4	0.5	3.1	305.6	162.0	94.6	57.6	19.1	48.7	8.0	1.4	0.4	20.6	20.4	0.4	11.7	2.9	142.3	65.2	6.4	0.1	4.7	122.5	16.6	3.1	102.2	31.2	1.2	473.8	7.1	160.2	24.3	68.9	62.4	49.7	180.0	30.3	0.9	1.1	0.8	45.4	0.6	19.1	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.8	0.4	0.0	0.0	0.6	0.4	0.0	0.1	0.0	0.0	0.0	0.1	116.1	115.2	90.6	156.0	147.1	117.1	101.7	140.7	117.0	95.0	109.5	97.3	150.4	3.2	2.3	0.0	2.9	174.6	237.3	22.6	107.0	35.5	41.5	32.8	43.5	55.8	11.9	36.8	6.2	1.0	5.1	395.1	3.9	43.0	2.0	15.6	55.7	84.3	54.5	3.4	0.0	7.7	2.6	241.4	39.8	10.1	13.4	80.9	47.8	1.5	54.6	6.7	0.0	244.6	12.2	2.2	76.6	13.1	386.8	6.6	60.5	0.0	5.8	13.4	0.0	0.0	0.0	97.5	313.2	356.9	1.1	293.3	413.8	19.7	24.5	10.2	131.5	14.0	142.9	1.4	7.6	61.4	202.4	1.4	29.6	15.1	220.4	206.5
NT5E	"CALJA, CD73, eN, eNT, NT5"	ENSG00000135318	"5'-nucleotidase ecto"	P21589	6	85449584-85495791	"CD markers, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 112.6;retina: 94.4"	"Cell type enhanced"	"Detected in many"		"Glandular and luminal cells: 58.0;Oligodendrocyte precursor cells: 61.3;Pancreatic endocrine cells: 124.8;Rod photoreceptor cells: 81.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"naive B-cell: 33.0;naive CD8 T-cell: 30.7"	"Group enriched"	"Detected in many"	41	"B-cells: 33.0;T-cells: 30.7"	"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 807.8;LHCN-M2: 934.3;TIME: 546.2;U-87 MG: 821.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017357	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA		3000000	"Cluster 21: B-cells - Adaptive immune response"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA017357: AB_1846330"	"unprognostic (1.92e-2)"	"unprognostic (4.44e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.57e-3)"	"unprognostic (9.33e-2)"	"unprognostic (1.82e-3)"	"unprognostic (1.20e-2)"	"prognostic unfavorable (6.66e-4)"	"unprognostic (5.45e-2)"	"unprognostic (1.80e-1)"	"prognostic unfavorable (1.32e-5)"	"unprognostic (1.39e-1)"	"unprognostic (3.11e-2)"	"prognostic unfavorable (1.02e-4)"	"unprognostic (3.49e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.78e-1)"	20.7	6.0	9.8	11.9	11.9	0.6	14.1	11.2	10.7	112.6	14.9	29.4	40.1	49.4	6.3	8.6	20.7	17.2	8.7	8.5	11.3	17.2	54.8	6.8	9.6	11.7	14.1	39.3	1.8	1.8	11.8	25.3	13.0	13.3	31.9	94.4	6.6	34.2	2.1	6.4	20.9	73.9	14.7	13.0	8.1	10.4	12.7	5.2	23.7	9.8	11.3	15.8	28.5	12.1	48.9	26.0	42.9	0.8	95.1	302.4	0.4	306.1	332.7	147.5	275.2	0.4	469.6	0.0	107.3	270.2	379.0	24.5	0.1	308.0	348.8	0.8	0.1	0.1	7.3	6.0	47.5	0.2	0.7	77.4	3.7	302.0	191.3	807.8	124.9	0.3	0.3	1.4	934.3	8.3	0.0	0.2	0.8	8.2	34.6	1.5	9.5	1.3	323.1	21.8	0.3	5.5	3.8	18.8	104.9	2.2	0.4	8.3	546.2	120.6	0.9	152.9	506.8	22.7	15.3	0.5	821.7	0.4	385.3	0.0	0.0	0.5	3.7	0.0	6.4	23.7	4.2	11.7	0.0	33.0	4.1	30.7	0.5	0.7	0.0	0.1	1.7	6.4	9.8	11.9	11.2	10.7	8.5	11.3	11.7	14.1	13.0	14.7	12.7	12.1	6.4	0.0	5.8	36.9	21.6	5.2	1.7	6.1	2.8	4.4	1.2	0.3	1.7	27.1	4.8	1.8	10.4	0.6	2.2	49.2	3.9	3.8	0.6	19.3	20.8	20.5	0.0	0.0	1.6	4.1	2.5	39.4	11.2	58.0	0.0	0.1	49.6	33.7	1.3	0.0	2.1	27.7	0.0	3.5	8.2	1.3	13.1	2.1	7.2	11.2	0.5	9.1	0.0	61.3	0.7	124.8	46.0	25.6	3.6	1.5	8.3	27.6	4.8	81.6	0.0	3.3	9.6	0.0	0.3	0.6	4.8	15.2	5.0	0.1	18.0	9.6
NTRK1	"MTC, TRK, TRKA"	ENSG00000198400	"Neurotrophic receptor tyrosine kinase 1"	P04629	1	156815640-156881850	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins"	"Differentiation, Neurogenesis"	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"adrenal gland: 7.0;brain: 21.7"	"Group enriched"	"Detected in some"	10	"Bipolar cells: 22.8;granulocytes: 55.9;Horizontal cells: 57.2"	"Cancer enhanced"	"Detected in some"		"glioma: 1.3"	"Group enriched"	"Detected in many"	6	"cerebral cortex: 7.6;medulla oblongata: 19.8;pons: 21.7"	"Immune cell enriched"	"Detected in single"	116	"basophil: 94.5"	"Lineage enriched"	"Detected in single"	768	"granulocytes: 94.5"	"Cell line enriched"	"Detected in some"	4	"HMC-1: 82.1"	"Region enhanced"	"Detected in many"		"basal ganglia: 8.4"	"Region enriched"	"Detected in single"	6	"basal ganglia: 4.1"	"CAB004606, HPA035799, HPA076570"	Approved		Approved	Vesicles,Cytosol		NA	NA		79000	"Cluster 38: Basophils - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 62: Horizontal cells - Visual perception"	"Vesicles, Cytosol"		"CAB004606: AB_628397, HPA035799: AB_2674788, HPA076570: "	"unprognostic (5.89e-3)"	"unprognostic (7.56e-2)"	"unprognostic (2.74e-2)"	"unprognostic (5.99e-3)"	"unprognostic (7.26e-2)"	"unprognostic (1.43e-3)"	"unprognostic (1.56e-1)"	"unprognostic (7.42e-3)"	"unprognostic (7.63e-2)"	"unprognostic (1.35e-1)"	"unprognostic (6.73e-2)"	"unprognostic (2.29e-2)"	"unprognostic (3.18e-11)"	"unprognostic (2.18e-3)"	"unprognostic (3.79e-2)"	"unprognostic (1.07e-1)"	"unprognostic (4.89e-1)"	0.8	7.0	0.7	0.4	1.8	0.7	0.2	1.8	7.6	0.7	0.7	0.8	0.5	1.0	0.0	0.1	0.5	0.4	1.0	0.3	2.8	3.0	0.0	0.5	0.1	19.8	1.5	0.1	0.2	0.0	0.7	0.2	21.7	1.4	0.0	1.9	0.5	0.3	0.4	0.1	0.3	0.6	0.2	0.1	0.5	1.6	0.4	0.3	0.2	0.2	0.0	0.3	0.5	0.6	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.2	0.1	0.0	0.0	0.0	11.9	0.0	14.0	0.0	0.0	0.0	0.0	82.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	4.4	1.6	0.0	0.2	0.0	2.4	0.2	0.0	1.5	2.5	0.0	0.2	0.0	0.5	1.5	18.2	0.0	0.1	0.0	0.3	0.0	0.1	0.3	0.0	1.1	0.0	0.0	3.5	0.6	0.0	0.0	0.0	0.1	94.5	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.2	0.7	1.8	1.8	7.6	0.3	2.8	19.8	1.5	21.7	0.2	0.4	0.6	0.1	0.0	1.3	0.3	0.0	0.0	0.0	0.0	0.0	22.8	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	1.6	0.2	0.0	4.2	0.7	0.0	0.0	4.3	0.0	0.1	55.9	0.0	0.0	0.0	0.1	57.2	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	2.8	0.0	0.5	0.0	0.5	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.9	3.2	2.7	0.0	0.1	0.0	1.0	0.1	0.0	0.0
OAF	MGC52117	ENSG00000184232	"Out at first homolog"	Q86UD1	11	120211032-120230334	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"liver: 396.6"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 135.9;Fibroblasts: 135.9;Hepatocytes: 218.8;Muller glia cells: 279.4;Theca cells: 149.0;Urothelial cells: 192.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"classical monocyte: 3.3;intermediate monocyte: 1.6;myeloid DC: 2.4"	"Group enriched"	"Detected in many"	14	"dendritic cells: 2.4;monocytes: 3.3"	"Cell line enhanced"	"Detected in many"		"EFO-21: 115.5;Hep G2: 190.1;NB-4: 139.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047412	Uncertain		Approved	Nucleoplasm	"Secreted - unknown location"	NA	NA		69000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm		"HPA047412: AB_10960631"	"unprognostic (1.59e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.80e-1)"	"unprognostic (5.69e-2)"	"prognostic unfavorable (5.71e-5)"	"unprognostic (2.11e-1)"	"unprognostic (3.98e-3)"	"unprognostic (5.09e-2)"	"unprognostic (3.90e-2)"	"unprognostic (3.28e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.12e-2)"	"unprognostic (7.15e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.95e-1)"	66.0	91.5	47.7	18.0	56.8	10.8	42.6	35.8	57.1	66.7	40.5	61.9	47.7	54.2	16.0	22.8	54.6	34.5	55.1	48.1	36.5	51.4	396.6	19.2	5.8	39.0	37.8	61.0	74.1	6.7	27.4	8.1	37.1	33.5	36.5	30.7	53.9	13.7	13.2	12.0	57.3	29.1	35.9	54.4	33.5	3.7	45.0	4.6	25.9	12.2	3.7	42.6	40.4	44.6	24.9	7.5	30.9	14.4	47.8	53.4	1.7	47.7	53.8	20.5	30.0	7.5	37.3	0.0	115.5	35.6	33.7	25.7	8.9	13.2	8.2	18.7	21.1	21.1	4.7	190.1	42.4	46.7	7.9	66.8	7.9	19.8	54.8	39.9	59.7	12.7	14.0	22.7	5.0	9.4	0.3	139.9	11.6	7.3	40.8	11.8	0.9	23.7	31.8	13.4	1.5	10.0	14.0	15.2	40.2	8.6	4.8	74.7	32.7	39.3	14.7	40.8	4.6	0.8	0.7	0.4	30.3	76.2	14.1	0.0	3.3	0.0	0.1	1.6	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.2	0.1	0.0	0.3	0.5	0.1	0.8	47.7	56.8	35.8	57.1	48.1	36.5	39.0	37.8	37.1	35.9	45.0	44.6	19.4	0.0	0.6	102.2	3.7	9.4	33.6	7.3	12.5	3.2	6.0	7.0	5.5	34.3	3.5	71.7	2.1	2.1	1.1	135.9	27.4	14.8	0.2	4.7	70.9	40.0	22.8	12.8	0.6	28.7	5.5	135.9	11.7	12.2	1.3	2.6	12.5	218.8	6.0	0.0	2.3	56.5	4.1	11.5	20.9	1.1	16.8	11.0	16.0	23.4	10.2	279.4	0.0	5.5	11.0	28.2	56.5	4.5	14.5	31.3	111.1	79.3	0.4	10.6	52.6	8.6	40.8	0.7	6.9	11.3	10.2	6.2	3.1	149.0	45.8	192.5
OGN	"mimecan, OIF, SLRR3A"	ENSG00000106809	Osteoglycin	P20774	9	92383268-92404696	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Growth factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 216.0"	"Group enriched"	"Detected in many"	8	"Endometrial stromal cells: 104.1;Fibroblasts: 326.2;Leydig cells: 166.2;Peritubular cells: 212.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	9	"T-reg: 1.7"	"Lineage enriched"	"Detected in single"	9	"T-cells: 1.7"	"Group enriched"	"Detected in some"	4	"ASC TERT1: 22.2;HSkMC: 9.7;JURKAT: 15.7;MOLT-4: 32.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013132	Approved		Supported	"Endoplasmic reticulum"	"Secreted in other tissues"	NA	NA		170000000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 33: Fibroblasts - ECM organization"	"Endoplasmic reticulum"		"HPA013132: AB_1854825"	"unprognostic (2.31e-1)"	"unprognostic (3.94e-3)"	"unprognostic (1.74e-1)"	"unprognostic (2.08e-2)"	"unprognostic (2.60e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.44e-4)"	"unprognostic (4.42e-2)"	"unprognostic (1.01e-2)"	"prognostic unfavorable (4.04e-4)"	"unprognostic (2.47e-1)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (1.92e-4)"	"unprognostic (3.37e-3)"	"unprognostic (3.86e-2)"	"unprognostic (2.20e-3)"	"prognostic unfavorable (2.03e-4)"	100.1	22.5	1.4	6.0	3.0	0.2	53.8	4.7	6.8	216.0	11.0	43.0	10.6	130.5	44.9	30.8	67.1	164.7	79.8	1.7	2.3	6.4	4.1	18.6	2.1	1.8	1.8	91.8	11.1	117.3	19.1	22.7	2.0	57.9	32.2	0.0	3.2	19.3	2.6	3.8	23.6	118.0	2.3	2.4	22.0	13.3	2.2	4.5	14.7	22.0	5.6	54.0	23.3	2.1	0.0	0.0	0.0	0.0	4.4	22.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.2	0.0	9.7	0.0	0.0	0.0	0.0	0.0	15.7	0.0	0.0	0.0	0.1	32.2	0.3	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	1.7	0.0	1.4	3.0	4.7	6.8	1.7	2.3	1.8	1.8	2.0	2.3	2.2	2.1	10.3	6.4	1.5	1.0	0.4	4.2	0.1	0.0	1.2	0.6	0.7	0.4	2.6	10.0	7.4	3.7	0.0	2.0	0.6	0.1	0.0	0.0	1.2	2.9	104.1	5.2	0.0	0.0	1.9	0.0	1.7	326.2	7.7	1.7	1.3	0.0	20.0	0.1	4.6	0.0	1.8	0.0	0.0	0.3	11.1	4.2	166.2	2.3	1.8	16.9	0.2	0.1	0.0	2.0	1.6	0.0	0.0	212.1	0.7	0.4	0.0	0.0	2.9	0.2	6.6	4.7	22.7	0.6	0.6	0.7	4.5	5.7	2.1	1.6	0.0	0.2
OLFML3	"HNOEL-iso, OLF44"	ENSG00000116774	"Olfactomedin like 3"	Q9NRN5	1	113979391-114035572	"Predicted intracellular proteins, Predicted secreted proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 136.6;Fibroblasts: 246.9;Leydig cells: 73.3;Theca cells: 126.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	8	"myeloid DC: 2.1"	"Lineage enriched"	"Detected in single"	12	"dendritic cells: 2.1"	"Cell line enhanced"	"Detected in many"		"ASC diff: 577.3;ASC TERT1: 312.6;BJ hTERT+: 374.8;HSkMC: 581.6;LHCN-M2: 602.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027991			Supported	Vesicles	"Secreted to extracellular matrix"	NA	NA		3000000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"	Vesicles		"HPA027991: AB_2732440"	"unprognostic (1.04e-1)"	"unprognostic (8.06e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.50e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.02e-1)"	"unprognostic (3.72e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.04e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.77e-1)"	"prognostic unfavorable (3.45e-5)"	"unprognostic (6.80e-3)"	"unprognostic (1.88e-1)"	"unprognostic (2.61e-1)"	"unprognostic (4.41e-3)"	85.6	42.6	5.7	24.9	7.4	0.9	89.7	7.2	12.4	170.6	8.2	71.9	15.1	124.7	42.6	26.6	96.3	95.0	56.6	5.4	6.7	34.1	36.3	55.4	12.0	9.8	7.7	177.4	35.2	9.9	17.9	111.8	8.6	42.9	34.5	0.2	16.7	73.8	10.3	37.6	32.3	94.6	9.2	9.9	48.4	9.3	9.7	8.9	21.8	38.2	14.9	71.1	98.8	11.2	0.0	19.7	9.7	0.1	577.3	312.6	0.6	77.1	374.8	26.5	85.3	25.2	0.2	0.0	4.1	222.4	0.2	0.0	3.2	0.3	4.0	0.0	0.0	0.0	0.1	19.3	149.6	0.2	0.0	581.6	0.0	37.2	0.5	10.7	2.1	0.0	0.0	0.1	602.3	0.3	0.2	0.4	45.8	0.0	0.7	0.1	142.6	0.3	0.0	0.0	0.3	5.4	0.1	0.2	10.5	143.3	224.6	0.9	1.8	14.9	27.6	5.9	0.0	0.2	0.1	0.0	7.3	0.0	94.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	5.7	7.4	7.2	12.4	5.4	6.7	9.8	7.7	8.6	9.2	9.7	11.2	13.6	0.0	3.7	0.0	0.4	13.0	0.2	0.0	0.6	0.0	2.1	2.9	1.4	4.3	0.8	1.8	0.0	6.8	1.1	0.2	0.0	0.8	2.9	6.2	136.6	9.5	6.0	0.0	0.0	0.0	4.9	246.9	5.6	3.5	1.3	0.3	45.7	0.5	33.3	0.0	0.0	0.6	0.0	5.9	22.7	1.7	73.3	15.5	12.4	16.9	0.6	0.0	0.0	0.0	0.1	0.3	0.1	33.1	0.2	0.7	0.0	0.5	0.0	0.1	0.0	44.8	28.0	0.3	0.4	1.2	11.5	12.4	2.6	126.1	0.2	0.2
PAMR1	"DKFZP586H2123, RAMP"	ENSG00000149090	"Peptidase domain containing associated with muscle regeneration 1"	Q6UXH9	11	35431823-35530300	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"		"Serine protease homolog"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	7	"Astrocytes: 380.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 86.9;ASC TERT1: 354.7;BJ hTERT+: 357.7;fHDF/TERT166: 86.7;HSkMC: 123.1;U-87 MG: 82.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Secreted - unknown location"	NA	NA		5600000		"Cluster 57: Non-specific - Angiogenesis"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 64: Astrocytes - Nervous system maintenance"				"unprognostic (3.38e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.00e-3)"	"unprognostic (6.50e-3)"	"unprognostic (1.01e-1)"	"unprognostic (2.07e-2)"	"unprognostic (6.92e-2)"	"unprognostic (3.32e-2)"	"unprognostic (4.07e-2)"	"unprognostic (1.91e-2)"	"unprognostic (1.36e-2)"	"prognostic unfavorable (5.08e-5)"	"prognostic unfavorable (6.29e-4)"	"unprognostic (2.08e-1)"	"unprognostic (9.98e-2)"	"unprognostic (8.25e-2)"	32.8	14.9	25.1	0.6	27.4	0.0	15.4	22.0	23.2	59.9	13.9	14.9	4.5	58.2	18.3	10.0	22.6	20.3	23.2	22.5	26.2	7.1	12.6	5.9	1.3	37.9	35.9	3.4	5.3	1.7	6.4	55.9	32.4	21.2	6.6	0.9	5.7	17.9	2.7	19.8	9.9	14.9	46.1	5.7	5.4	0.2	34.1	2.8	7.0	9.0	1.7	28.0	41.3	38.8	0.0	0.0	0.1	0.0	86.9	354.7	0.1	42.8	357.7	4.9	8.3	32.7	0.0	0.0	0.0	86.7	0.1	0.1	0.0	0.0	3.3	0.0	0.8	0.0	0.0	0.0	50.1	0.0	0.0	123.1	1.8	9.7	1.3	0.1	0.0	0.0	0.0	0.1	0.3	0.1	0.0	0.1	0.7	0.0	0.2	0.0	0.2	0.2	0.0	8.4	0.1	0.0	0.0	0.0	0.0	14.3	2.0	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.1	0.0	82.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.1	27.4	22.0	23.2	22.5	26.2	37.9	35.9	32.4	46.1	34.1	38.8	2.5	0.0	0.0	380.3	0.0	19.1	1.4	14.8	1.2	0.1	0.7	19.7	1.3	0.0	2.4	1.8	0.0	2.2	0.0	0.0	0.0	1.4	0.1	4.5	26.2	1.1	0.0	0.0	13.1	0.0	1.4	50.2	1.1	0.8	0.0	0.6	0.0	0.0	2.0	0.0	8.2	0.2	0.0	0.0	5.5	0.1	0.3	0.5	1.8	28.1	0.6	0.0	0.0	9.5	1.4	0.1	0.0	0.0	0.0	0.4	0.2	0.0	1.8	0.2	0.0	1.6	5.8	0.0	0.2	0.1	9.2	3.4	0.6	0.2	0.0	0.2
PCOLCE	"PCPE, PCPE1"	ENSG00000106333	"Procollagen C-endopeptidase enhancer"	Q15113	7	100602363-100608175	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"Endometrial stromal cells: 491.6;Fibroblasts: 439.9;Leydig cells: 140.5;Smooth muscle cells: 442.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 879.0;BJ hTERT+: 663.0;fHDF/TERT166: 404.5;HSkMC: 973.2;SH-SY5Y: 689.9;U-2197: 1213.4"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"spinal cord: 81.1"	"CAB017623, HPA042927"	Approved		Approved	"Golgi apparatus,Vesicles"	"Secreted to extracellular matrix"	NA	NA		1300000000	"Cluster 22: NK-cells - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 18: U-2197 - ECM organization"	"Cluster 10: Non-specific - Unknown function"	"Golgi apparatus, Vesicles"		"CAB017623: AB_2251882, HPA042927: AB_2678224"	"unprognostic (4.14e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.70e-2)"	"unprognostic (4.48e-2)"	"unprognostic (1.33e-2)"	"unprognostic (3.93e-2)"	"prognostic unfavorable (9.76e-4)"	"unprognostic (2.16e-2)"	"unprognostic (1.73e-1)"	"unprognostic (6.13e-2)"	"prognostic unfavorable (1.68e-5)"	"unprognostic (1.04e-2)"	"unprognostic (3.21e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.43e-2)"	101.5	45.5	2.4	51.5	3.8	0.6	72.6	3.5	10.2	162.8	4.6	30.5	7.8	81.7	11.0	26.9	80.6	112.5	110.8	2.3	2.5	21.9	59.7	72.4	41.3	3.0	2.4	47.7	20.6	10.3	31.2	59.5	2.9	45.5	16.7	0.2	24.9	33.5	16.9	45.0	21.6	59.9	3.1	13.8	22.9	13.7	3.6	10.5	49.1	32.7	17.4	86.4	86.7	2.5	0.2	0.5	2.2	3.0	321.5	879.0	2.4	355.5	663.0	161.1	142.7	14.5	0.8	1.1	1.2	404.5	0.5	0.2	0.0	1.2	15.9	2.5	2.5	0.3	6.1	19.8	82.1	0.1	3.5	973.2	0.3	86.3	0.6	0.4	0.1	1.7	8.3	2.0	0.7	2.1	0.6	3.3	72.2	0.0	4.2	1.0	1.5	0.8	0.4	0.6	1.1	689.9	0.2	2.4	1.6	8.2	2.0	0.0	3.5	391.8	107.6	1213.4	0.2	0.4	0.5	0.1	136.6	1.2	68.2	0.0	0.0	0.4	0.1	0.3	0.3	0.1	0.2	0.1	0.2	0.0	0.1	0.1	0.0	0.4	0.2	0.0	0.1	0.0	2.4	3.8	3.5	10.2	2.3	2.5	3.0	2.4	2.9	3.1	3.6	2.5	33.6	9.6	2.8	2.3	2.5	40.0	3.3	4.2	6.8	4.3	6.6	11.3	16.3	4.3	5.5	5.5	0.0	13.3	4.5	0.8	27.4	6.4	14.8	15.1	491.6	17.2	1.8	5.7	0.5	5.1	11.2	439.9	7.1	11.0	1.3	0.7	33.9	44.8	20.8	16.8	2.5	0.9	6.1	1.9	53.6	27.6	140.5	5.5	32.0	9.4	0.8	12.1	6.2	1.5	0.2	4.1	1.3	50.4	2.1	2.2	0.1	2.5	6.8	2.0	32.9	14.2	442.2	32.8	21.0	3.6	33.1	25.2	9.4	22.6	0.7	3.0
PDGFD	"IEGF, MSTP036, SCDGF-B"	ENSG00000170962	"Platelet derived growth factor D"	Q9GZP0	11	103907189-104164379	"Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins"		"Developmental protein, Growth factor, Mitogen"	Proto-oncogene	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 106.5;ovary: 78.0"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 32.9;dendritic cells: 30.0;Ductal cells: 30.6;Fibroblasts: 44.3;Inhibitory neurons: 95.0;Microglial cells: 28.1;NK-cells: 46.4"	"Cancer enhanced"	"Detected in all"		"renal cancer: 17.0"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"eosinophil: 9.5;gdT-cell: 16.4;memory CD8 T-cell: 7.2;naive CD8 T-cell: 6.0;NK-cell: 17.1"	"Group enriched"	"Detected in many"	29	"granulocytes: 9.5;NK-cells: 17.1;T-cells: 16.4"	"Group enriched"	"Detected in many"	6	"ASC diff: 139.8;HHSteC: 42.6"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"spinal cord: 39.4"	"HPA046183, HPA066271"	Approved		Approved	"Golgi apparatus,Vesicles"	"Secreted to blood"	NA	NA		95000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Golgi apparatus, Vesicles"		"HPA046183: AB_2679573, HPA066271: AB_2685645"	"unprognostic (2.21e-1)"	"unprognostic (9.35e-2)"	"unprognostic (5.60e-2)"	"unprognostic (1.72e-1)"	"unprognostic (5.81e-2)"	"unprognostic (8.83e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.01e-1)"	"unprognostic (6.78e-2)"	"unprognostic (2.26e-1)"	"unprognostic (7.01e-3)"	"prognostic unfavorable (9.60e-4)"	"unprognostic (1.19e-1)"	"unprognostic (6.72e-2)"	"unprognostic (3.57e-3)"	20.4	106.5	0.5	3.4	0.8	0.9	21.7	0.7	1.3	25.1	9.0	8.8	4.1	11.8	7.1	1.9	9.3	34.0	23.2	0.8	2.2	7.7	2.3	3.1	7.4	5.1	6.6	78.0	25.7	17.1	13.4	7.0	9.4	10.0	9.8	1.5	8.6	37.4	2.2	7.9	4.8	9.7	1.8	2.8	23.4	3.3	2.0	3.7	18.3	8.8	5.4	15.8	15.4	2.3	0.0	7.8	4.0	0.0	139.8	4.2	0.1	0.9	0.8	0.7	0.8	0.0	1.3	7.4	1.4	7.3	5.2	0.4	0.0	0.2	0.3	0.0	3.2	0.2	1.6	0.3	42.6	0.0	0.1	14.7	0.0	0.1	0.0	0.2	8.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.3	0.0	1.4	0.0	2.1	0.0	6.7	0.0	0.1	9.6	0.0	13.8	3.2	1.8	0.0	2.0	1.0	0.1	1.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	2.8	0.6	0.0	9.5	16.4	0.0	1.4	0.4	1.7	7.2	0.0	0.0	0.2	6.0	0.2	17.1	0.1	0.0	0.1	4.2	0.5	0.8	0.7	1.3	0.8	2.2	5.1	6.6	9.4	1.8	2.0	2.3	15.6	0.0	0.0	1.0	1.6	3.1	7.7	0.2	1.8	2.3	1.7	9.4	4.5	32.9	0.6	5.5	0.0	0.2	30.0	0.2	0.0	30.6	8.2	0.8	1.8	10.3	1.8	1.3	13.9	4.4	0.2	44.3	0.0	1.4	0.0	8.1	2.9	0.0	0.3	26.9	95.0	1.0	0.0	1.3	3.7	13.3	0.3	0.8	0.0	28.1	0.9	1.5	46.4	2.0	2.8	3.0	0.5	2.2	8.4	1.6	0.0	0.3	0.0	0.5	6.6	1.9	3.7	0.4	4.3	0.3	2.0	0.0	10.2	5.2	0.6	3.2
PDGFRL	PRLTS	ENSG00000104213	"Platelet derived growth factor receptor like"	Q15198	8	17576433-17644071	"Disease related genes, Predicted secreted proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 36.0;Fibroblasts: 186.2;Leydig cells: 74.6;Peritubular cells: 70.7"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 22.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"AN3-CA: 189.4;BJ hTERT+: 159.1;HSkMC: 86.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052801			Approved	"Nucleoplasm,Nucleoli,Golgi apparatus"	"Secreted - unknown location"	NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 50: Fibroblasts - ECM organization"	"Golgi apparatus"	"Nucleoplasm, Nucleoli"	"HPA052801: AB_2681956"	"unprognostic (1.25e-1)"	"unprognostic (1.73e-1)"	"unprognostic (5.10e-2)"	"unprognostic (1.59e-2)"	"unprognostic (7.39e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.32e-1)"	"unprognostic (6.54e-2)"	"unprognostic (3.86e-1)"	"unprognostic (7.46e-2)"	"unprognostic (1.63e-1)"	"unprognostic (6.72e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (1.58e-3)"	"unprognostic (1.26e-1)"	"unprognostic (4.47e-3)"	"unprognostic (6.00e-3)"	34.1	4.2	2.5	3.9	3.5	0.2	51.9	2.8	3.0	27.8	1.9	9.0	0.9	15.8	10.3	3.0	23.3	13.4	11.1	2.3	2.3	1.3	0.7	4.7	1.2	2.7	2.6	42.9	6.9	9.0	7.4	9.0	2.5	5.4	3.1	0.6	13.1	6.7	18.4	11.0	2.6	26.0	2.4	0.8	6.2	6.5	2.9	3.8	33.0	38.0	2.0	6.5	12.0	3.3	0.0	17.7	1.0	189.4	5.6	2.5	13.8	4.6	159.1	7.5	31.3	1.0	0.2	0.0	0.9	2.5	24.7	0.0	11.6	0.9	3.7	0.2	14.5	0.0	5.3	4.1	14.6	0.0	0.0	86.9	0.1	9.2	0.1	0.0	13.0	1.6	0.0	2.4	1.1	12.5	0.2	0.4	9.9	0.7	3.6	0.0	0.2	0.4	1.0	11.4	0.6	1.2	1.4	1.7	3.3	11.4	0.6	0.0	2.6	0.2	6.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.5	3.5	2.8	3.0	2.3	2.3	2.7	2.6	2.5	2.4	2.9	3.3	15.5	0.0	3.6	2.3	0.3	13.3	0.5	4.3	0.6	0.6	2.9	3.3	4.5	1.5	2.8	0.0	0.0	14.9	0.7	0.4	0.0	4.1	36.0	2.4	5.4	4.1	1.2	0.0	1.1	7.1	19.9	186.2	0.5	4.7	0.0	0.3	1.4	0.2	3.5	0.0	3.5	1.3	2.0	0.0	14.6	6.7	74.6	1.6	10.6	1.9	1.6	1.4	0.0	3.0	1.3	3.1	0.1	70.7	0.2	1.9	0.4	0.1	0.2	0.4	0.0	8.0	10.7	0.8	1.9	0.6	9.9	9.7	1.7	1.5	0.4	0.5
PENK		ENSG00000181195	Proenkephalin	P01210	8	56436674-56446671	"Plasma proteins, Predicted secreted proteins, Transporters"		"Endorphin, Neuropeptide, Opioid peptide"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"adrenal gland: 376.2;brain: 164.1;testis: 129.0"	"Cell type enhanced"	"Detected in some"		"Basal respiratory cells: 758.4;Leydig cells: 1137.9;Peritubular cells: 225.7;Spermatocytes: 274.1"	"Cancer enhanced"	"Detected in many"		"lung cancer: 4.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 14.3;ASC TERT1: 8.6;BJ: 7.7;THP-1: 7.7"	"Region enriched"	"Detected in all"	7	"basal ganglia: 3626.9"	"Region enriched"	"Detected in all"	7	"basal ganglia: 923.2"	"HPA013138, CAB016390"	Enhanced				"Secreted in other tissues"	NA	NA		220000	"Cluster 21: B-cells - Adaptive immune response"	"Cluster 43: Testis - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"CAB016390: AB_2161515, HPA013138: AB_1855191"	"unprognostic (6.89e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.71e-2)"	"unprognostic (1.17e-3)"	"unprognostic (1.56e-2)"	"unprognostic (3.58e-3)"		"unprognostic (1.31e-2)"	"unprognostic (3.60e-1)"	"unprognostic (6.34e-2)"	"unprognostic (5.73e-2)"	"unprognostic (3.47e-2)"	"unprognostic (4.24e-2)"	"unprognostic (1.73e-3)"	"unprognostic (1.11e-1)"	"unprognostic (4.48e-2)"	"unprognostic (3.98e-3)"	8.6	376.2	29.9	4.4	164.1	0.0	4.9	45.2	45.6	9.2	0.5	23.1	1.1	8.1	0.0	1.4	7.6	12.5	25.6	2.7	74.0	0.2	0.2	3.7	0.1	81.4	15.9	29.7	1.1	0.0	17.1	2.9	51.3	22.4	2.0	0.6	2.7	23.4	3.0	0.8	4.2	4.6	54.0	0.1	10.0	129.0	38.0	0.2	1.0	5.3	0.1	0.6	6.2	10.1	0.0	0.0	0.1	0.0	14.3	8.6	0.0	7.7	2.5	1.3	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	29.9	164.1	45.2	45.6	2.7	74.0	81.4	15.9	51.3	54.0	38.0	10.1	0.2	0.0	1.5	0.3	0.5	0.1	0.2	758.4	0.0	0.3	0.1	0.6	0.8	0.0	8.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	85.7	0.1	3.1	0.9	0.0	0.0	0.4	0.0	0.1	16.8	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	15.4	0.0	2.0	0.0	0.7	60.8	1137.9	1.2	0.0	1.9	0.0	0.0	0.0	0.5	0.4	0.0	0.0	225.7	0.0	0.2	0.0	0.0	3.6	0.0	6.6	1.7	1.2	274.1	19.1	0.1	0.4	0.0	0.2	3.1	0.0	0.0
PODN	"MGC24995, PCAN, PODOCAN, SLRR5A"	ENSG00000174348	Podocan	Q7Z5L7	1	53062052-53085501	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	13	"Fibroblasts: 123.5;Leydig cells: 268.7;Peritubular cells: 261.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"gdT-cell: 5.1;memory CD8 T-cell: 1.4;naive CD8 T-cell: 1.6"	"Lineage enriched"	"Detected in single"	52	"T-cells: 5.1"	"Cell line enhanced"	"Detected in some"		"ASC diff: 23.0;BJ: 39.2;fHDF/TERT166: 23.9;HHSteC: 94.1;U-2197: 46.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"								"Secreted to extracellular matrix"	NA	NA		910000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 18: U-2197 - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"				"unprognostic (8.69e-2)"	"unprognostic (4.73e-2)"	"unprognostic (3.18e-2)"	"prognostic unfavorable (1.54e-4)"	"unprognostic (1.46e-1)"	"unprognostic (4.51e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.88e-1)"	"unprognostic (3.65e-1)"	"unprognostic (1.90e-3)"	"unprognostic (1.71e-1)"	"unprognostic (3.53e-2)"	"prognostic unfavorable (2.02e-5)"	"unprognostic (5.91e-3)"	"unprognostic (1.62e-1)"	"unprognostic (6.11e-2)"	"unprognostic (5.02e-2)"	191.0	14.3	9.1	13.3	8.2	0.2	116.3	6.4	8.7	106.1	7.1	76.1	11.6	105.1	19.7	36.1	127.5	103.8	87.1	6.8	8.1	5.2	12.5	66.3	3.8	7.3	10.3	178.0	20.8	2.9	19.5	18.1	8.2	69.8	8.2	0.6	48.8	34.4	20.2	45.4	26.1	44.7	6.7	3.3	75.5	26.9	10.3	10.8	71.5	30.5	2.7	101.3	87.9	6.7	0.0	0.0	0.0	0.0	23.0	3.1	0.1	39.2	5.3	0.4	0.3	0.0	0.0	0.0	0.6	23.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	94.1	0.0	0.0	14.9	0.0	0.9	0.0	1.0	1.2	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.1	0.0	0.1	0.0	1.6	0.0	0.0	0.0	0.0	0.0	46.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.3	1.4	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.8	9.1	8.2	6.4	8.7	6.8	8.1	7.3	10.3	8.2	6.7	10.3	6.7	8.5	0.0	3.3	0.0	0.0	6.4	0.4	0.0	0.6	0.5	0.8	0.9	1.7	1.5	0.6	0.0	0.0	0.4	1.3	0.0	0.0	0.0	1.6	0.3	11.2	3.8	0.0	0.0	0.0	0.0	0.4	123.5	2.6	0.3	0.0	0.7	4.2	0.1	0.6	0.0	1.9	0.0	0.0	0.3	8.8	9.2	268.7	1.3	5.4	6.5	0.0	0.3	3.1	5.5	0.2	0.0	0.0	261.1	1.6	0.5	0.1	0.0	0.0	0.5	0.0	4.4	16.0	0.7	0.6	0.7	6.0	0.5	1.6	0.0	0.0	0.2
PTGIS	"CYP8A1, PGIS"	ENSG00000124212	"Prostaglandin I2 synthase"	Q16647	20	49503874-49568137	"Disease related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted membrane proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism"	"Isomerase, Lyase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 80.7;urinary bladder: 81.7"	"Cell type enhanced"	"Detected in many"		"Endothelial cells: 28.1;Fibroblasts: 70.8;Hepatic stellate cells: 117.8;Leydig cells: 26.8;Peritubular cells: 104.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"ASC diff: 45.1;ASC TERT1: 45.2;U-2197: 143.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB009517, HPA014193, HPA052244"	Enhanced		Approved	"Endoplasmic reticulum"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 18: U-2197 - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Endoplasmic reticulum"		"CAB009517: AB_2173209, HPA014193: AB_1855746, HPA052244: AB_2732574"	"unprognostic (7.68e-2)"	"unprognostic (1.90e-1)"	"unprognostic (5.09e-3)"	"unprognostic (1.38e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.02e-2)"	"unprognostic (2.45e-2)"	"unprognostic (5.22e-2)"	"prognostic unfavorable (4.74e-8)"	"unprognostic (2.29e-2)"	"unprognostic (7.61e-2)"	"unprognostic (4.89e-3)"	"prognostic unfavorable (9.99e-5)"	43.2	4.7	0.7	9.0	2.5	0.3	24.0	0.3	1.9	29.5	1.8	38.9	3.2	79.0	16.1	16.5	80.7	31.3	40.4	0.5	0.8	4.0	6.0	18.2	0.7	0.6	0.4	38.1	2.5	0.3	0.9	1.1	0.4	22.2	6.6	0.2	7.6	8.3	4.0	7.2	10.5	40.5	0.6	0.5	17.9	5.1	1.0	0.3	7.8	2.4	0.8	81.7	18.2	0.6	0.0	0.1	1.9	0.1	45.1	45.2	0.5	1.0	5.7	0.2	0.0	0.0	0.0	0.1	18.4	13.7	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	5.6	0.0	0.1	3.3	0.0	0.6	0.0	15.1	0.7	0.0	0.0	0.1	0.1	0.0	0.1	0.2	8.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.4	0.4	0.1	0.2	0.0	8.2	0.1	0.0	0.0	0.8	2.4	143.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.1	0.0	0.1	0.0	0.0	0.7	2.5	0.3	1.9	0.5	0.8	0.6	0.4	0.4	0.6	1.0	0.6	5.3	3.2	2.7	0.0	0.0	3.7	0.7	0.0	0.0	1.1	2.2	1.3	5.0	2.8	1.9	3.7	0.0	0.3	0.3	0.0	0.0	0.6	1.8	0.0	0.9	28.1	0.0	2.7	2.7	0.0	0.2	70.8	1.5	0.1	0.0	25.0	117.8	1.0	0.3	0.0	2.4	0.0	0.0	3.1	6.7	3.3	26.8	1.0	1.8	6.5	0.1	0.4	0.0	1.0	0.2	1.2	0.0	104.9	0.3	0.4	0.0	0.2	2.2	4.5	0.0	7.9	3.5	0.7	1.4	0.5	4.8	0.3	1.0	0.5	0.0	0.6
PTK7	CCK4	ENSG00000112655	"Protein tyrosine kinase 7 (inactive)"	Q13308	6	43076307-43161719	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Cell adhesion, Wnt signaling pathway"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 317.3;Endometrial stromal cells: 84.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	10	"plasmacytoid DC: 13.5"	"Lineage enriched"	"Detected in many"	10	"dendritic cells: 13.5"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003222	Approved				"Secreted to blood"	NA	NA		12000000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 29: Early spermatids - Spermatogenesis"			"HPA003222: AB_1079713"	"unprognostic (1.80e-1)"	"unprognostic (7.49e-3)"	"unprognostic (6.22e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.15e-2)"	"unprognostic (5.85e-3)"	"unprognostic (9.81e-3)"	"unprognostic (1.47e-3)"	"unprognostic (7.15e-2)"	"unprognostic (5.11e-3)"	"unprognostic (8.17e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.73e-1)"	"unprognostic (3.61e-1)"	"unprognostic (9.12e-2)"	"unprognostic (5.70e-3)"	15.0	5.0	9.6	6.7	8.4	2.8	17.5	8.5	8.9	69.5	36.0	9.4	6.5	87.4	87.1	30.1	38.2	24.7	8.8	8.7	10.8	29.3	1.6	33.9	3.9	10.2	11.4	85.3	16.4	13.0	21.1	48.8	8.7	37.9	8.5	6.0	36.7	25.4	0.6	34.6	9.5	38.7	9.0	27.8	12.2	41.7	11.2	30.4	23.0	1.5	6.4	22.3	43.6	8.2	9.1	2.5	83.6	141.6	88.0	89.9	119.4	94.2	145.5	77.0	99.4	77.0	31.0	0.2	74.0	107.3	56.4	99.5	38.0	87.5	49.3	0.7	52.0	8.5	17.1	105.2	132.5	0.3	0.4	129.1	77.4	103.2	32.6	135.8	10.1	35.0	6.2	0.2	36.4	7.0	32.5	12.6	39.1	0.8	7.0	33.3	119.0	0.3	61.0	42.4	48.3	91.6	14.8	1.5	50.0	87.8	51.9	19.5	6.8	84.1	53.1	0.4	51.0	0.5	0.9	3.2	19.1	0.3	14.1	0.4	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.4	0.0	0.0	1.4	0.2	0.7	0.0	13.5	0.0	0.8	9.6	8.4	8.5	8.9	8.7	10.8	10.2	11.4	8.7	9.0	11.2	8.2	3.0	16.0	13.1	10.7	0.8	17.3	19.9	40.4	27.9	4.3	23.5	32.5	1.6	5.7	14.6	12.9	56.3	19.1	6.3	1.7	1.9	21.0	317.3	23.5	84.7	8.7	21.6	4.0	8.7	6.9	2.2	30.0	8.6	25.2	1.3	25.3	2.2	0.0	3.5	0.0	5.3	3.9	42.7	0.0	9.8	48.9	18.3	4.1	16.0	1.0	1.0	20.1	0.0	3.5	1.4	10.5	4.1	18.4	1.4	11.8	0.6	0.6	15.4	2.2	13.1	8.7	27.9	2.8	21.2	13.7	10.4	8.2	3.0	17.7	6.3	11.8
RAB3IL1	GRAB	ENSG00000167994	"RAB3A interacting protein like 1"	Q8TBN0	11	61897301-61920269	"Predicted intracellular proteins"	"Protein transport, Transport"	"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 110.9;Hofbauer cells: 65.3;Late spermatids: 133.8;Leydig cells: 56.2;Peritubular cells: 45.1;Theca cells: 47.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"GAMG: 36.9;HHSteC: 36.9;K-562: 34.4;RPMI-8226: 44.3;U-2197: 56.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039723	Uncertain		Approved	"Centriolar satellite,Cytosol"		NA	NA				"Cluster 71: Testis - DNA repair"	"Cluster 18: U-2197 - ECM organization"	"Cluster 34: Spermatids - Unknown function"	"Centriolar satellite, Cytosol"		"HPA039723: AB_10795406"	"unprognostic (1.62e-1)"	"unprognostic (3.59e-2)"	"prognostic unfavorable (6.08e-4)"	"unprognostic (1.97e-2)"	"unprognostic (8.95e-2)"	"unprognostic (1.30e-2)"	"prognostic unfavorable (1.61e-7)"	"unprognostic (7.93e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.86e-1)"	"unprognostic (3.43e-2)"	"prognostic unfavorable (1.49e-4)"	"unprognostic (1.42e-2)"	"unprognostic (1.20e-1)"	"prognostic unfavorable (3.30e-4)"	"unprognostic (1.59e-3)"	29.8	9.5	10.9	7.9	11.2	13.8	22.8	10.3	13.4	38.6	12.7	13.6	4.7	30.0	4.6	6.2	24.0	11.3	20.5	10.5	10.8	16.0	6.9	11.8	6.5	12.8	11.0	37.1	5.1	7.8	9.5	15.9	11.8	10.6	2.6	3.1	12.2	5.1	7.6	15.2	9.9	9.3	11.6	28.2	9.4	41.2	14.8	9.0	15.1	10.0	2.4	19.0	20.7	12.7	6.9	13.3	0.4	7.3	26.9	19.9	1.5	5.5	13.7	8.0	5.4	1.9	1.5	0.1	10.1	8.4	36.9	3.7	9.6	0.5	1.2	0.0	2.1	12.8	5.1	7.2	36.9	0.5	0.3	10.7	6.9	3.9	9.1	1.3	0.7	7.1	34.4	0.3	4.7	12.3	0.0	0.1	4.3	1.2	14.1	0.7	1.9	44.3	0.7	0.5	0.6	4.9	3.4	2.9	25.0	2.2	2.2	1.6	0.6	29.3	13.2	56.5	2.3	0.4	2.1	0.0	5.7	15.8	12.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.9	11.2	10.3	13.4	10.5	10.8	12.8	11.0	11.8	11.6	14.8	12.7	5.5	0.0	0.0	1.6	0.8	5.1	0.9	0.0	0.6	0.5	1.3	1.9	1.9	2.8	0.6	1.8	0.0	1.3	0.1	0.1	1.9	2.2	110.9	1.9	27.8	9.6	0.0	34.5	0.4	1.0	2.0	24.3	1.1	1.8	0.0	1.1	16.1	1.4	65.3	1.7	1.3	0.0	0.0	19.9	10.2	133.8	56.2	6.8	8.8	8.4	0.0	6.5	0.0	1.0	0.7	1.1	0.0	45.1	0.0	1.6	0.0	15.9	0.0	8.2	0.0	3.4	8.2	1.7	9.1	0.2	4.0	1.4	0.6	47.6	0.2	0.2
RCN3	RLP49	ENSG00000142552	"Reticulocalbin 3"	Q96D15	19	49528003-49546962	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Transport"	Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 54.7;Fibroblasts: 105.1;Leydig cells: 38.2;Peritubular cells: 44.8;Smooth muscle cells: 66.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"naive CD4 T-cell: 6.8"	"Group enriched"	"Detected in many"	9	"granulocytes: 2.5;NK-cells: 1.8;T-cells: 6.8"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 166.6;ASC diff: 283.3;ASC TERT1: 175.4;BJ: 353.8;BJ hTERT+ SV40 Large T+ RasG12V: 179.6;fHDF/TERT166: 304.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043134, HPA050402"	Uncertain		Supported	"Endoplasmic reticulum,Vesicles"	"Intracellular and membrane"	No	No		1600000	"Cluster 32: T-cells - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"	"Endoplasmic reticulum"	Vesicles	"HPA043134: AB_2678332, HPA050402: AB_2681114"	"unprognostic (7.10e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.77e-3)"	"unprognostic (8.87e-2)"	"unprognostic (3.36e-3)"	"unprognostic (1.27e-1)"	"unprognostic (2.30e-3)"	"unprognostic (1.16e-1)"	"unprognostic (7.47e-2)"	"unprognostic (9.75e-2)"	"unprognostic (2.85e-1)"	"unprognostic (3.86e-2)"	"prognostic unfavorable (5.80e-12)"	"unprognostic (5.26e-2)"	"unprognostic (3.90e-2)"	"unprognostic (1.56e-2)"	"unprognostic (4.20e-3)"	67.9	35.3	15.8	33.6	17.2	6.8	48.2	15.5	24.1	78.8	23.5	43.5	39.9	47.4	4.4	11.4	41.4	25.2	56.7	16.0	19.1	41.2	62.3	40.8	8.7	17.4	17.0	50.0	16.4	3.9	20.7	31.1	19.0	32.4	11.4	1.4	19.1	12.1	11.7	25.3	43.2	25.7	16.8	65.9	23.4	17.2	24.5	4.0	26.4	7.5	4.1	43.2	46.3	18.8	3.2	4.3	2.7	166.6	283.3	175.4	1.9	353.8	86.5	122.0	179.6	4.2	1.3	1.3	19.5	304.0	1.3	0.3	6.8	0.5	49.2	0.1	2.5	19.5	1.5	9.1	105.7	0.1	43.0	119.5	0.2	93.2	0.4	3.2	43.8	2.3	8.7	1.0	87.8	2.9	0.1	2.0	1.4	8.8	24.5	0.5	3.9	4.0	1.4	0.0	1.7	10.5	0.3	1.1	0.3	2.8	1.3	11.5	121.4	1.7	52.4	135.3	0.1	14.9	44.5	2.6	7.9	9.6	13.4	0.0	0.2	1.6	0.7	0.0	0.7	0.4	1.7	0.6	0.4	0.2	6.8	2.3	2.5	1.8	0.3	0.2	1.6	1.1	15.8	17.2	15.5	24.1	16.0	19.1	17.4	17.0	19.0	16.8	24.5	18.8	12.0	0.0	6.1	4.6	2.8	18.6	0.6	2.9	3.4	0.8	1.7	3.3	2.1	1.5	0.8	1.8	0.0	2.5	1.4	10.5	1.9	1.6	2.2	1.5	54.7	10.6	1.2	0.0	1.0	0.5	5.0	105.1	6.6	1.6	1.3	7.0	27.1	3.7	22.6	1.7	1.1	7.6	0.0	11.4	23.2	3.0	38.2	11.9	10.6	10.3	3.1	0.6	0.0	1.5	0.8	1.5	7.9	44.8	4.8	0.9	13.1	0.6	0.9	0.8	13.1	37.5	66.5	6.5	6.8	2.8	13.9	6.2	2.2	17.2	8.0	0.4
RGS10		ENSG00000148908	"Regulator of G protein signaling 10"	O43665	10	119499817-119542719	"Predicted intracellular proteins"		"GTPase activation, Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 222.9"	"Cell type enhanced"	"Detected in many"		"granulocytes: 291.2;Hofbauer cells: 528.1;Kupffer cells: 297.2;Langerhans cells: 358.3;Macrophages: 529.3;monocytes: 294.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 474.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004559, HPA021305, HPA058485"	Enhanced	Supported	Supported	"Nucleoplasm,Plasma membrane"		NA	NA		840000	"Cluster 32: T-cells - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 51: Myeloid cells - Hemostasis"	"Nucleoplasm, Plasma membrane"		"CAB004559: AB_628216, HPA021305: AB_1856225, HPA058485: AB_2683732"	"unprognostic (1.64e-2)"	"prognostic favorable (6.81e-4)"	"unprognostic (7.98e-2)"	"prognostic favorable (6.32e-4)"	"unprognostic (5.21e-2)"	"unprognostic (6.19e-2)"	"unprognostic (4.32e-3)"	"unprognostic (6.35e-2)"	"unprognostic (9.90e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.30e-1)"	"prognostic unfavorable (4.20e-10)"	"unprognostic (2.50e-1)"	"unprognostic (9.20e-2)"	"unprognostic (7.70e-2)"	"unprognostic (7.92e-3)"	25.1	20.6	20.0	59.3	20.2	74.5	40.7	22.3	30.4	63.9	22.3	114.3	34.2	38.5	15.8	51.5	28.5	38.3	13.4	20.7	24.5	18.8	11.4	28.1	119.0	28.6	24.5	22.5	7.0	6.9	13.8	45.6	28.9	43.2	49.7	2.6	41.0	20.3	31.5	22.9	58.3	42.8	26.1	48.7	30.0	4.9	26.1	222.9	33.0	11.6	96.5	50.3	45.8	37.2	165.2	31.2	2.4	294.7	41.4	262.6	25.9	74.9	118.1	45.3	73.5	9.8	38.7	66.8	38.1	60.9	45.7	35.4	44.3	48.2	123.8	32.0	42.8	183.1	8.9	24.2	63.1	40.0	474.0	100.7	63.1	88.3	84.4	159.4	88.2	65.4	47.6	58.5	55.0	79.2	221.9	134.8	13.5	21.2	71.1	43.8	0.3	26.1	24.7	40.4	10.8	9.3	14.4	192.6	285.3	36.3	35.1	71.7	108.3	25.4	21.9	36.1	67.8	2.7	46.0	27.0	7.6	166.5	11.4	184.8	116.0	1.4	77.9	151.4	82.9	36.0	169.6	134.9	224.3	21.7	397.5	303.3	52.5	44.3	130.4	133.2	202.3	372.5	20.0	20.2	22.3	30.4	20.7	24.5	28.6	24.5	28.9	26.1	26.1	37.2	10.4	0.0	13.1	2.6	60.3	36.8	25.7	104.5	27.9	0.2	68.9	96.6	1.1	1.5	39.7	1.8	0.0	14.0	70.1	7.1	60.7	0.8	2.1	89.8	25.1	12.7	18.7	156.6	0.2	6.4	34.8	68.6	11.2	53.6	291.2	101.2	13.2	1.5	528.1	0.0	1.8	85.7	32.6	297.2	358.3	5.1	50.1	529.3	94.3	67.5	294.5	1.8	50.4	0.5	0.2	9.9	10.0	9.4	32.1	88.8	3.3	5.2	24.6	0.8	13.1	14.4	31.8	0.3	9.3	39.6	28.1	10.1	164.7	3.5	19.3	41.4
ROBO1	"DUTT1, FLJ21882, SAX3"	ENSG00000169855	"Roundabout guidance receptor 1"	Q9Y6N7	3	78597239-79767998	"Predicted intracellular proteins, Predicted membrane proteins"	"Chemotaxis, Differentiation, Neurogenesis"	"Developmental protein, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 309.4;Inhibitory neurons: 1518.9;Oligodendrocyte precursor cells: 348.3;Oligodendrocytes: 479.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013524, HPA052968, HPA074461"	Uncertain		Enhanced	"Plasma membrane"		NA	NA		16000000	"Cluster 32: T-cells - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane"		"CAB013524: , HPA052968: AB_2682001, HPA074461: AB_2732256"	"unprognostic (2.89e-1)"	"unprognostic (6.42e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.30e-1)"	"unprognostic (4.77e-2)"	"unprognostic (1.61e-3)"	"prognostic unfavorable (9.88e-4)"	"unprognostic (2.44e-1)"	"unprognostic (2.92e-2)"	"unprognostic (2.00e-1)"	"unprognostic (6.40e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.65e-1)"	"unprognostic (6.77e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.39e-2)"	"unprognostic (1.16e-2)"	12.4	8.6	12.7	10.7	13.7	0.2	4.9	4.3	9.5	13.4	0.0	7.8	3.1	9.5	7.2	12.3	4.7	7.7	6.7	7.8	10.8	3.1	3.6	7.6	9.3	8.8	16.3	16.4	1.9	1.8	7.4	7.8	9.9	12.9	6.0	3.9	5.4	11.9	4.5	20.5	4.3	10.5	7.5	9.0	4.8	10.3	15.5	13.3	4.8	5.4	18.2	13.9	11.1	12.4	0.2	26.9	25.7	41.3	35.0	22.8	1.4	21.1	28.0	16.3	13.8	0.6	11.5	0.0	0.1	26.2	13.0	10.9	31.5	21.6	20.5	0.4	39.1	16.4	51.4	43.4	8.4	0.3	4.1	38.3	28.9	61.9	29.1	30.5	16.5	0.0	2.2	49.0	16.8	13.1	0.0	0.1	32.8	7.9	9.6	0.9	27.2	0.3	0.1	8.9	19.7	13.7	45.5	9.9	16.2	24.6	31.8	0.4	0.3	54.1	23.4	32.7	36.1	1.7	0.0	0.0	49.2	0.1	45.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	12.7	13.7	4.3	9.5	7.8	10.8	8.8	16.3	9.9	7.5	15.5	12.4	4.3	3.2	11.0	81.0	1.9	33.1	20.6	17.9	39.9	11.7	4.1	3.6	3.6	0.0	9.0	7.3	4.2	9.7	0.0	0.1	0.0	0.5	23.9	1.6	23.2	14.3	1.2	4.0	309.4	0.2	8.3	34.6	3.6	2.3	1.3	5.1	16.1	0.3	1.5	1.7	1518.9	1.4	22.4	2.6	10.0	65.9	19.9	1.5	14.2	51.5	1.9	5.7	0.0	348.3	479.3	0.2	5.1	24.5	1.3	20.5	4.9	0.4	2.9	1.0	13.1	24.7	16.8	2.7	7.0	30.3	33.8	5.6	0.9	71.1	2.6	52.7
ROR2	"BDB, BDB1, NTRKR2"	ENSG00000169071	"Receptor tyrosine kinase like orphan receptor 2"	Q01974	9	91563091-91950228	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"	"Wnt signaling pathway"	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 18.4;Endometrial stromal cells: 19.3;Fibroblasts: 14.4;Inhibitory neurons: 18.6;Microglial cells: 15.9;Oligodendrocyte precursor cells: 27.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	6	"MAIT T-cell: 1.0"	"Lineage enriched"	"Detected in single"	6	"T-cells: 1.0"	"Cell line enhanced"	"Detected in many"		"AF22: 24.5;HHSteC: 63.1;HSkMC: 52.2;U-266/70: 38.3;U-266/84: 27.5"	"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	7	"cerebellum: 7.2;spinal cord: 3.7"	HPA021868	Uncertain					NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA021868: AB_1856406"	"unprognostic (9.38e-3)"	"unprognostic (4.69e-1)"	"unprognostic (2.26e-1)"	"unprognostic (8.48e-3)"	"unprognostic (1.23e-1)"	"unprognostic (2.38e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.31e-1)"	"unprognostic (8.03e-2)"	"unprognostic (2.03e-1)"	"unprognostic (5.76e-2)"	"unprognostic (2.66e-1)"	"prognostic unfavorable (9.86e-7)"	"unprognostic (2.16e-3)"	"unprognostic (9.13e-2)"	"prognostic unfavorable (4.28e-8)"	"unprognostic (1.25e-2)"	6.9	5.7	0.8	3.9	0.6	0.1	4.4	0.4	0.5	18.7	28.2	32.7	2.2	23.7	1.5	8.2	11.6	8.6	11.1	1.4	0.8	1.4	0.5	5.5	0.5	1.7	2.1	13.9	1.6	16.6	1.6	3.5	0.9	13.9	2.2	1.0	1.6	13.3	0.3	4.2	7.7	11.0	1.2	3.3	12.8	3.4	1.2	3.0	5.6	0.7	1.0	17.5	10.6	0.7	0.0	0.2	24.5	0.0	5.3	0.5	6.8	0.4	6.3	4.0	7.8	0.0	0.0	0.0	0.1	0.8	3.9	0.2	5.2	0.0	1.7	0.0	4.2	0.0	18.3	0.0	63.1	0.0	0.0	52.2	0.0	5.6	0.0	0.0	0.0	0.2	14.7	0.0	0.0	0.4	0.1	3.6	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	7.2	0.6	0.0	0.0	5.0	14.8	0.0	0.0	0.0	4.8	2.0	0.0	38.3	27.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.6	0.4	0.5	1.4	0.8	1.7	2.1	0.9	1.2	1.2	0.7	0.3	0.0	0.0	1.6	0.1	3.1	11.3	0.9	1.2	1.4	3.7	3.0	8.2	1.5	0.2	0.0	0.0	0.4	0.0	0.5	0.0	2.5	4.5	18.4	19.3	1.4	3.0	0.0	1.4	1.5	0.2	14.4	2.6	7.5	1.3	0.1	0.4	0.0	0.8	0.0	18.6	2.8	0.0	0.0	4.8	8.6	5.9	0.4	5.4	15.9	1.6	7.4	0.0	27.6	0.4	0.6	1.6	9.1	0.1	8.6	0.0	0.0	0.2	0.5	6.6	0.0	2.9	2.3	14.3	0.1	2.3	0.4	0.7	0.4	0.8	5.3
SCRG1	SCRG-1	ENSG00000164106	"Stimulator of chondrogenesis 1"	O75711	4	173384701-173406380	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 30.7;choroid plexus: 15.2"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 46.4;Muller glia cells: 148.3;Oligodendrocyte precursor cells: 102.1"	"Cancer enriched"	"Detected in many"	6	"glioma: 35.7"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	5	"WM-115: 17.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012882	Approved				"Secreted in brain"	NA	NA		240000	"Cluster 17: Basophils - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 5: Muller glia cells - Visual perception"			"HPA012882: AB_1856635"	"unprognostic (1.09e-1)"	"unprognostic (1.83e-2)"	"unprognostic (2.60e-5)"	"unprognostic (2.58e-1)"	"unprognostic (3.22e-2)"	"unprognostic (7.51e-2)"	"unprognostic (3.58e-2)"	"unprognostic (1.14e-3)"	"unprognostic (2.08e-1)"	"unprognostic (2.25e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.95e-10)"	"unprognostic (4.86e-2)"	"unprognostic (2.21e-1)"	"unprognostic (4.34e-3)"	"unprognostic (8.74e-4)"	1.3	0.8	19.0	0.6	20.5	0.7	0.5	20.6	30.7	1.6	15.2	4.4	0.5	1.8	0.9	0.4	2.5	1.5	2.9	19.4	20.3	0.2	0.1	0.4	0.2	22.8	19.9	0.8	0.3	0.0	1.0	0.2	22.5	2.3	0.5	2.3	1.1	3.2	0.5	0.5	0.9	4.7	21.6	0.5	2.8	10.8	19.4	0.0	0.3	0.0	0.1	2.0	0.8	24.7	0.1	0.0	0.6	0.2	0.2	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.2	0.4	0.2	0.5	0.2	0.1	3.5	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.5	0.0	0.2	0.1	0.3	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.2	0.1	0.2	0.2	0.1	0.0	0.1	0.1	0.1	17.1	1.8	0.5	0.3	0.2	0.4	0.1	0.2	0.1	0.2	0.2	0.3	0.2	0.3	1.2	0.5	0.5	0.3	0.1	0.1	19.0	20.5	20.6	30.7	19.4	20.3	22.8	19.9	22.5	21.6	19.4	24.7	1.3	0.0	3.0	46.4	1.0	3.6	1.1	0.0	0.0	14.5	2.4	3.9	1.3	0.0	0.7	0.0	37.5	0.2	3.3	0.3	0.0	0.3	18.3	0.7	1.7	2.1	1.2	0.0	19.0	0.0	0.4	17.3	1.1	0.4	8.9	0.9	4.2	0.3	0.6	16.8	20.9	0.5	0.0	3.3	2.6	32.3	26.1	3.8	23.2	2.8	1.9	148.3	2.1	102.1	26.4	0.2	0.1	20.7	1.0	1.9	0.4	0.3	0.8	28.3	13.1	2.4	20.3	3.1	2.4	0.1	2.6	0.7	3.1	0.5	0.3	1.0
SERPINF1	"EPC-1, PEDF, PIG35"	ENSG00000132386	"Serpin family F member 1"	P36955	17	1762029-1777565	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes, Dwarfism, Osteogenesis imperfecta"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"choroid plexus: 1875.2"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 697.8;Cytotrophoblasts: 795.6;Fibroblasts: 951.9;Hepatocytes: 765.0;Leydig cells: 1818.0;Peritubular cells: 1045.7"	"Cancer enhanced"	"Detected in all"		"liver cancer: 245.2"	"Region enhanced"	"Detected in many"		"hippocampal formation: 85.4"	"Immune cell enriched"	"Detected in many"	18	"plasmacytoid DC: 1454.4"	"Lineage enriched"	"Detected in all"	121	"dendritic cells: 1454.4"	"Group enriched"	"Detected in many"	4	"ASC diff: 1232.0;ASC TERT1: 956.3;Hep G2: 606.0;HHSteC: 410.6;HSkMC: 1313.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005825	Uncertain				"Secreted to blood"	NA	NA	9290000000	44000000000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"			"HPA005825: AB_1079921"	"unprognostic (3.85e-1)"	"prognostic favorable (5.49e-4)"	"unprognostic (9.44e-2)"	"unprognostic (2.32e-2)"	"unprognostic (2.96e-2)"	"unprognostic (2.09e-1)"	"unprognostic (3.32e-3)"	"unprognostic (2.33e-1)"	"unprognostic (7.88e-2)"	"unprognostic (5.92e-2)"	"unprognostic (1.69e-1)"	"unprognostic (4.18e-2)"	"prognostic unfavorable (1.40e-8)"	"unprognostic (2.11e-3)"	"unprognostic (2.82e-1)"	"unprognostic (4.53e-3)"	"unprognostic (1.25e-3)"	535.5	57.5	5.7	124.2	9.6	11.9	490.2	17.9	28.0	558.7	1875.2	131.3	41.9	358.2	90.2	109.3	557.4	559.7	376.5	85.4	1.1	35.1	974.8	158.9	133.5	0.1	5.1	408.3	207.6	11.2	62.4	311.6	1.3	202.8	52.0	61.4	124.6	105.8	434.8	162.9	131.7	221.7	2.8	133.2	124.7	277.7	25.4	106.2	193.1	465.5	117.7	323.4	273.5	7.0	0.5	3.7	2.8	2.0	1232.0	956.3	20.4	56.8	49.8	0.6	0.0	9.7	0.5	2.3	1.9	71.8	0.3	3.2	86.0	4.4	0.0	0.6	46.0	1.0	1.2	606.0	410.6	1.1	1.1	1313.4	6.9	0.9	1.1	11.4	0.6	4.2	117.5	0.4	63.2	0.2	7.0	7.2	30.7	0.3	1.0	2.9	219.9	1.6	0.1	6.0	1.9	42.2	0.7	0.7	57.0	3.4	6.7	184.2	2.0	0.5	17.6	14.1	1.2	0.7	2.4	28.1	1.7	0.6	0.8	0.1	12.0	1.1	0.6	4.4	0.4	9.0	0.7	0.9	79.8	5.2	2.0	5.5	1.7	1.3	0.2	1454.4	0.8	14.2	5.7	9.6	17.9	28.0	85.4	1.1	0.1	5.1	1.3	2.8	25.4	7.0	59.0	3.2	10.4	0.3	10.8	95.0	238.0	697.8	27.9	59.3	6.7	71.2	12.1	11.5	167.7	1.8	223.1	795.6	226.1	0.0	0.0	0.3	11.2	12.5	372.4	26.2	0.0	19.2	5.3	24.5	98.7	951.9	11.2	6.7	22.9	1.7	28.2	765.0	151.6	3.3	2.6	0.0	366.2	60.4	262.6	53.0	1818.0	79.0	108.5	9.4	79.0	11.6	1.0	0.5	2.0	6.8	0.1	1045.7	7.0	155.5	0.2	27.3	105.5	39.1	19.7	193.3	202.8	12.7	8.7	4.5	78.6	534.8	14.3	10.2	0.3	47.7
SFRP4	"FRP-4, frpHE, FRZB-2"	ENSG00000106483	"Secreted frizzled related protein 4"	Q6FHJ7	7	37905932-38025695	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Differentiation, Wnt signaling pathway"	"Developmental protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"cervix: 619.9;endometrium 1: 467.1;fallopian tube: 214.0"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 472.1;Fibroblasts: 196.4;Granulosa cells: 102.8;Peritubular cells: 188.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 10.0;HSkMC: 3.9;U-937: 3.9"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in many"	5	"spinal cord: 53.5"	"HPA009712, HPA050585"	Enhanced				"Secreted in female reproductive system"	NA	NA		2500000		"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"			"HPA009712: AB_1856778, HPA050585: AB_2681183"	"unprognostic (5.93e-2)"	"unprognostic (5.84e-3)"	"unprognostic (2.75e-2)"	"unprognostic (1.58e-3)"	"unprognostic (2.61e-1)"	"unprognostic (2.35e-2)"	"unprognostic (4.02e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.76e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (1.36e-5)"	"unprognostic (7.37e-3)"	"unprognostic (1.61e-1)"	"unprognostic (4.35e-3)"	"unprognostic (1.89e-3)"	29.1	15.6	2.3	1.4	3.0	0.8	60.0	2.7	4.5	619.9	2.1	4.4	1.2	467.1	18.7	2.3	214.0	17.3	22.4	2.5	4.6	4.3	0.6	14.7	7.3	4.0	4.8	79.2	5.0	2.8	20.5	0.2	3.2	16.1	2.6	2.3	6.5	43.9	4.1	1.5	1.4	87.9	4.0	13.9	2.3	16.8	2.7	1.6	14.9	7.0	2.0	37.4	61.0	3.9	0.0	1.8	2.1	0.0	10.0	0.4	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.1	2.2	0.2	0.1	0.0	0.2	0.2	0.0	0.0	0.1	0.2	1.5	0.1	0.3	0.0	3.9	0.5	0.4	0.0	0.7	0.1	0.1	0.0	0.2	0.1	0.3	0.0	1.2	0.1	0.0	0.0	0.1	1.3	0.0	0.1	0.2	0.1	0.2	0.0	0.0	0.2	0.4	0.0	0.0	0.7	0.0	0.8	1.2	0.1	0.4	0.1	0.1	0.2	3.9	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	3.0	2.7	4.5	2.5	4.6	4.0	4.8	3.2	4.0	2.7	3.9	5.5	0.0	1.8	0.3	0.7	1.0	1.5	0.1	0.6	0.0	0.5	2.3	1.0	0.0	0.7	0.0	0.0	0.2	0.4	0.0	0.0	0.0	1.0	22.5	472.1	4.6	0.0	0.0	0.0	0.5	0.3	196.4	0.0	14.1	0.0	102.8	3.3	0.1	0.2	0.0	0.5	0.0	0.0	0.0	4.4	2.8	41.7	7.1	0.0	2.8	0.0	2.7	0.0	17.6	0.2	0.1	0.0	188.4	0.0	2.4	0.0	1.8	0.0	0.3	0.0	30.5	25.3	0.2	0.4	0.1	1.6	0.3	9.2	1.2	0.1	0.5
SMOC2	SMAP2	ENSG00000112562	"SPARC related modular calcium binding 2"	Q9H3U7	6	168441151-168673445	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Fibroblasts: 149.8;Leydig cells: 321.8;Peritubular cells: 769.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 8.1;EFO-21: 2.8;RPMI-8226: 11.3;RPTEC TERT1: 3.8;SuSa: 9.1"	"Region enhanced"	"Detected in many"		"hippocampal formation: 25.7"	"Region enhanced"	"Detected in single"		"spinal cord: 1.4"						"Secreted to extracellular matrix"	NA	NA		120000	"Cluster 21: B-cells - Adaptive immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 50: Fibroblasts - ECM organization"				"unprognostic (3.23e-1)"	"unprognostic (5.29e-2)"	"unprognostic (3.70e-2)"	"unprognostic (1.53e-2)"	"unprognostic (2.43e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.20e-1)"	"unprognostic (4.77e-2)"	"unprognostic (4.41e-1)"	"unprognostic (1.40e-2)"	"unprognostic (2.60e-1)"	"unprognostic (6.44e-2)"	"prognostic unfavorable (1.16e-6)"	"unprognostic (3.50e-2)"	"unprognostic (2.68e-1)"	"unprognostic (6.35e-2)"	"unprognostic (6.20e-3)"	67.8	14.0	10.6	13.0	12.7	0.0	61.0	10.8	16.2	82.1	42.3	44.1	21.4	164.0	147.2	53.1	119.6	100.8	57.2	10.6	11.3	13.0	4.0	14.7	14.7	11.8	11.8	124.1	25.2	12.2	4.5	18.8	11.9	31.0	24.9	2.8	17.1	54.6	42.1	28.9	27.8	76.5	10.2	4.4	144.7	44.2	12.2	10.9	43.5	54.8	11.1	68.7	21.8	10.0	2.4	0.0	8.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.4	1.0	0.0	0.0	0.0	0.0	11.3	3.8	0.0	1.7	0.3	0.0	0.3	0.1	9.1	0.0	0.0	0.0	0.0	1.7	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	10.6	12.7	10.8	16.2	10.6	11.3	11.8	11.8	11.9	10.2	12.2	10.0	8.1	0.0	1.7	0.7	0.0	11.1	8.0	0.0	1.2	7.1	12.5	12.1	7.7	0.0	1.8	11.0	0.0	2.5	0.0	3.6	0.0	0.0	2.6	40.3	42.3	11.0	19.7	0.0	0.5	0.0	1.7	149.8	1.1	58.4	0.0	17.2	3.3	0.0	1.2	0.0	9.7	4.5	0.0	0.0	3.9	17.2	321.8	2.9	3.6	6.5	0.0	0.4	0.0	2.0	0.1	0.1	0.4	769.2	0.1	6.7	2.0	0.0	2.2	0.8	46.0	14.7	63.3	3.9	5.1	0.8	2.7	2.6	1.7	17.3	47.4	1.1
SPATA18	FLJ32906	ENSG00000163071	"Spermatogenesis associated 18"	Q8TC71	4	52051304-52097299	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 68.3;testis: 28.8"	"Cell type enriched"	"Detected in many"	4	"Late spermatids: 2341.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 31.5;BEWO: 24.4;BJ hTERT+: 15.9;HSkMC: 29.3;hTCEpi: 28.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA036854, HPA036855"	Enhanced		Supported	Mitochondria		NA	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Mitochondria		"HPA036854: AB_10670927, HPA036855: AB_2675352"	"unprognostic (6.54e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.46e-1)"	"prognostic favorable (1.32e-5)"	"unprognostic (1.02e-2)"	"unprognostic (1.53e-2)"	"unprognostic (7.27e-2)"	"unprognostic (4.49e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.73e-1)"	"unprognostic (3.13e-1)"	"unprognostic (3.13e-2)"	"prognostic favorable (3.73e-9)"	"unprognostic (4.38e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.01e-2)"	"unprognostic (4.00e-2)"	2.1	5.0	2.4	0.7	2.2	0.0	6.3	1.3	1.0	10.7	15.6	4.1	2.1	4.2	2.0	4.6	68.3	6.7	1.8	2.5	2.7	5.3	5.4	8.0	0.3	6.8	8.3	1.8	2.0	4.5	4.9	1.9	5.5	4.2	5.6	0.1	10.1	5.6	0.8	6.6	2.2	3.1	6.0	0.6	4.9	28.8	2.6	3.2	1.2	1.3	0.9	2.8	3.4	3.8	0.0	3.8	1.8	0.0	12.7	31.5	24.4	9.3	15.9	0.6	0.7	0.0	1.5	0.0	0.0	12.3	0.2	0.3	0.1	7.1	0.3	0.0	1.1	0.0	0.0	8.0	11.2	0.0	0.0	29.3	28.7	1.0	4.5	5.1	6.9	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	1.4	1.9	2.0	1.0	0.0	0.0	9.7	0.0	0.2	9.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	2.2	1.3	1.0	2.5	2.7	6.8	8.3	5.5	6.0	2.6	3.8	0.3	9.6	3.0	0.3	0.0	5.2	8.5	9.4	8.6	0.0	6.0	6.7	2.2	8.6	15.1	0.0	0.0	1.7	0.3	1.8	1.9	1.2	561.1	124.6	1.8	1.2	1.8	0.0	1.7	2.6	1.8	4.3	11.2	4.7	2.5	1.9	1.4	3.4	0.3	0.0	0.5	1.6	6.1	0.6	1.6	2341.5	10.8	1.1	0.0	2.8	0.1	0.0	0.0	0.5	0.1	2.0	2.7	10.9	0.0	5.1	1.9	7.4	141.4	0.0	0.0	1.8	3.9	13.9	7.1	7.1	7.5	0.8	0.2	2.5	4.3	6.8
SPON2	DIL1	ENSG00000159674	"Spondin 2"	Q9BUD6	4	1166932-1208962	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 187.1"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 427.0;Endometrial stromal cells: 256.6;Extravillous trophoblasts: 355.8;Fibroblasts: 257.7;NK-cells: 1096.8"	"Cancer enriched"	"Detected in all"	7	"prostate cancer: 243.7"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"gdT-cell: 255.9"	"Lineage enriched"	"Detected in all"	5	"T-cells: 255.9"	"Group enriched"	"Detected in many"	5	"HHSteC: 303.8;HSkMC: 546.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA040170, HPA066095"	Approved		Approved	Vesicles	"Secreted to blood"	NA	NA		2600000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 63: NK-cells & T-cells - Immune response"	Vesicles		"HPA040170: AB_2676868, HPA066095: AB_2685615"	"unprognostic (1.22e-1)"	"unprognostic (3.56e-1)"	"unprognostic (3.07e-2)"	"prognostic favorable (2.03e-4)"	"unprognostic (7.64e-2)"	"unprognostic (6.28e-2)"	"unprognostic (2.70e-3)"	"unprognostic (2.28e-3)"	"unprognostic (2.76e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.23e-2)"	"unprognostic (2.74e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.01e-2)"	"prognostic unfavorable (9.22e-4)"	66.2	40.4	4.0	18.8	7.7	19.5	50.6	15.6	3.9	161.4	3.5	51.5	18.5	187.1	4.4	40.6	49.7	32.2	35.5	3.5	0.8	37.1	79.1	63.0	3.9	2.9	1.7	34.4	18.7	0.9	15.1	19.2	3.5	111.8	7.2	0.7	28.8	8.4	19.1	38.3	63.5	42.7	0.2	26.9	43.8	4.7	1.8	1.8	16.3	6.6	1.0	68.4	94.0	1.5	0.4	0.6	0.0	0.0	10.2	79.0	3.0	6.2	5.0	0.8	1.0	0.0	0.1	1.8	9.7	26.9	0.9	45.0	0.0	0.2	0.0	0.3	0.1	0.2	3.0	12.7	303.8	0.2	1.5	546.6	0.0	0.6	0.0	0.0	0.0	4.1	0.3	9.2	0.0	0.3	5.3	12.2	3.5	9.7	0.7	1.0	3.3	7.9	0.0	0.0	1.7	1.1	1.1	0.0	2.9	1.7	0.4	1.5	0.1	0.2	0.9	20.5	0.0	1.3	2.7	0.6	0.1	6.5	0.0	3.7	0.9	1.0	255.9	1.1	5.5	0.7	33.1	105.8	0.4	1.0	14.4	96.8	9.8	50.4	2.2	42.9	0.1	123.2	4.0	7.7	15.6	3.9	3.5	0.8	2.9	1.7	3.5	0.2	1.8	1.5	9.8	0.0	5.6	1.3	6.6	36.8	2.0	82.5	2.2	3.7	5.1	3.8	4.0	24.3	43.0	1.8	0.0	3.4	427.0	9.7	1.9	3.8	0.2	12.7	256.6	5.7	13.8	4.0	8.4	1.3	355.8	257.7	10.7	6.6	6.3	0.2	15.4	40.4	12.8	0.0	0.6	9.7	73.2	5.8	15.4	0.5	29.8	9.5	26.6	6.5	9.2	0.9	1096.8	0.5	0.7	1.5	6.7	9.4	64.0	15.8	16.3	28.3	32.6	0.4	6.6	22.5	89.9	0.2	0.5	21.3	21.5	38.9	100.8	8.1	7.9	13.2
SSC5D	"FLJ35258, S5D-SRCRB"	ENSG00000179954	"Scavenger receptor cysteine rich family member with 5 domains"	A1L4H1	19	55488404-55519099	"Predicted intracellular proteins, Predicted secreted proteins"	"Immunity, Innate immunity"	"Developmental protein, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 39.7"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 19.3;Fibroblasts: 27.0;Leydig cells: 18.0;Peritubular cells: 15.8;Skeletal myocytes: 32.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 26.9;BJ: 22.7;fHDF/TERT166: 27.5;hTERT-RPE1: 23.2;U-87 MG: 27.8"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA042008, HPA053316"	Approved		Approved	Nucleoplasm,Cytosol	"Secreted in other tissues"	Yes	NA		88000000		"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Nucleoplasm, Cytosol"		"HPA042008: AB_10804124, HPA053316: "	"unprognostic (1.23e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.78e-2)"	"unprognostic (1.28e-2)"	"unprognostic (4.55e-2)"	"unprognostic (6.65e-2)"	"unprognostic (3.68e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.85e-2)"	"unprognostic (1.34e-3)"	"unprognostic (1.40e-1)"	"unprognostic (6.20e-3)"	"prognostic unfavorable (4.26e-8)"	"unprognostic (7.73e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.20e-2)"	"unprognostic (2.21e-3)"	13.1	2.2	2.6	3.6	4.6	0.1	8.8	3.0	2.1	23.0	1.8	33.6	1.9	39.7	3.9	5.7	17.0	12.9	17.6	1.8	2.1	3.6	1.7	9.1	1.3	3.9	2.6	14.5	1.8	0.3	17.6	1.9	4.0	8.8	2.8	1.1	3.4	12.8	3.6	5.6	8.7	20.1	2.2	11.1	9.8	2.6	3.6	2.0	3.8	2.8	0.5	10.6	15.9	2.1	0.1	1.4	0.5	0.0	3.3	26.9	0.0	22.7	5.5	3.7	4.6	0.4	0.0	1.2	0.3	27.5	1.1	0.0	0.0	0.0	1.9	0.1	0.3	5.6	1.5	0.0	5.2	0.1	9.6	12.3	0.0	5.4	0.0	23.2	0.0	0.7	0.2	0.3	0.6	0.1	0.1	0.5	0.9	0.0	0.2	0.7	1.2	0.3	2.5	0.0	2.9	0.4	0.4	0.0	0.5	0.5	0.4	1.2	7.9	1.0	1.3	1.1	3.8	0.4	0.0	0.1	27.8	0.3	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	4.6	3.0	2.1	1.8	2.1	3.9	2.6	4.0	2.2	3.6	2.1	3.5	3.2	0.6	4.2	0.3	1.9	0.3	0.3	0.0	5.3	0.8	1.1	2.8	0.0	0.1	0.0	2.1	0.1	0.4	0.8	1.9	0.1	0.6	1.5	19.3	3.3	0.0	0.0	1.5	0.0	0.1	27.0	2.0	0.9	0.0	0.5	2.2	0.0	1.2	3.3	1.1	0.4	0.0	1.0	3.8	1.3	18.0	2.0	1.8	2.8	0.7	2.1	0.0	0.0	0.3	0.1	0.3	15.8	0.3	0.3	4.6	0.2	0.7	1.9	0.0	32.1	6.8	0.9	1.1	0.4	1.8	0.0	0.5	0.9	1.4	0.2
STMN3	SCLIP	ENSG00000197457	"Stathmin 3"	Q9NZ72	20	63639705-63657682	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 291.7"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 108.5;Granulosa cells: 254.2;Horizontal cells: 109.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Lineage enriched"	"Detected in many"	5	"T-cells: 6.2"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 125.1;MOLT-4: 142.0;REH: 143.8;SCLC-21H: 192.5;SH-SY5Y: 146.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012947	Enhanced		Supported	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 14: REH - Unknown function"	"Cluster 40: Granulosa cells - Unknown function"	"Golgi apparatus"	Cytosol	"HPA012947: AB_1857606"	"unprognostic (7.59e-2)"	"unprognostic (4.36e-1)"	"unprognostic (5.28e-2)"	"unprognostic (2.33e-1)"	"unprognostic (3.60e-2)"	"unprognostic (6.30e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.92e-2)"	"unprognostic (4.35e-2)"	"unprognostic (1.65e-3)"	"unprognostic (7.52e-2)"	"unprognostic (2.52e-3)"	"unprognostic (2.73e-2)"	"unprognostic (9.87e-2)"	"unprognostic (4.08e-2)"	"unprognostic (9.08e-3)"	23.4	49.7	188.4	21.3	197.6	11.4	20.0	112.5	291.7	29.2	16.6	26.5	5.5	30.0	5.0	11.6	27.9	10.9	17.1	215.0	162.0	24.8	3.7	23.6	25.8	259.6	158.1	50.5	16.4	17.5	102.2	10.0	266.1	24.3	5.2	38.8	11.7	12.7	4.3	20.2	24.8	14.7	100.8	48.2	15.1	9.0	159.3	43.5	63.9	3.7	12.4	21.9	19.0	179.9	10.4	11.6	74.4	125.1	1.9	7.3	5.1	12.0	0.4	35.8	16.8	73.6	13.7	0.5	36.3	4.6	2.0	68.6	52.2	1.3	11.1	5.2	14.0	5.1	17.0	27.6	9.9	3.9	42.0	15.3	0.3	11.5	2.9	1.5	1.3	34.4	98.8	2.2	9.6	11.7	142.0	17.7	76.5	2.4	81.7	143.8	12.1	58.0	60.9	2.0	192.5	146.6	5.7	3.4	14.9	5.9	2.1	25.9	1.9	0.8	20.4	0.8	2.6	4.9	10.4	3.6	2.1	14.3	48.8	1.1	0.0	1.1	2.5	0.1	2.7	0.2	5.2	4.5	0.1	0.6	6.2	5.3	0.1	0.0	0.1	1.1	0.9	2.0	188.4	197.6	112.5	291.7	215.0	162.0	259.6	158.1	266.1	100.8	159.3	179.9	5.8	6.4	2.5	16.3	17.1	8.2	6.9	11.9	8.6	108.5	4.7	14.7	2.3	4.3	3.2	3.7	52.1	11.7	13.4	1.1	13.7	4.0	10.0	1.6	17.9	7.8	37.2	4.6	56.9	2.5	4.0	25.4	2.0	2.7	4.5	254.2	6.8	0.0	2.3	109.4	67.1	0.6	4.1	2.2	7.6	18.8	30.1	3.5	7.2	7.5	4.6	37.2	16.5	21.1	11.3	2.2	0.1	35.7	5.3	4.5	0.1	5.0	0.8	44.5	13.1	3.0	20.9	3.3	6.7	1.6	4.3	8.8	28.6	51.0	0.6	2.7
SULF1	"hSulf-1, KIAA1077, SULF-1"	ENSG00000137573	"Sulfatase 1"	Q8IWU6	8	69466624-69660915	"Predicted intracellular proteins"	Apoptosis	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 180.3"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 214.2;Fibroblasts: 52.8;Inhibitory neurons: 63.0;Late spermatids: 101.4;Muller glia cells: 162.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 315.4;BJ hTERT+: 420.2;fHDF/TERT166: 520.0;U-2197: 126.1;WM-115: 175.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054728	Supported				"Intracellular and membrane"	NA	NA				"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 5: Muller glia cells - Visual perception"			"HPA054728: AB_2682586"	"unprognostic (2.89e-2)"	"unprognostic (5.07e-2)"	"unprognostic (3.87e-2)"	"unprognostic (5.30e-2)"	"unprognostic (3.60e-2)"	"unprognostic (7.62e-2)"	"unprognostic (3.77e-2)"	"unprognostic (2.93e-2)"	"unprognostic (3.58e-1)"	"unprognostic (1.45e-1)"	"unprognostic (3.69e-2)"	"unprognostic (7.82e-2)"	"prognostic unfavorable (1.06e-7)"	"unprognostic (8.91e-3)"	"unprognostic (4.23e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.69e-2)"	24.1	2.6	8.1	24.4	6.4	0.0	8.0	2.2	2.7	14.5	180.3	36.4	10.0	28.7	14.2	18.3	11.3	30.6	14.2	6.4	7.4	9.9	1.8	9.7	6.3	1.9	18.2	14.2	3.5	1.4	9.7	4.2	5.8	50.8	20.6	60.0	4.3	41.9	2.2	2.6	14.1	72.6	3.4	2.2	4.0	2.2	18.6	2.2	19.9	11.2	4.8	32.1	9.5	3.0	0.0	0.0	57.3	0.0	6.2	27.3	0.4	315.4	420.2	10.9	1.7	0.0	1.2	0.5	0.2	520.0	0.0	0.4	0.8	0.5	2.1	0.0	1.1	0.0	1.0	0.0	1.5	0.1	0.5	35.6	3.7	18.2	6.7	15.2	1.4	0.0	0.0	0.6	8.5	1.3	0.0	0.0	6.5	0.0	0.4	0.0	23.2	0.9	0.0	0.0	1.1	0.0	0.0	0.5	0.0	22.6	76.7	0.0	0.0	29.0	0.8	126.1	0.0	0.1	0.0	0.1	0.1	0.1	175.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	6.4	2.2	2.7	6.4	7.4	1.9	18.2	5.8	3.4	18.6	3.0	10.6	9.6	6.2	3.9	0.1	0.9	2.7	7.8	26.2	1.8	1.3	13.7	4.3	2.8	13.5	5.5	0.0	0.3	0.0	0.0	0.0	0.3	214.2	1.0	30.5	13.5	1.2	2.7	9.6	0.0	0.0	52.8	0.0	1.0	0.0	0.1	15.4	0.5	0.3	0.0	63.0	0.3	0.0	0.6	1.3	101.4	6.5	0.8	0.0	1.0	0.0	162.8	0.0	3.5	0.6	0.7	0.1	1.9	0.0	1.4	0.0	0.1	5.5	6.5	0.0	5.2	42.4	1.6	1.4	2.5	0.3	0.3	0.3	0.1	0.0	0.4
SVEP1	"bA427L11.3, C9orf13, FLJ13529, POLYDOM"	ENSG00000165124	"Sushi, von Willebrand factor type A, EGF and pentraxin domain containing 1"	Q4LDE5	9	110365248-110579880	"Predicted intracellular proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 38.6;placenta: 61.7"	"Cell type enhanced"	"Detected in many"		"Fibroblasts: 92.8;Inhibitory neurons: 50.3;Leydig cells: 42.0;Oligodendrocytes: 140.5;Syncytiotrophoblasts: 67.3;Theca cells: 34.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"ASC diff: 147.1;ASC TERT1: 84.7;BJ hTERT+: 62.3;HHSteC: 53.8;HSkMC: 66.7"	"Region enhanced"	"Detected in some"		"cerebellum: 2.8"	"Region enriched"	"Detected in all"	5	"cerebellum: 20.8"	"HPA020610, HPA021520"	Enhanced				"Intracellular and membrane"	NA	NA		160000000		"Cluster 82: Adipose tissue - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"			"HPA020610: AB_2197021, HPA021520: AB_1855533"	"unprognostic (4.47e-2)"	"unprognostic (6.01e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.31e-1)"	"unprognostic (2.62e-2)"	"unprognostic (9.13e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.08e-2)"	"unprognostic (3.31e-3)"	"unprognostic (2.25e-1)"	"unprognostic (1.51e-1)"	"unprognostic (4.11e-2)"	"prognostic unfavorable (8.33e-4)"	"unprognostic (9.84e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.55e-3)"	38.6	4.2	1.5	2.5	8.6	0.0	23.2	8.9	2.8	10.6	0.9	9.7	1.2	8.6	5.6	3.5	12.4	6.2	6.5	1.1	3.4	3.9	2.9	19.7	3.8	2.7	5.3	3.9	4.7	5.3	0.8	61.7	3.3	1.7	5.1	0.0	4.1	2.1	4.4	11.3	8.7	9.5	1.0	5.2	7.7	1.0	4.3	1.8	7.4	5.5	2.4	9.7	12.1	6.1	0.0	0.1	1.2	0.0	147.1	84.7	0.0	16.3	62.3	1.2	1.9	1.5	0.0	0.0	0.0	3.9	0.1	0.0	0.0	12.2	1.0	0.0	0.3	0.1	1.4	0.0	53.8	0.0	2.9	66.7	0.0	12.1	3.2	1.4	0.0	0.0	0.1	0.0	0.9	0.0	0.0	0.0	0.7	0.7	0.0	0.0	0.0	0.0	0.0	0.5	0.8	0.2	7.5	2.0	0.0	10.6	0.0	0.0	0.0	2.3	0.0	1.0	0.0	1.3	2.5	0.0	7.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	8.6	8.9	2.8	1.1	3.4	2.7	5.3	3.3	1.0	4.3	6.1	7.4	0.0	0.5	2.9	0.1	5.7	0.6	0.5	1.2	0.5	0.4	0.9	1.8	5.7	0.1	0.0	0.0	12.2	0.3	0.0	0.0	0.9	0.3	0.5	13.8	2.0	0.0	0.0	16.9	0.2	1.6	92.8	4.1	0.3	0.0	0.0	2.2	0.0	3.0	0.0	50.3	0.0	0.0	0.0	8.2	0.6	42.0	0.6	7.2	13.1	0.0	0.0	0.0	3.0	140.5	0.0	1.2	0.0	0.1	0.5	0.0	0.0	0.1	0.0	0.0	3.5	7.8	0.4	1.5	0.4	3.3	67.3	1.2	34.1	0.2	0.2
TCF21	"bHLHa23, POD1"	ENSG00000118526	"Transcription factor 21"	O43680	6	133889113-133895553	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 100.4;ovary: 88.3;placenta: 137.2"	"Group enriched"	"Detected in some"	5	"Fibroblasts: 123.8;Leydig cells: 102.2;Peritubular cells: 116.9;Sertoli cells: 118.3"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"cerebral cortex: 1.7;hippocampal formation: 1.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"HHSteC: 51.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA013189	Uncertain					NA	NA				"Cluster 19: Lung - Lung function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 33: Fibroblasts - ECM organization"			"HPA013189: AB_10601215"	"unprognostic (2.43e-2)"	"unprognostic (8.45e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.60e-1)"		"unprognostic (8.60e-2)"	"unprognostic (4.78e-5)"	"unprognostic (2.58e-2)"		"unprognostic (6.66e-2)"	"unprognostic (9.74e-2)"	"unprognostic (2.88e-2)"	"unprognostic (2.91e-3)"	"unprognostic (2.01e-2)"	"unprognostic (8.48e-2)"	"unprognostic (5.37e-2)"	"unprognostic (2.95e-1)"	8.9	10.7	0.1	11.0	0.0	0.0	0.3	0.4	1.7	3.3	2.7	24.6	23.4	9.4	13.1	19.4	3.5	20.2	22.6	1.6	0.0	38.3	5.1	58.5	0.3	0.2	0.0	88.3	10.4	1.3	3.5	137.2	0.1	37.0	21.2	0.0	0.1	42.2	1.1	0.1	26.7	14.3	0.0	100.4	21.0	3.4	0.1	0.1	0.3	0.7	0.0	40.3	8.5	0.1	0.0	1.3	0.0	0.2	0.2	0.0	0.6	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.3	0.0	51.1	0.0	0.0	1.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.3	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	1.0	2.2	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	1.7	1.6	0.0	0.2	0.0	0.1	0.0	0.1	0.1	0.2	3.2	1.1	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.5	0.0	0.0	5.5	0.0	2.2	0.0	0.0	0.0	0.0	0.5	0.0	0.6	1.3	0.0	0.0	0.0	0.0	1.9	123.8	0.5	0.0	0.0	0.5	0.7	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	2.2	102.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	116.9	0.1	0.3	0.0	0.0	0.0	0.0	118.3	0.3	20.8	0.3	0.4	1.4	0.0	5.7	0.1	14.5	0.0	0.4
THBS3		ENSG00000169231	"Thrombospondin 3"	P49746	1	155195588-155209051	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	29	"Early spermatids: 297.1;Late spermatids: 1075.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 76.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA006293, HPA073242"	Approved		Approved	Vesicles	"Secreted to extracellular matrix"	NA	NA		9400000	"Cluster 35: T-regs - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 31: Spermatids - Spermatogenesis"	Vesicles		"HPA006293: AB_10602898, HPA073242: AB_2732223"	"unprognostic (2.57e-1)"	"unprognostic (1.63e-2)"	"prognostic unfavorable (2.43e-4)"	"prognostic unfavorable (1.44e-4)"	"unprognostic (2.63e-1)"	"unprognostic (1.30e-1)"	"unprognostic (3.62e-2)"	"unprognostic (4.23e-1)"	"unprognostic (4.54e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.30e-1)"	"prognostic unfavorable (2.38e-12)"	"unprognostic (2.06e-2)"	"unprognostic (9.41e-2)"	"unprognostic (8.50e-3)"	"unprognostic (2.26e-1)"	16.7	9.3	4.5	8.9	5.1	9.1	16.3	3.0	5.3	24.9	7.9	25.0	5.4	33.6	21.0	14.1	24.4	16.7	23.2	4.9	5.4	16.4	14.5	15.6	5.7	4.8	6.7	24.9	19.1	10.8	15.9	8.8	4.5	20.0	10.7	4.7	13.3	15.5	5.8	18.8	14.1	28.6	3.3	11.0	14.5	14.9	6.4	4.4	23.6	8.0	6.2	18.8	19.4	4.2	3.3	7.8	28.3	28.9	15.1	17.5	1.7	13.3	19.6	6.1	10.9	1.0	24.0	2.2	14.7	29.4	1.8	7.9	0.8	5.0	4.5	5.3	1.9	1.9	9.8	1.1	16.3	1.6	3.9	30.3	17.2	8.9	12.2	76.2	11.0	4.9	1.7	4.6	5.5	12.0	1.3	3.0	6.5	6.9	3.9	26.2	1.2	5.3	12.7	8.2	41.7	23.8	3.4	6.5	6.8	40.7	19.1	4.1	8.5	20.1	4.6	3.8	4.7	11.1	1.4	0.5	18.2	1.7	1.7	0.0	1.6	0.6	0.6	0.8	0.4	0.5	0.9	0.7	1.3	0.2	1.0	0.3	0.7	0.3	0.2	0.2	1.7	0.8	4.5	5.1	3.0	5.3	4.9	5.4	4.8	6.7	4.5	3.3	6.4	4.2	4.0	0.0	14.3	7.2	1.4	7.9	2.6	3.1	4.6	2.5	6.6	6.1	1.7	5.7	2.8	0.0	0.0	1.7	3.5	3.3	1.9	4.9	297.1	5.3	10.3	5.6	4.8	0.8	11.2	2.5	1.8	22.6	5.6	5.0	0.0	7.5	2.9	5.4	9.9	8.4	6.3	4.3	6.1	3.8	8.6	1075.2	23.3	3.7	10.6	0.0	1.9	1.5	1.0	0.0	3.2	3.7	2.9	10.1	1.4	2.3	2.7	3.8	2.6	3.7	0.0	11.8	8.1	20.8	4.8	3.7	5.3	1.4	2.2	2.4	3.4	2.2
TIMP2	CSC-21K	ENSG00000035862	"TIMP metallopeptidase inhibitor 2"	P16035	17	78852977-78925387	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Metalloenzyme inhibitor, Metalloprotease inhibitor, Protease inhibitor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"ovary: 941.0"	"Cell type enhanced"	"Detected in many"		"Fibroblasts: 475.9;Late spermatids: 491.0;Leydig cells: 353.6;Peritubular cells: 770.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 13.6"	"Group enriched"	"Detected in many"	4	"granulocytes: 13.6;monocytes: 5.0"	"Cell line enhanced"	"Detected in many"		"ASC diff: 1327.4;ASC TERT1: 1618.4;BJ hTERT+: 960.2;fHDF/TERT166: 1070.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB010203	Approved				"Secreted to extracellular matrix"	NA	NA		110000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"			"CAB010203: AB_2204966"	"unprognostic (1.03e-1)"	"unprognostic (1.71e-2)"	"unprognostic (9.81e-2)"	"unprognostic (1.76e-3)"	"unprognostic (3.24e-2)"	"unprognostic (3.05e-1)"	"unprognostic (4.31e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.39e-1)"	"unprognostic (4.73e-2)"	"unprognostic (3.97e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.38e-3)"	"unprognostic (4.62e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.77e-3)"	461.0	185.1	171.5	92.3	140.8	20.1	290.6	110.6	122.1	576.3	117.9	280.5	71.0	525.4	116.8	176.0	272.7	397.9	244.8	128.6	157.0	120.7	62.8	231.7	77.7	157.4	161.5	941.0	79.1	64.0	103.6	218.1	156.2	196.2	107.6	43.5	107.2	267.5	56.6	245.2	149.5	381.6	141.5	172.0	140.9	150.4	178.0	80.0	155.6	119.8	38.7	261.2	331.0	168.1	170.0	84.0	93.0	178.8	1327.4	1618.4	50.2	585.0	960.2	280.1	221.1	30.8	288.6	0.2	200.8	1070.2	307.4	32.9	29.1	25.2	291.4	3.4	16.6	0.1	156.0	48.1	392.7	2.6	1.2	641.1	12.0	276.8	44.3	722.5	375.9	54.4	0.2	0.5	292.5	19.5	176.8	29.7	16.6	34.2	122.8	118.0	213.2	73.4	178.7	2.3	47.6	290.3	366.6	170.8	776.3	111.6	86.8	42.2	450.3	744.2	140.5	438.0	102.8	84.1	74.9	1.5	171.0	32.0	367.6	0.0	5.0	7.4	0.0	3.4	0.0	0.1	0.1	0.0	2.2	0.2	0.2	0.3	13.6	0.2	4.3	1.4	0.1	0.9	171.5	140.8	110.6	122.1	128.6	157.0	157.4	161.5	156.2	141.5	178.0	168.1	147.9	112.2	34.3	24.2	18.7	98.9	9.0	5.7	9.1	37.5	9.7	37.6	41.9	52.9	20.8	25.8	8.4	4.3	6.1	46.0	0.0	78.0	143.7	17.0	190.3	115.0	7.8	12.4	9.8	22.0	87.7	475.9	17.9	24.4	7.0	97.5	259.5	7.9	208.8	3.3	107.7	14.3	12.2	177.4	171.4	491.0	353.6	184.8	275.7	96.5	87.3	39.9	5.2	60.8	143.5	83.3	6.0	770.7	33.1	10.1	12.8	0.8	5.4	12.7	92.1	111.8	171.9	8.5	7.7	5.6	75.9	14.8	17.5	96.0	2.3	6.9
TMEM30B	CDC50B	ENSG00000182107	"Transmembrane protein 30B"	Q3MIR4	14	61277370-61281761	"Predicted membrane proteins, Transporters"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 124.0;Prostatic glandular cells: 101.1;Urothelial cells: 131.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 68.7;CAPAN-2: 54.4;HaCaT: 31.7;HBEC3-KT: 39.0;hTCEpi: 29.1;MCF7: 44.6;RT4: 94.9;T-47d: 30.4"	"Not detected"	"Not detected"							HPA043162	Uncertain					NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 15: RT4 - Unknown function"	"Cluster 22: Epithelial cell types - Mixed function"			"HPA043162: AB_10796688"	"unprognostic (4.06e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.72e-1)"	"unprognostic (3.47e-2)"	"unprognostic (2.01e-1)"	"unprognostic (6.20e-2)"	"unprognostic (2.45e-3)"	"unprognostic (3.43e-2)"	"unprognostic (9.10e-2)"	"unprognostic (2.20e-1)"	"unprognostic (5.10e-2)"	"unprognostic (2.26e-1)"	"prognostic favorable (5.89e-5)"	"unprognostic (2.21e-1)"	"unprognostic (2.89e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.85e-1)"	3.9	1.6	0.5	3.7	0.7	0.4	14.8	0.5	1.0	16.4	0.9	29.1	43.3	3.8	28.2	14.1	15.2	23.9	2.0	0.3	0.7	12.3	12.3	14.5	1.2	0.6	0.5	2.5	35.7	59.1	18.2	5.7	0.5	21.9	26.1	0.3	27.7	13.4	1.2	8.6	34.4	1.7	0.5	0.7	42.2	2.6	0.6	5.3	50.0	1.9	4.4	16.1	9.3	0.4	68.7	0.2	0.0	0.0	6.7	1.6	0.1	0.1	0.0	0.0	0.0	11.6	54.4	0.0	0.1	0.0	0.0	31.7	0.0	39.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	29.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	44.6	0.0	0.1	0.6	28.2	1.6	0.0	1.5	0.2	0.0	94.9	11.2	0.1	0.8	25.6	0.1	1.9	30.4	0.1	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.3	0.1	0.0	0.0	0.7	0.5	0.0	0.2	0.0	0.0	0.0	0.1	0.5	0.7	0.5	1.0	0.3	0.7	0.6	0.5	0.5	0.5	0.6	0.4	0.6	28.9	31.9	0.0	0.6	64.9	124.0	19.5	61.5	0.0	32.2	16.5	1.9	47.1	24.5	40.5	0.0	28.0	1.1	90.8	13.7	24.8	0.9	23.8	3.9	3.9	23.4	0.0	0.0	37.2	11.4	5.5	62.7	45.3	2.5	0.7	4.2	14.1	2.0	0.0	0.0	73.1	20.3	1.0	6.8	1.6	8.7	1.5	5.4	1.0	0.6	2.9	2.1	0.0	0.1	31.9	75.3	79.0	0.4	101.1	73.6	1.0	22.7	0.3	13.1	2.4	5.4	5.9	3.6	43.3	63.6	35.8	3.6	0.9	64.7	131.9
TNXB	"TNXB1, TNXB2, TNXBS, XB, XBS"	ENSG00000168477	"Tenascin XB"	P22105	6	32041153-32115334	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"		"Disease variant, Ehlers-Danlos syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 274.8"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 54.7;Fibroblasts: 318.4;Granulosa cells: 94.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"ASC diff: 12.4;ASC TERT1: 20.1;U-2197: 15.8;U-87 MG: 8.2"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"								"Secreted to extracellular matrix"	NA	NA		1500000000		"Cluster 72: Non-specific - Transcription"	"Cluster 18: U-2197 - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"				"unprognostic (5.87e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.62e-3)"	"unprognostic (9.57e-2)"	"unprognostic (1.16e-1)"	"unprognostic (9.51e-4)"	"unprognostic (5.71e-2)"	"unprognostic (2.30e-1)"	"unprognostic (6.30e-3)"	"unprognostic (1.84e-1)"	"unprognostic (6.61e-2)"	"unprognostic (2.17e-1)"	"unprognostic (9.70e-2)"	"unprognostic (3.13e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.90e-2)"	"unprognostic (1.01e-1)"	68.0	274.8	2.0	0.9	3.1	3.4	40.0	4.4	1.8	45.1	3.5	35.9	3.0	66.7	3.2	18.1	37.4	4.7	73.8	0.7	0.8	13.0	17.6	51.1	0.8	1.5	1.1	67.0	3.7	0.4	6.8	3.8	1.5	15.6	1.7	0.3	19.5	1.0	14.2	27.4	29.0	3.1	2.2	30.7	18.8	11.4	3.0	0.7	27.7	7.2	0.4	34.5	35.2	0.4	0.1	0.3	0.3	0.2	12.4	20.1	0.2	0.0	0.4	0.1	0.1	0.2	0.0	0.0	0.4	1.2	0.0	0.1	0.0	0.0	0.1	1.3	1.1	0.2	0.6	0.0	2.8	0.0	0.3	0.2	0.2	0.5	0.0	0.5	0.0	0.5	0.7	0.4	0.0	0.2	0.0	0.1	0.3	0.0	3.5	0.3	0.1	0.2	0.0	0.1	0.1	0.2	1.3	0.0	0.1	0.1	0.0	0.3	0.2	0.1	0.4	15.8	0.0	0.4	0.4	0.2	8.2	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.0	3.1	4.4	1.8	0.7	0.8	1.5	1.1	1.5	2.2	3.0	0.4	54.7	3.2	2.4	2.6	0.5	32.9	0.2	0.3	0.6	1.3	1.3	1.8	2.5	4.3	0.2	0.0	0.0	0.5	1.0	0.0	0.0	0.2	3.0	1.3	39.7	38.8	0.0	25.0	7.1	0.0	2.6	318.4	6.1	1.1	0.0	94.8	12.8	0.9	0.7	0.0	4.2	0.1	0.0	0.6	39.1	2.8	27.1	4.7	32.0	17.8	0.0	1.2	0.0	1.0	1.2	0.0	0.1	4.5	2.5	0.5	0.0	0.3	0.9	0.6	0.0	21.7	20.8	4.1	2.1	1.6	26.6	1.0	4.8	5.6	0.2	0.4
TRIM9	"RNF91, SPRING"	ENSG00000100505	"Tripartite motif containing 9"	Q9C026	14	50975262-51096061	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 63.3;retina: 20.9"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 324.2;Excitatory neurons: 545.6;Inhibitory neurons: 381.1;Oligodendrocyte precursor cells: 582.1;Oligodendrocytes: 143.7"	"Cancer enriched"	"Detected in some"	8	"glioma: 25.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 32.2;HAP1: 23.0;HDLM-2: 36.5;SCLC-21H: 32.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA				"Cluster 6: Brain - Smell perception"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"				"unprognostic (1.22e-1)"	"unprognostic (6.37e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.10e-3)"	"unprognostic (6.67e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.24e-3)"	"unprognostic (7.66e-2)"	"unprognostic (1.88e-1)"	"unprognostic (3.06e-2)"	"unprognostic (2.38e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.55e-1)"	"unprognostic (9.00e-2)"	"unprognostic (7.57e-6)"	"unprognostic (1.85e-3)"	0.9	2.1	31.1	1.2	39.6	0.9	1.2	63.3	45.5	3.7	0.0	6.3	0.2	4.6	1.3	0.4	0.8	4.4	1.2	45.6	14.1	1.0	2.3	0.5	0.2	12.4	18.9	1.3	0.6	0.1	13.5	0.3	12.3	0.8	0.9	20.9	2.1	3.1	0.6	0.9	1.2	3.2	12.4	0.3	1.0	1.0	28.0	0.9	0.5	0.4	0.2	0.7	1.8	32.3	0.0	3.7	5.7	32.2	0.0	0.0	2.1	0.0	0.0	0.4	0.9	2.5	0.3	0.4	0.2	0.5	5.5	0.1	23.0	0.0	0.9	36.5	4.6	1.8	0.1	0.0	0.0	1.3	1.2	0.9	0.0	0.6	0.0	0.1	0.0	3.1	0.0	0.2	0.9	0.1	7.2	0.9	1.9	0.1	4.9	4.2	8.3	0.2	0.1	0.0	32.7	2.6	0.5	0.1	7.3	0.3	0.5	0.9	0.0	2.1	0.9	0.0	1.5	0.6	0.1	0.4	9.6	0.9	12.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.1	39.6	63.3	45.5	45.6	14.1	12.4	18.9	12.3	12.4	28.0	32.3	0.1	0.0	0.0	324.2	0.2	0.5	0.1	0.2	0.6	51.5	0.6	4.3	1.4	1.5	0.0	0.0	33.3	0.4	0.0	2.2	1.9	0.3	0.2	0.3	0.3	0.4	1.2	0.0	545.6	0.0	2.9	1.6	0.0	0.7	0.0	0.8	0.7	0.1	0.2	1.7	381.1	0.0	2.0	0.3	0.3	0.2	2.1	0.0	7.2	28.1	0.0	44.4	0.0	582.1	143.7	0.1	0.1	4.1	1.1	0.2	0.0	0.3	0.0	25.9	0.0	14.8	0.4	0.4	0.8	0.2	0.0	0.3	0.4	0.1	0.2	0.0
TSHZ3	"KIAA1474, TSH3, ZNF537"	ENSG00000121297	"Teashirt zinc finger homeobox 3"	Q63HK5	19	31149979-31349436	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 32.8"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 54.0;Excitatory neurons: 34.4;Inhibitory neurons: 84.7;Oligodendrocyte precursor cells: 59.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 1.9"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 22.2;RH-30: 46.4;U-138 MG: 32.8;U-87 MG: 21.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008834, HPA071010"	Approved		Enhanced	"Nucleoplasm,Plasma membrane"		No	No			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	"Plasma membrane"	"HPA008834: AB_1080731, HPA071010: "	"unprognostic (2.56e-1)"	"unprognostic (3.88e-1)"	"unprognostic (4.56e-2)"	"unprognostic (3.66e-1)"	"unprognostic (1.66e-3)"	"unprognostic (4.07e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.58e-3)"	"unprognostic (2.23e-1)"	"unprognostic (3.91e-2)"	"prognostic unfavorable (2.92e-4)"	"unprognostic (8.76e-3)"	"unprognostic (8.22e-2)"	"unprognostic (1.91e-2)"	"unprognostic (1.73e-3)"	7.0	3.6	4.6	4.8	4.5	1.1	6.2	0.0	8.6	18.8	0.3	16.1	2.2	21.5	9.2	5.7	13.0	9.3	5.7	5.7	0.4	3.2	1.3	6.3	1.2	3.1	1.0	32.8	1.5	1.3	4.6	5.7	1.5	11.6	4.0	1.8	3.3	9.5	1.9	3.0	5.5	18.4	3.9	5.4	6.7	2.7	3.1	0.8	10.2	2.3	0.5	14.8	8.8	4.9	0.0	2.0	0.7	0.0	9.4	22.2	0.0	6.0	8.8	3.7	6.6	0.0	1.2	0.0	0.0	14.8	7.0	1.0	2.7	5.3	8.2	0.0	2.2	0.0	0.0	0.0	19.4	5.2	9.1	13.0	4.5	13.7	6.8	0.0	0.0	4.4	0.0	0.0	16.9	0.9	0.0	0.0	0.7	0.0	0.0	5.9	46.4	0.0	0.0	0.0	0.0	13.8	0.1	0.0	4.7	4.4	0.0	3.6	0.0	32.8	10.3	3.4	8.8	0.0	0.0	0.0	21.2	8.8	0.9	0.0	0.9	0.0	1.1	0.3	0.0	0.0	0.3	0.4	0.0	0.0	0.1	0.3	1.9	0.0	0.1	0.0	0.3	0.3	4.6	4.5	0.0	8.6	5.7	0.4	3.1	1.0	1.5	3.9	3.1	4.9	8.3	3.2	1.1	10.1	0.2	4.8	7.3	9.2	15.4	14.0	0.8	2.4	2.1	1.5	5.1	3.7	0.0	0.4	2.5	0.0	0.0	0.4	0.2	1.3	54.0	9.0	0.0	0.4	34.4	0.6	0.3	20.2	0.0	1.3	1.3	2.6	17.2	0.2	11.6	16.8	84.7	0.0	2.0	9.7	10.4	1.1	17.7	5.0	5.4	14.0	6.4	0.2	0.0	59.3	1.9	0.6	0.0	29.3	0.3	3.8	0.0	0.1	1.3	0.2	0.0	29.7	7.8	0.3	4.0	1.7	1.7	0.8	1.7	1.0	0.0	3.2
VIM		ENSG00000026025	Vimentin	P08670	10	17228241-17237593	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"		"Cataract, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Granulosa cells: 4879.0;Langerhans cells: 4893.1;Leydig cells: 5013.2;Muller glia cells: 8977.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 18287.8;fHDF/TERT166: 10084.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000080, HPA001762, CAB058687"	Enhanced		Supported	"Intermediate filaments"		NA	NA		35000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 41: Macrophages - Immune response"	"Intermediate filaments"		"CAB000080: AB_2304493, CAB058687: AB_2665570, HPA001762: AB_1080568"	"unprognostic (1.02e-1)"	"unprognostic (2.58e-1)"	"unprognostic (2.87e-2)"	"prognostic favorable (9.75e-6)"	"unprognostic (3.81e-2)"	"unprognostic (2.52e-1)"	"unprognostic (3.21e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.05e-1)"	"unprognostic (9.29e-2)"	"unprognostic (5.61e-2)"	"prognostic unfavorable (8.69e-8)"	"unprognostic (1.87e-3)"	"unprognostic (7.32e-2)"	"unprognostic (1.82e-1)"	"unprognostic (9.47e-3)"	3467.6	423.1	349.3	610.6	369.5	1455.5	2362.8	289.1	527.4	1816.3	568.1	923.2	218.4	1226.5	400.0	451.5	1458.7	960.2	1364.3	337.5	404.6	473.6	192.8	1133.2	806.2	667.4	328.2	3690.8	370.0	224.8	574.5	1030.0	443.7	570.0	400.8	731.0	628.5	551.8	363.7	1126.8	674.7	1109.3	414.6	819.9	522.8	251.7	472.7	412.2	1391.1	555.8	744.7	983.5	1366.6	425.5	21.2	1119.0	1981.0	3180.7	6407.4	18287.8	3.0	5238.5	3458.9	3859.2	3421.5	8.5	70.4	2.9	273.2	10084.4	1804.7	8.4	283.8	147.0	3734.1	3567.5	387.2	563.2	523.5	0.3	1967.3	301.1	222.8	6746.8	6.5	5712.0	3213.4	9020.8	6366.3	372.4	889.3	1575.4	6939.5	4.5	736.6	911.2	632.4	1.4	1394.0	564.8	2745.9	95.7	3925.3	0.8	8.1	946.6	1.4	6.9	5447.5	1133.1	8.6	341.8	5459.0	3819.8	1644.5	3244.7	6311.5	1754.4	953.7	130.4	5775.4	28.9	3726.3	667.8	751.8	215.2	219.5	469.3	278.7	176.3	357.0	285.0	866.0	117.5	217.1	217.2	409.3	99.2	471.2	342.3	481.5	615.4	349.3	369.5	289.1	527.4	337.5	404.6	667.4	328.2	443.7	414.6	472.7	425.5	3211.7	157.0	349.4	53.5	605.8	725.8	21.6	361.2	58.1	74.2	108.8	539.1	109.5	94.4	157.3	108.5	50.1	22.1	1110.1	9.1	5.9	198.8	58.1	922.9	2314.1	2923.2	309.1	236.5	0.4	569.0	45.8	3443.0	101.4	693.7	2776.4	4879.0	2195.6	19.2	3541.4	33.7	0.3	1.8	16.2	2841.2	4893.1	131.6	5013.2	3177.8	3082.5	85.3	3893.1	8977.0	259.5	1.0	0.4	525.9	1.5	2336.6	2097.2	79.5	3.1	181.6	90.7	284.1	1420.0	3171.9	3714.2	55.1	27.5	39.4	473.0	52.7	1566.3	1791.1	6.2	28.9
ZNF365	"KIAA0844, UAN"	ENSG00000138311	"Zinc finger protein 365"	Q70YC5	10	62374192-62480288	"Predicted intracellular proteins"	Neurogenesis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 22.7;esophagus: 10.2"	"Group enriched"	"Detected in some"	6	"Excitatory neurons: 112.7;Oligodendrocyte precursor cells: 113.6;Oligodendrocytes: 195.5"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"cerebral cortex: 22.7;hippocampal formation: 8.3;thalamus: 8.0;white matter: 16.6"	"Group enriched"	"Detected in many"	9	"gdT-cell: 2.4;memory CD4 T-cell: 2.1;memory CD8 T-cell: 2.7;naive CD8 T-cell: 2.7;NK-cell: 6.4;T-reg: 5.9"	"Group enriched"	"Detected in many"	62	"NK-cells: 6.4;T-cells: 5.9"	"Cell line enhanced"	"Detected in many"		"HaCaT: 22.3;PC-3: 13.9;U-251 MG: 18.6;U-87 MG: 12.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052446	Supported		Approved	Vesicles,Centrosome		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Vesicles, Centrosome"		"HPA052446: AB_2681836"	"unprognostic (7.46e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.26e-3)"	"unprognostic (1.21e-1)"	"unprognostic (4.05e-3)"	"unprognostic (1.73e-1)"	"unprognostic (7.67e-2)"	"unprognostic (2.15e-2)"	"unprognostic (3.11e-3)"	"unprognostic (3.06e-2)"	"unprognostic (7.90e-2)"	"unprognostic (1.12e-6)"	"unprognostic (2.49e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.20e-4)"	"unprognostic (2.89e-2)"	0.1	1.3	1.0	0.1	2.8	0.0	0.3	1.5	22.7	0.9	0.0	0.0	0.1	0.1	0.2	10.2	0.1	0.3	1.0	8.3	0.0	0.1	0.0	0.7	0.0	0.0	3.2	0.0	0.4	5.6	1.6	0.1	0.0	1.8	0.1	5.1	1.1	2.0	0.0	0.8	0.1	0.1	0.0	0.3	0.0	0.5	8.0	0.5	0.6	0.1	1.4	0.8	1.1	16.6	6.3	0.6	0.1	0.0	0.1	0.0	0.0	5.5	5.8	2.6	2.1	0.0	1.0	0.0	0.2	3.1	8.4	22.3	0.0	0.4	3.5	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.2	7.2	0.9	6.6	0.9	0.0	0.0	0.0	5.5	2.1	0.7	0.0	0.9	0.0	13.9	0.0	0.2	0.0	0.3	2.8	0.1	1.2	1.1	0.2	0.6	0.0	0.0	0.0	0.0	1.1	6.1	0.0	18.6	0.0	0.0	0.0	12.9	0.0	1.8	0.0	0.0	0.0	2.4	0.0	0.0	0.0	2.1	2.7	0.0	0.0	0.4	2.7	0.0	6.4	0.0	0.0	5.9	0.8	1.0	2.8	1.5	22.7	8.3	0.0	0.0	3.2	0.0	0.0	8.0	16.6	0.0	0.0	0.0	15.3	0.2	0.5	3.7	0.6	0.0	13.5	0.3	0.3	2.6	1.5	0.1	3.7	2.1	0.0	2.8	0.0	0.0	0.2	0.5	0.3	0.2	0.2	0.0	0.0	112.7	0.0	0.0	0.9	0.0	0.6	0.0	0.1	0.0	0.0	0.1	18.5	23.4	0.0	0.0	0.3	1.1	0.3	0.0	0.4	0.0	6.5	0.0	2.7	0.0	113.6	195.5	0.9	0.0	0.0	1.9	1.2	0.0	0.7	0.1	5.3	0.0	0.8	0.8	0.1	0.7	0.0	0.4	0.0	3.9	0.2	0.0	6.0